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Abstract 
Alcohol is among the leading contributors to the global burden of morbidity and 
mortality. Alcohol Use Disorders (AUD) account for the majority of this burden. Numerous 
interventions have demonstrated effectiveness in the treatment of AUD, but treatment 
response is modest and relapse rates remain high. No one treatment approach has 
demonstrated unequivocal superiority, prompting calls for individualised intervention 
strategies. Insufficient understanding of the mechanisms involved in AUD maintenance and 
treatment response impair the design and implementation of such approaches. The aim of this 
thesis was to progress understanding of potential treatment targets within personalised 
treatments for AUD. Alcohol craving, alcohol outcome expectancies, and rash impulsivity 
comprise the focus of this thesis, as each has been implicated in AUD maintenance and 
treatment response. A series of studies examining clinical applications of alcohol craving, 
outcome expectancies, and rash impulsivity within personalised AUD interventions were 
conducted.  
Study 1 (Chapter Two) examined the clinical utility of alcohol craving, focusing on 
issues of measurement. Highlighting the absence of a theoretically and psychometrically 
robust measure of craving which is also brief enough to be routinely administered within 
busy clinical settings, the study aimed to develop a new measure. Using data from 747 
treatment seeking AUD patients the 22-item Alcohol Craving Experience Questionnaire 
(ACE) was reduced to 5-items while preserving its key theoretical elements, psychometric 
integrity, and clinical implications. The shortened ‘Mini ACE’ (MACE) is ideal for use with 
AUD populations in time-limited settings, such as weekly assessment in treatment contexts. 
An extended review of common issues in craving measurement is provided in the following 
chapter (Chapter Three). The chapter is intended to assist researchers and treatment providers 
in the selection, effective application, interpretation of the scales comprising the Alcohol 
Craving Experience Questionnaire. 
Study 2 (Chapter Four) highlights an absence of research on targeting alcohol outcome 
expectancies within Cognitive Behavioural Therapy (CBT) for AUD. Alcohol expectancies 
of 175 patients who completed a 12-week CBT program for AUD were assessed pre-and 
post-treatment. Several positive expectancies were predictive of drinking behaviour during 
treatment, and most reduced toward community norms post-treatment. However, positive 
expectancy change was not related to drinking behaviour during treatment, challenging 
cognitive theory emphasising the importance of this process. Increase in negative 
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expectations of alcohols effect on mood was associated with fewer drinking days, supporting 
emphasis on modification of negative alcohol expectations within treatment. Further 
implications of both positive and negative alcohol outcome expectancies regarding AUD 
treatment are discussed. 
Study 3 (Chapter Five) is a large clinical randomised controlled trial (RCT; n = 379) 
examining the effectiveness of personalising AUD treatment based on individual differences 
in a) alcohol craving, b) alcohol outcome expectancies, and c) rash impulsivity. Patients were 
randomly assigned to Treatment as Usual (TAU, 8 sessions of standard CBT for AUD) or 
Targeted Treatment (TT). TT manualised content for 4 of 8-sessions sessions to address the 
risk-factor most elevated for each patient based on measures standardised by AUD norms 
(either Craving, Expectancy or Impulsivity). No significant differences in treatment outcome 
were observed between overall TT and standard, CBT (TAU) conditions. Craving and 
impulsivity, though not positive outcome expectancies, were found to reduce more for 
patients within their respective target modules. Only reduction in craving was associated with 
reduced drinking, supporting an indirect effect for personalised interventions targeting 
craving. The effectiveness of targeting rash impulsivity and outcome expectancies within 
personalised AUD could not be confirmed. Alcohol craving stands out as useful construct for 
consideration within future research of personalised interventions. 
 Study 4 (Chapter Six) examined the association between alcohol craving and rash 
impulsivity in the prediction of treatment response. Craving and rash impulsivity were 
positively associated among 470 AUD patients. Both were found to predict lapse-risk during 
treatment, though impulsivity was mediated by craving. Patients with higher craving pre-
treatment, were found to have more persistent craving as treatment progressed, which 
increased risk of lapse. These findings have clinical implications for the assessment and 
treatment of AUD, as well as theoretical implications for cognitive models of craving and 
impulsivity. The mediating role of craving is further considered in the context of the RCT 
findings (Chapter Three, Study 4). 
These four studies progress understanding of key mechanisms implicated within AUD 
maintenance and treatment response. Support was found for the utility of alcohol craving, 
outcome expectancies, and rash impulsivity as prognostic markers for AUD treatment. The 
novel contributions of this thesis pertain to understanding their utility as treatment targets. 
The processes which determine treatment response are complex, requiring equally 
sophisticated procedures to effectively adapt treatment to individuals. The findings of this 
program of research can inform the progression of such approaches. 
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1.1 Alcohol Use Disorder 
Alcohol consumption is among the leading contributors to the global burdens of 
morbidity and mortality (World Health Organization, 2014). The majority of this burden is 
attributable to Alcohol Use Disorders (AUDs; Rehm et al., 2014, 2015; World Health 
Organization, 2014). Advances in the treatment of AUDs have been modest, despite 
extensive research conducted internationally. A number of interventions have demonstrated 
effectiveness in the treatment of AUD (Institute of Medicine, 1990; Marel et al., 2016; Miller 
& Wilbourne, 2002), though relapse rates are high (Assanangkornchai & Srisurapanont, 
2007; Connor, Haber, & Hall, 2016). Comprehensive reviews of AUD treatment and 
rehabilitative services have concluded that no single treatment is effective for all persons and 
that individual differences are likely to dictate differential treatment response (Institute of 
Medicine, 1990; Mann & Hermann, 2010; Miller & Wilbourne, 2002). This introductory 
chapter aims to: 
i. Review the social and economic impact of AUDs; 
ii. Explain diagnostic criterion for AUD; 
iii. Summarise progression of AUD treatment and evidence; 
iv. Review efforts at personalised AUD treatment; 
v. Identify avenue for the progression of personalised AUD treatment, and; 
vi. Present a rationale for the research questions examined in the thesis. 
1.1.1 Diagnosis and Features 
AUDs have been diagnostically conceptualised in several ways. The International 
Classification of Diseases, Version 10, differentiates between “harmful use” and 
“dependence” (World Health Organization, 1992). The American Psychiatric Association 
previously distinguished “alcohol abuse” and “alcohol dependence” (American Psychiatric 
Association, 2000). The most recent edition of the Diagnostic and Statistical Manual of 
Mental Disorders (5th edition) includes only one category, “Alcohol Use Disorder” which lies 
on a continuum of three points of severity: mild, moderate, and severe (American Psychiatric 
Association, 2013). Diagnosis of AUD is ascertained by a problematic pattern of alcohol use 
leading to clinically significant impairment or distress, as manifested by at least two of 11 
symptoms which occur within a 12-month period (American Psychiatric Association, 2013). 
The symptoms encompass: perceived lack of control of alcohol use; desire to reduce or 
control use; high temporal cost of use; craving; impaired social or occupational functioning; 
use in hazardous situations; use despite physical or psychological illness caused or 
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exacerbated by alcohol; alcohol tolerance; and alcohol withdrawal. The presence of 2-3 
symptoms indicates ‘mild’ severity, 4-5 symptoms indicate ‘moderate’ severity, and six or 
more symptoms are classified as ‘severe’ AUD.  
1.1.2 Prevalence and socioeconomic burden 
Approximately six percent of all deaths and five percent of the global burden of 
disease and injury is attributable to alcohol (World Health Organization, 2014). One year 
prevalence of AUDs is estimated at 11.1% in the United Kingdom (UK), 7.4% in the United 
States (U.S.), and 3.5% in Australia (World Health Organization, 2014). Alcohol has been 
causally implicated to more than 60 diseases, with the majority of health associated burden 
arising through injury, liver disease, cardiovascular diseases, cancers, and gastrointestinal 
disease (Connor, Haber, & Hall, 2016; Rehm, Gmel, Sempos, & Trevisan, 2002). Within 
mental-health settings, 25% of patients have a comorbid AUD (Zimmermann, Lubman, & 
Cox, 2012), reflecting their contribution to the development and exacerbation of other mental 
disorders (Hasin, Stinson, Ogburn, & Grant, 2007; Rehm, 2011). Detrimental effects of 
alcohol misuse extend beyond the individual to their family and communities. Affected social 
domains include health, occupational, and criminal justice systems. The costs associated with 
alcohol misuse are estimated to be more than one percent of the gross domestic products of 
high and middle-income countries (Rehm et al., 2009). The estimated cost of alcohol misuse 
in Australia was 15 billion dollars per annum in 2004-2005 (Collins & Lapsley, 2008). The 
economic benefit of evidence-based AUD treatment has been estimated at a net savings of 
five to seven times the cost spent by the public sector (Ettner et al., 2006; UKATT Research 
Team, 2005a). Social benefits have also been estimated to offset the costs of treatment, with 
savings occurring through reductions in crime and gains in employment (McCollister & 
French, 2003).  
1.2 AUD Treatment 
 AUD treatments typically include two stages: detoxification and relapse prevention. 
Inpatient detoxification is the recommended first step for highly dependent, heavy drinking 
patients, for whom it is unsafe to attempt to detoxify or dramatically reduce alcohol 
consumption on their own. Severe alcohol withdrawal symptoms may include generalised 
tonic-clonic seizures, visual, hallucinations or illusions, and delirium (American Psychiatric 
Association, 2013). While in detoxification, withdrawal symptoms are typically managed by 
benzodiazepines administered in high doses and tapered over 5-7 days (Perry, 2014). 
4 
 
Chapter One  Introduction and Overview 
 
Following detoxification, the primary treatment options include outpatient psychosocial 
interventions and pharmacotherapy (P. Haber, Lintzeris, Proude, & Lopatko, 2009).  
Psychosocial interventions typically aim to enhance patients’ skills and self-efficacy 
to avoid drinking, manage craving, challenge patients beliefs and attitudes to drinking, and 
build motivation for abstinence (Martin & Rehm, 2012; Sannibale & Lintzeris, 2009). A 
number of evidence-based psychosocial interventions for AUD are available, with no single 
intervention demonstrating superior effectiveness (Raistrick, Heather, & Godfrey, 2006). 
Typical effect sizes for psychosocial interventions fall within the low to moderate range 
(Martin & Rehm, 2012). There is also evidence for the use of some medications in the 
treatment of AUD (Jonas et al., 2014; Mason & Lehert, 2012; Roesner et al., 2010). Within 
Australia, there are three medications licensed for treatment of AUD: naltrexone, 
acamprosate, and disulfiram (marketed as ReVia®, Campral® and Antabuse®). Naltrexone 
and acamprosate have both demonstrated moderate effect sizes in the treatment of AUDs 
(Jonas et al., 2014). It is recommended that pharmacotherapy is used in conjunction with 
psychosocial interventions (Morley, Haber, & Lintzeris, 2009). Prescription of naltrexone and 
acamprosate under the Australian Pharmaceutical Benefits Scheme requires concurrent 
enrolment in a comprehensive abstinence-oriented treatment program. Patients who do not 
respond to these interventions may consider residential rehabilitation (Connor et al., 2016). 
However, financial constraints and limited availability of residential facilities are often 
barriers. The majority of research is dedicated to improving the efficacy of more cost-
effective and less resource intensive outpatient psychosocial interventions and 
pharmacotherapies.  
1.2.1 Psychosocial Interventions 
The majority of psychological treatments for AUD are regarded as psychosocial 
interventions (Martin & Rehm, 2012). Psychosocial interventions consider problematic 
alcohol use to be inherently learned within a social environment, proposing they can be 
modified and replaced by more adaptive behaviours (Bandura, 1986, 1999; Sannibale & 
Lintzeris, 2009). Psychosocial treatment researchers recognise the role of biological and 
genetic factors in AUDs and encourage the integration of adjunctive treatment content and 
processes (Sannibale & Lintzeris, 2009). A variety of psychosocial interventions have been 
developed and subjected to extensive evaluation. A summary of some of the most common 
treatments studied in research and employed in practice is provided in Table 1-1. 
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Table 1-1. Descriptions and level of evidence for common psychosocial interventions for AUD*  
  Description Level of Evidence 
Cognitive behaviour 
therapy 
This approach addresses cognitive, affective, and interpersonal triggers for alcohol use. It enhances drinking 
refusal self-efficacy skills; identifies and modifies alcohol expectancies; improves problem-solving skills; and 
develops more effective coping strategies, including relaxation approaches. 
High 
Motivational 
enhancement therapy 
This therapy is a patient-centred approach that enhances motivation to change behaviour. It uses a collaborative 
therapeutic approach to assist patients to recognise and resolve ambivalence, and develop their own reasons to 
reduce or abstain from drinking. Key strategies include collaborative identification of the gap between the 
patient’s present and desired health (ie, goal–status discrepancy), recognition of their resistance to change, 
avoidance of confrontational communication, and guided assessment of the pros and cons for change. 
High 
Behavioural therapies 
based on conditioning 
Cue exposure: repeated exposure to conditioned cues (eg, image or smell of alcohol, or associated emotion) can 
induce habituation or craving. Exposure to cues during treatment in the absence of drinking (with or without 
coping skill practice) is thought to reduce habituation. It is often combined with other cognitive therapy or 
skills. 
 
Contingency management: this approach introduces a tangible reinforcer, such as money or vouchers, to 
increase session attendance or abstinence. It is more suitable for inpatient and residential settings, and needs 
more translatable evidence. 
Low, Moderate 
12-step facilitation This approach offers continuous mutual peer support, usually in the form of self-help groups run by Alcoholics 
Anonymous. Participation is free of charge. Participants need to “surrender to a higher power” to facilitate 
change. Some groups use a buddy system (a sponsor) to provide support between group meetings. 
Mixed 
*Table from Connor, Haber, & Hall, (2016).  
. 
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1.2.1.1 Cognitive-behavioural therapies.  
Psychosocial interventions with the greatest empirical support typically adhere to 
cognitive and behavioural strategies (Connor et al., 2016; Raistrick et al., 2006). The 
mechanisms of action of common cognitive-behavioural techniques are depicted by Larimer 
et al.’s (1999) figure of covert antecedents and immediate determinants of relapse (Figure 
1-1) based on Marlatt and Gordon’s (1985) theory of relapse prevention. The model shows 
that a patient’s coping response to high-risk situations is central to sustained abstinence. 
Effective coping enhances patient’s confidence in coping with the situation (increase self-
efficacy) and reduces the likelihood of relapse. Conversely, ineffective coping responses 
undermine self-efficacy, leading patient’s positive expectations of alcohol use to precipitate 
alcohol lapse. The initial lapse can induce feelings of guilt and failure, which in combination 
with positive alcohol outcome expectancies, can increase the probability of relapse (Marlatt 
& Gordon, 1985). CBT interventions are designed to circumvent or interrupt the relapse 
process at various points. Given the wide variety of available evidence-based interventions, 
considerable effort has been made to identify which is most effective in the treatment of 
AUD. Such efforts include systematic reviews, government commissioned reviews, meta-
analyses, and large scale multisite studies.  
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Figure 1-1. Covert antecedents and immediate determinants of relapse and intervention strategies for identifying and preventing or avoiding those 
determinants. Figure from Larimer et al. (1999).
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1.2.1.2 Mesa-Grande Project 
Miller and colleagues periodically undertook systematic reviews of clinical trials 
examining the outcome of treatments for alcohol problems (Miller, Andrews, Wilbourne, & 
Bennett, 1998; Miller, Wilbourne, & Hettema, 2003; Miller & Wilbourne, 2002). Evidence 
was weighted differentially according to the methodological strength of the study, and 
compiled in a large table (termed Mesa Grande). Cumulative evidence scores (CES) were 
generated for 48 treatment modalities from 381 clinical trials. The strongest support was 
generated for (in rank order): brief interventions, motivation enhancement therapy (MET), 
social skills training (SST), the community reinforcement approach (CRA), and behaviour 
contracting. When studies examining clinical populations were examined independently, 
brief intervention, SST, CRA, behaviour contracting, and CBMT showed the most evidence 
(Miller et al., 2003). Results are summarised in Table 1-2.  
Table 1-2. Mesa Grande Summary scores for psychotherapeutic treatment modalities 
with three or more studies*  
Treatment modality All studies Clinical Population 
 
Rank % positive N Rank 
Brief intervention 1 68 31 1 
Motivational enhancement 2 71 17 8 
Social skills training 3 68 25 2 
Community reinforcement 4 100 4 3 
Behavior contracting 5 80 5 4 
Behavioral marital therapy 6 62 8 5.5 
Case management 7 67 6 5.5 
Self-monitoring 8 50 6 15 
Cognitive therapy 9 40 10 7 
Client-centered counselling 10 57 7 10 
*Table from R.K. Hester and W.R. Miller: handbook of alcoholism treatment approaches 3rd 
edition (2003) modified by (Mann & Hermann, 2010).  
 
The Mesa Grande methodology is criticised for failing to consider differences in 
statistical power across studies, multiple statistical tests for treatment effects, inconsistent 
comparison groups across studies, and variations in patient characteristics across studies 
(Finney, 2000). Finney (2000) sought to evaluate these potential biases by contrasting Mesa 
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Grande findings to three alternative reviews of similar methodology. The first adjusted for 
study power (Finney & Monahan, 1996), the second for client characteristics (Miller, Brown, 
et al., 1995), and the third made no adjustments (Holder, Longabaugh, Miller, & Rubonis, 
1991). Of 19 treatment modalities assessed, seven varied by more than six rank positions 
across the three methods. Two treatment modalities, the community reinforcement approach 
and social skills training, maintained consistently high rankings across methodologies. Finney 
(2000) suggested that the high rankings of these cognitive-behavioural approaches provide 
strong evidence for the effectiveness of interventions which focus on improving patients’ 
ability to cope with everyday life circumstances (including those involving relapse risk), and 
developing skills tailored to individual environmental demands. Contemporary CBT 
interventions comprise a combination of these strategies (Beck, Wright, Newman, & Liese, 
1993; Kadden et al., 2003). The modalities that had least support across studies included 
methods designed to educate, confront, surprise or develop insight into the origin of alcohol 
misuse (Miller & Wilbourne, 2002).  
1.2.1.3 Meta-analyses 
The Mesa Grande Project is valuable for ascertaining the relative degree of research 
support for an intervention. However, due to its reliance upon statistical significance it does 
not offer insight into differential effectiveness of interventions. The primary alternative to 
this methodology is quantitative meta-analysis which utilises effect size calculations to 
determine superiority of the effectiveness of treatment modalities. Several meta-analyses 
support and extend upon the findings of the Mesa Grande Project. One meta-analysis 
including 72 trials across substance types found MET to be effective when administered in 
isolation and was also shown to improve outcomes when added to alternative interventions 
(Hettema, Steele, & Miller, 2005). The mean effect size (Cohen d) was 0.77 post-treatment 
and 0.30 at one year follow up. A meta-analysis of 53 cognitive behavioural interventions, 
including studies identified as relapse-prevention or coping skills training, found small but 
significant pooled effects post-treatment (g = 0.154) which remained significant at 6-9 (g = 
0.115) at 12-month follow-up (g = 0.096) (Magill & Ray, 2009). Twelve RCTs examined in a 
meta-analysis found behavioural couples therapy to be superior to individual interventions (d 
= 0.54) (Powers, Vedel, & Emmelkamp, 2008).  
1.2.1.4 Government Commissioned Reviews 
Multiple reviews into AUD treatment have been commissioned by governments 
internationally (Berglund, Thelander, & Jonsson, 2003; Institute of Medicine, 1990; Shand, 
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Gates, Fawcett, & Mattick, 2003; Slattery et al., 2002), with the aim of assessing the cost-
effectiveness of AUD treatment, maximising the efficiency of allocated healthcare resources, 
and informing clinicians, health administrators and policymakers of best practice. 
Reviews by Scotland (Slattery et al., 2002), Sweden (Berglund et al., 2003), the U.S. 
(Institute of Medicine, 1990), and Australia (Mattick & Jarvis, 1993; Shand et al., 2003), 
have all supported the effectiveness of motivational and cognitive-behavioural interventions. 
No review has suggested superiority of a single intervention approach. Well defined, 
structured psychosocial interventions, such as cognitive-behavioural methods and 12-step 
approaches, were most likely to result in improved treatment outcomes. Less structured 
approaches, such as general counselling, had less evidence. 
The research discussed has evaluated evidence from a variety of review designs (e.g. 
meta-analysis, box score approaches, and systematic reviews). These methods reduce 
likelihood of incorrectly supporting the effectiveness of a treatment (false positive) and 
missing the presence of genuine effects (false negative) by increasing sample size, 
maximising power, and requiring replication. However, on a large enough scale 
methodologically robust trials may offer greater validity, due to enhanced control and 
consistency over patient characteristics, treatment protocols, and research methodology.   
1.2.1.5 Project MATCH 
The Project Matching Alcoholism Treatments to Client Heterogeneity (MATCH) was a 
large scale multisite trial funded by the National Institute on Alcohol Abuse and Alcoholism 
(NIAAA) and conducted within the U.S. The aim of project match was to assess whether a 
priori hypothesised interactions between patient characteristics and treatment types were 
supported by improved outcomes (See section 1.3 Patient-Treatment Matching for a review). 
Though not the primary intention, the main effects of the treatment conditions offer unique 
insight into the differential effectiveness of three prominent treatment modalities.  
Seventeen-thousand and twenty-six patients were recruited across nine treatment sites 
(Project MATCH Research Group, 1997). Patients were randomly assigned to one of three 
treatment conditions: 12-step facilitation (TSF), CBT, and MET. Treatments were 
manualised and delivered by trained therapists and delivered in person on a one-one basis. 
Sessions were video recorded to evaluate treatment. CBT and TSF included 12 weekly 
sessions. MET comprised four sessions spread over 12 weeks. Patient assessments were 
comprehensive, comprising eight hours over three sessions. Follow up assessment were 
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conducted post-treatment and at three-month intervals for 12 months following treatment 
completion.  
Overall, no clinically meaningful differences in the drinking outcomes of patients were 
identified across conditions at the end of treatment or at three year follow up (Project 
MATCH Research Group, 1997, 1998a). These findings hold important implications for 
treatment selection and implementation. First, this was the first evidence for the equivalence 
of TSF to other evidence based treatments for treatment for alcohol problems. However, the 
TSF condition was substantively different to traditional 12-step programs (eg. Alcoholics 
Anonymous). For instance TSF was conducted individually and did not include a sponsor. 
The second important implication is that the briefer, MET condition was not significantly 
different to TSF or CBT. This effect occurred regardless of pre-treatment dependence 
severity. As MET was approximately one third of the length and financial cost of the other 
conditions, it is is recommended for first-line intervention in stepped-care procedures, and an 
excellent active control condition for clinical RCTs. 
1.2.1.6 The UK Alcohol Treatment Trial 
Acknowledging the implication from project MATCH, that MET could replace CBT to 
reduced burden of cost and administration, the UK Medical Research Council (MRC) sought 
to validate these findings in Britain (UKATT Research Team, 2001). To achieve this, three 
necessary steps were outlined:  
1. A multicentre trial of treatment for alcohol problems in the UK to determine replicability 
of the findings of the treatment main-effects of project MATCH. 
2. Compare MET to a more intensive treatment approach hypothesised to be superior to 
MET as indicated by theory and research.  
3. To identify patient characteristics which may inform differential treatment response to 
MET relative to more intensive forms of treatment (UKATT Research Team, 2001). 
In 1998 the MRC funded a multicentre, randomised controlled trial of treatment for alcohol 
problems, the United Kingdom Alcohol Treatment Trial (UKATT). The second step was to 
identify an intensive treatment approach predicted to be more effective than MET which was 
not utilised in project MATCH. The UKATT research Team identified that patients with 
clinically significant alcohol problems consistently responded best to interventions with 
social or interpersonal elements (UKATT Research Team, 2001). The new treatment 
modality, Social Behaviour and Network Therapy (SBNT) was developed for the UKATT by 
integrating a variety of cognitive and behavioural strategies intended to assist patients in 
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building positive social support for a change in drinking behaviour (Copello, Orford, 
Hodgson, Tober, & Barrett, 2002). These strategies were drawn from alternative 
interventions with strong research support. Within the UKATT, both SBNT and MET were 
conducted over eight weeks, with SBNT comprising eight weekly 50-minute sessions and 
MET three 50-minute sessions. Grounded in a strong theoretical foundation with extensive 
research support for its comprising strategies, SBNT provided an alternative intensive 
treatment to which MET may be compared. The UKATT subsequently sought to test two 
primary hypotheses: 
1. The less intensive, motivationally based treatment (MET) will be as effective as more 
intensive, socially based treatment (SBNT) 
2. The more intensive, socially based treatment (SBNT) will be as cost-effective as less 
intensive, motivationally based treatment (MET). 
Seven-hundred and forty-two patients with alcohol problems were recruited by seven 
treatment sites in Britain; 689 (93.0%) were followed up at three months and 617 (83.2%) at 
12 months. Both SBNT and MET treatment groups were observed to have lower alcohol 
consumption, dependence, and alcohol-related problems, as well as improved mental health-
related quality of life at 12 month follow up. No significant differences in alcohol-related 
outcomes were observed between the two groups. Savings in expenditure on health, social, 
and criminal justice services were estimated to be five times the cost of each treatment 
(UKATT Research Team, 2005a). No significant differences were observed in the cost 
effectiveness of MET versus SBNT.  
1.2.1.7 Summary of evidence 
Major statistical summaries of research, government commissioned systematic reviews, 
and large-scale national multicentre research trials have failed to identify a single ‘best’ 
psychosocial treatment for AUD, despite managing to identify several with inadequate 
evidence of efficacy. This is not to say all treatments are equal, just that there are many 
evidence-based methods for treatment of AUD. The state of evidence lends itself to 
maximising efficiency of health care delivery by sequentially electing the least resource 
intensive treatments in a stepped-care approach (P. S. Haber & Lintzeris, 2009). Current 
treatment approaches have aligned with this evidence, with motivation oriented interventions 
the most widely implemented front-line treatments (Connor et al., 2016). Motivational 
approaches have the added benefit of guiding patients into more intensive interventions if 
required. As the majority of strategies with the highest levels of evidence are of cognitive-
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behavioural orientation (Miller & Wilbourne, 2002), CBT for AUD has the advantage of 
combining these strategies into comprehensive treatment frameworks well suited to 
outpatient AUD interventions. In severe cases where patients are unresponsive to outpatient 
interventions, structured residential treatment and rehabilitation programmes are 
recommended (Connor et al., 2016).  
1.2.2 Treatment Effectiveness 
Among the challenges for research examining the effectiveness of treatment approaches 
is the quantification of the outcome. Consideration of a wide range of outcomes is 
recommended (e.g. craving and quality of life, see Tiffany, Friedman, Greenfield, Hasin, & 
Jackson, 2011), though change in drinking behaviour is the primary focus. There is, however, 
debate about what constitutes meaningful change in drinking behaviour, which complicated 
further by differences in intervention goals (Mann, Aubin, & Witkiewitz, 2017).  
1.2.2.1  Outcomes: Abstinence versus Controlled Drinking  
Research has been unable to demonstrate differential effectiveness of ‘abstinence-
oriented’ versus ‘controlled drinking’ goals in psychotherapy research. A direct comparison 
of ‘abstinence-oriented’ and ‘controlled drinking’ treatments among 70 problem drinkers 
found no significant difference in alcohol consumption at one and two-year follow-up 
(Sanchez-Craig, Annis, Bornet, & MacDonald, 1984; M. B. Sobell & Sobell, 1973). A meta-
analysis of 17 behavioural self-control training paradigms also found no significant 
difference in alcohol consumption between abstinence-oriented and controlled drinking 
interventions (Walters, 2000). The appropriate goal may be determined by alcohol 
dependence severity, with a consensus forming that abstinence is the optimum outcome for 
severe AUD, while those with lower severity AUD may benefit from moderation (Connor et 
al., 2016; Rosenberg, 1993; M. B. Sobell & Sobell, 1995). In addition to AUD severity, 
patient beliefs about the importance of abstinence as a treatment goal are a necessary 
consideration in assessing treatment outcome from each goal (Adamson, Heather, Morton, & 
Raistrick, 2010; Rosenberg, 1993). Within the UKATT, all 742 patients were asked whether 
they were aiming for abstinence, ‘probably yes’ or ‘probably no’ (UKATT Research Team, 
2001). Patients aiming for abstinence demonstrated better outcomes than those aiming for 
moderation at both three and 12-month follow-up (Heather, Adamson, Raistrick, & Slegg, 
2010). However, when the ‘type of successful outcome’ was considered, patients aiming for 
abstinence were more likely to achieve abstinence, while patients preferring moderation were 
more likely to achieve non-problem drinking (Heather et al., 2010). These findings were 
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replicated by a re-analysis of the “Combined Pharmacotherapies and Behavioral 
Interventions” (COMBINE) study (Raymond F. Anton et al., 2006), finding patients who 
selected abstinence as a goal were more likely to be abstinent at follow up (Bujarski, 
O’Malley, Lunny, & Ray, 2013). Abstinence remains the recommended goal for patients 
seeking treatment for severe AUD (Connor et al., 2016; European Medicines Agency, 2010; 
Mann, Aubin, et al., 2017). However, intermediary reduced drinking strategies have 
recognised value and may be an important component of the progression of AUD treatment 
(Mann, Aubin, et al., 2017).  
1.2.2.2 Abstinence rates 
Average abstinence of untreated control-groups for randomised trials of alcohol 
treatment have been estimated at 21% at follow-up (Moyer & Finney, 2002). For treated 
patients, Monahan and Finney (1996) found an average abstinence rate of 43% at three 
months across 150 active treatment conditions. Miller, Walters, and Bennett, (2001), 
combined data of seven multisite AUD alcohol treatment trials, finding an average abstinence 
rate of 24%. Miller et al. (2001) emphasised that the estimates provided are not generalisable 
beyond the attributes of the sample and treatments delivered, as the multisite trial samples 
contained considerable variation in problem severity and personal characteristics (Miller, 
Walters, & Bennett, 2001). Considerable variance in abstinence estimates has been shown 
when differences in research procedures and samples recruited are considered (Monahan & 
Finney, 1996). In particular, research with more strict exclusion criteria and higher 
proportions of socially stable patients have better outcomes (Monahan & Finney, 1996). As 
the majority of research comes from highly controlled randomised controlled trials, 
abstinence rates may be inflated relative to ‘real-world’ clinical settings where criteria for 
inclusion in treatment are more liberal. As the UKATT was a large scale pragmatic trial it 
provides perhaps the most generalisable insight into abstinence outcomes. Within the 
UKATT, 14.3% and 21.2% of patient’s aiming for abstinence were abstinent at three and 12 
months respectively, compared to four and ten percent of patients who indicated a preference 
for controlled drinking. These findings are far more modest than the aforementioned meta-
analyses of RCTs, and even inferior to past estimates of untreated control groups (Moyer & 
Finney, 2002). Identification of externally valid estimates of post-treatment abstinence rates 
requires careful consideration of the research processes and samples used to generate these 
findings.  
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In summary, there are a variety of psychosocial interventions with established efficacy 
in the treatment of AUD. Despite this, abstinence rates following treatment remain low. One 
explanation for the consistent outcomes across psychosocial interventions and stagnation of 
progress in the improvement of AUD treatments is the failure to account for heterogeneity in 
alcohol problems (Litten et al., 2015; Project MATCH Research Group, 1997). In the interest 
of simplicity, AUDs are often investigated as a dichotomous outcome. Either you have an 
AUD, or you do not. Sensibly, the AUD group is then examined for commonalities believed 
to perpetuate the disorder which may serve as targets for intervention. The product of an 
AUD intervention is then a series of strategies targeting an archetype of AUD, rather than an 
individual. It has long been recognised that patients presenting with AUD are rarely a simple 
combination of the most common AUD symptoms and that individual differences are an 
important consideration (Institute of Medicine, 1990; Paul, 1967). It is known that individual 
progression to AUD is affected by complex interactions between genetic predisposition, 
neurobiological makeup, psychological vulnerabilities, and environmental factors (Dick and 
Kendler, 2012). When considering psychological vulnerability alone, in a 2007 national 
survey, 54 percent of Australians who met criteria for Alcohol Dependence had a comorbid 
anxiety disorder, while 35 percent met criteria for a mood disorder (Australian Bureau of 
Statistics, 2008). It should be expected then, that treating the same disorder with the same 
treatment will result in differential outcomes across individuals. It could further be predicted 
that a variety of treatment approaches with unique therapeutic targets would produce similar 
outcomes as a result of averaged in individual differences in response to each treatment. 
These were the conclusions of the U.S. government commissioned review of AUD treatment 
evidence (Institute of Medicine, 1990). It was proposed that the key to the progression of 
AUD treatment was in the identification of individual differences driving differential 
response and appropriate matching of patients to treatments likely to interact well with their 
characteristics.  
1.3 Patient-Treatment Matching 
 The previously discussed Project MATCH (see 1.2.1.5 Project MATCH) was initiated 
in response to the U.S. Institute of Medicine (1990) review and designed in accordance with 
its recommendations. The National Institute on Alcohol Abuse and Alcoholism provided $28 
million in funding for the national multi-site trial to investigate the utility of matching 
patients to treatments based on individual patient characteristics. Project MATCH randomly 
assigned 1726 patients to TSF, CBT, or MET (Project MATCH Research Group, 1997). Ten 
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primary patient characteristics were involved in matching hypotheses: (1) severity of alcohol 
involvement, (2) cognitive impairment, (3) client conceptual level, (4) gender, (5) meaning-
seeking, (6) motivational readiness to change, (7) psychiatric severity, (8) social support, (9) 
sociopathy, and (10) typology (Type A or B personality). Sixteen hypothesised contrasts 
between individual traits and each of the treatment conditions were tested at three months, 12 
months, and three years. Few matching hypothesis were supported, with none supported at all 
three time points (Project MATCH Research Group, 1997, 1998b, 1998c). It was concluded 
that treatment services need not consider the client characteristics studied in Project MATCH 
in decisions regarding treatment. The authors further acknowledged “…the intuitively 
appealing notion that treatment matching can appreciably enhance treatment effectiveness has 
been severely challenged” (Project MATCH Research Group, 1997, p. 1690). 
The UKATT also considered a-priori hypotheses of client–treatment matching effects 
in the evaluation of the effectiveness of client–treatment matching with respect to MET and 
SBNT (see 1.2.1.6 The UK Alcohol Treatment Trial). The UKATT highlighted several 
limitations of project MATCH intending to differ in several important ways: 1) The UKATT 
was intended to be more representative of ‘real-world’ treatment populations than Project 
MATCH; 2) The extensive assessment procedures of Project MATCH may have induced 
assessment reactivity effects diluting observation of matching effects; and 3) The high 
success rates of Project MATCH may have introduced ceiling effects impairing detection of 
client-treatment matching (UKATT Research Team, 2007). Five client-treatment matching 
hypotheses were tested (UKATT Research Team, 2007, pp 229):  
1. Clients with weak social networks at initial assessment will show better outcomes when 
treated with SBNT than with MET. 
2. Clients with low levels of readiness to change drinking behaviour at initial assessment 
will show better outcomes when treated with MET than with SBNT. 
3. There will be an interaction between clients’ severity of psychiatric morbidity and the 
relative effectiveness of MET and SBNT. 
4. Clients high in anger at initial assessment will show better outcomes when treated with 
MET than with SBNT. 
5. There will be an interaction between clients’ level of alcohol dependence at initial 
assessment and the relative effectiveness of MET and SBNT. 
Hypothesis four was intended to extend upon a secondary finding of Project Match that 
patients high in anger had better post-treatment outcomes after MET than CBT, and patients 
low in anger responded better to TSF or CBT than MET (Allen et al., 1997).  
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Among 742 patients recruited, no hypothesised matching effects were observed, 
including failure to support the significant secondary a priori hypothesis of project match 
(UKATT Research Team, 2007). In agreement with Project MATCH the authors concluded 
that treatment matching is unlikely to improve AUD treatment outcomes. 
Among the explanations for the failure to identify client-treatment matching effects is 
that research design impaired identification of matching effects. However, differences 
between the study design of Project MATCH and the UKATT provide some defence to this 
criticism. The high levels of experimental control within Project MATCH suggest that null 
findings are not a product of poor internal validity. Conversely, the pragmatic design of the 
UKATT indicates that failure to identify matching effects is the result of non-representative 
treatment conditions (external validity). If research design is indeed masking identification of 
matching effects, any true effects are unlikely to be very large, will be difficult to identify, 
and may not be clinically meaningful. The authors also suggested that the matching 
hypotheses may have been too simplistic, and certain combinations of patient characteristics 
and interactions between them could predict differential response to treatment conditions.  
A notable aspect of the matching characteristics chosen within Project MATCH was 
that few matching characteristics directly corresponded with unique risk-factors targeted by 
the interventions. For example, severity of alcohol involvement, cognitive impairment, client 
conceptual level, gender, support, sociopathy, and typology are not features directly targeted 
by the respective interventions. Any matching effects identified with these mechanisms 
would then arise from incidental processes rather than treatment effects. Matching may be 
improved by allocating patients to treatments based on the discrete mechanisms of action of 
the interventions. This method would also enable monitoring of change in the target trait to 
confirm the intended effects of the treatment. However, this approach would ‘pigeon-hole’ 
patients to treatments based on single mechanisms, leaving little flexibility in treatment 
approach. An alternative approach toward the progression of AUD involves adapting 
treatment to suit the patient (personalised treatment), rather than fitting the patient to the 
treatment (treatment matching; Kranzler & McKay, 2012).  
1.4 Personalised Treatment 
Personalised treatment is regarded as the next ‘frontier’ for treatments of mental health 
disorders, including AUD. Optimism is drawn from the advances in personalised medicine in 
the treatment of cancers and heart disease (Liu, Voors, Valente, & Van der Meer, 2014; 
Meyer & Ginsburg, 2002; Schwaederle et al., 2015). Current research aims to identify 
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distinct genetic, neurobiological, or psychological phenotypes which inform treatment 
response. For example, Mann et al. (2017) drew on psychological theory, neurobiological 
mechanisms, and pharmacological action to examine differential treatment response within 
the PREDICT study. Patients with abnormal opioidergic systems whose primary motives for 
drinking included positive reinforcement (reward-drinkers) were expected to respond better 
to Naltrexone (Mann, Roos, et al., 2017). Alternatively, patients with glutamatergic 
dysfunction, who primarily drink in the context of negative reinforcement (relief-drinkers) 
were expected to respond better to acamprosate (Mann, Roos, et al., 2017). Patients who were 
predominantly reward-drinkers and prescribed naltrexone had an 83% reduction in the 
likelihood of heavy drinking when contrasted to the placebo group. No evidence was found 
for additional benefit of acamprosate among relief-drinkers. This finding bares optimism for 
the identification of patient phenotypes which may inform personalised AUD interventions. 
Efforts have further been made to adapt therapy in the event that if patients are not 
adequately responding to treatment. Adaptive trial designs aim to construct algorithms for 
which identify non-responders and flexibly adjust the treatment protocols accordingly 
(Kranzler & McKay, 2012). Examples of early adaptive models include stepped-care 
procedures, where treatment is gradually intensified or reduced depending on treatment 
response (P. S. Haber & Lintzeris, 2009). Bischof and colleagues (2008) compared full care 
and stepped-care treatments for problem drinkers in Germany. The first component of the full 
intervention was computerised, then followed by four telephone intervention sessions 
(Bischof et al., 2008). In the stepped-care condition, the number of follow up sessions was 
determined by response to the computerised intervention. No significant differences in 
drinking outcomes were observed between stepped-care and full care, despite patients in the 
stepped-care condition receiving half as many telephone consults on average. McKay and 
colleagues found alcohol-dependent patients who did not achieve abstinence during a 4-week 
intensive outpatient program (IOP) benefited more from a telephone-based continuing care 
intervention (McKay, Lynch, Shepard, & Pettinati, 2005). These findings have important 
clinical implications by maintaining treatment effectiveness while reducing financial costs 
and treatment burden on the patient and provider. However, to date, adaptive algorithms have 
exclusively used drinking behaviour as the response variable determining treatment 
decisions. While this may improve treatment efficiency, it is unlikely to improve upon 
current outcomes and answer the question of how to turn non-responders into responders 
(Kranzler & McKay, 2012). Ultimately, the identification and integration of a variety of 
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markers of treatment response is needed to determine appropriate treatment strategy in 
extension to dose.  
Although adaptive treatment designs are a relatively new concept, service providers 
often deliver unstandardised adaptive treatments based on their case conceptualisation. Fully 
manualised interventions are rarely administered beyond research environments, with 
personally tailored interventions based on eclectic psychotherapy approaches being the norm, 
rather than the exception (Norcross & Wampold, 2011). This is evidenced by Larimer’s 
(1999) figure of precursors to relapse with appropriate intervention strategies, which outlines 
how the selection of treatment strategies may change based on each individual’s risk factors 
(Figure 1-1). Case conceptualisation and individualised treatment planning are central within 
psychological practice, but little effort has been made to standardise decision processes of 
individually tailored approaches. Development of a standardised procedure for personalised 
interventions first requires the identification of reliable predictors of treatment response with 
implications pertaining to treatment strategies. Pre-treatment assessment of these mechanisms 
would then inform treatment direction, much like non-standard patient intake, and frequent 
assessment of the mechanisms linked to treatment response would provide a variable to be 
integrated within adaptive treatment algorithms. The lack of development in this field is 
partly due to an absence of replicable research identifying characteristics with prognostic 
value which also inform treatment approaches (Adamson, Sellman, & Frampton, 2009). Such 
targets may include genetic, neurobiological, psychological, and social factors, as well as 
combinations among them which may be indicative of AUD phenotypes. This thesis will 
examine mechanisms which may be targeted directly or indirectly via psychosocial 
interventions.  
1.4.1 Candidate Psychosocial Targets for Personalised Treatment  
Litten et al. (2015) recommend a hueuristic framework by which target mechanisms 
can be derived for personalised interventions. They propose alcohol addiction is comprised of 
a 3-stage cycle: binge-intoxication, withdrawal–negative affect, and preoccupation–
anticipation (“craving”). This process follows a shift from drinking motivated by positive 
reinforcement expectations to drinking for relief. Seven primary functional processes are 
identified among the three stages of the addiction framework. The binge-intoxication stage 
includes incentive salience and habit engagement; the withdrawal–negative affect stage 
comprises reward deficits and stress sensitization; and the preoccupation–anticipation stage 
includes dysregulation of executive function, reward craving, and relief craving. The authors 
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emphasise that AUD involves elements of dysfunctional impulsivity and compulsivity. 
Motivations across each stage further reflect individual differences in expectations of the 
outcomes of alcohol consumption. These processes map well onto three prominent constructs 
within psychosocial conceptualisations of AUD and relapse prevention. These are impulsivity 
(Dawe, Gullo, & Loxton, 2004; Loree, Lundahl, & Ledgerwood, 2015) craving (Tiffany & 
Wray, 2012), and alcohol outcome expectancies (Jones, Corbin, & Fromme, 2001; Monk & 
Heim, 2013) respectively. Identifying individual differences in patient profiles comprising 
these constructs has potential for informing personalised interventions. 
1.4.1.1 Alcohol Craving 
Alcohol craving is defined by the American Psychiatric Association (APA) as “a strong 
desire to drink that makes it difficult to think of anything else” (American Psychiatric 
Association, 2013). Craving is a dynamic experience with variation in strength, frequency, 
and duration (Sayette et al., 2000). Reflecting its prevalence among individuals with AUD,  
alcohol craving is included as a diagnostic criterion in the DSM-V and ICD-10 (American 
Psychiatric Association, 2013; World Health Organization, 1992). Craving is believed to be a 
product of neuroadaptation to alcohol among heavy drinkers (T. E. Robinson & Berridge, 
1993, 2001). Initial abstinence causes an imbalance among adapted neurotransmitter systems, 
which is experienced subjectively as physiological discomfort inducing negative affect. 
Motivation to drink the arises from the perceived relief (negative reinforcement) offered by 
alcohol (Kavanagh, Andrade, & May, 2005). This process makes craving a prominent risk 
factor for lapse and relapse during AUD treatment (Bottlender & Soyka, 2004; Flannery, 
Poole, Gallop, & Volpicelli, 2003; Yoshimura, Komoto, & Higuchi, 2016). Flannery and 
colleagues (2003) assessed three separate craving scales in the prediction of drinking among 
183 alcohol dependent patients. All three scales were shown to be stronger predictors of 
craving in the week following assessment than past week drinking. Bottlender and Soyka 
(2004) found pre-treatment craving assessment of 74 alcohol dependent patients to be 
predictive of relapse during the outpatient treatment phase and at 12-month follow-up. 
 The majority of addiction treatment services within the U.S. consider craving within 
treatment planning (Pavlick, Hoffmann, & Rosenberg, 2009) and alcohol craving is a 
prominent target in psychological (Beck, Wright, Newman, & Liese, 1993; Marlatt & 
Gordon, 1985; Monti, Abrams, Kadden, & Cooney, 1989; Witkiewitz, Bowen, Douglas, & 
Hsu, 2013) and pharmacological interventions (Addolorato, Leggio, Abenavoli, & 
Gasbarrini, 2005; Haass-Koffler, Leggio, & Kenna, 2014). Craving is further recommended 
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by the National Institute on Drug Abuse (NIDA) as an outcome measure for substance-use 
disorder clinical trials (Tiffany et al., 2011). When considered as a candidate for personalised 
interventions, craving has prognostic value at pre-treatment and may serve as a useful marker 
for treatment response. Despite the recognised importance of craving in addiction research 
and treatment, understanding of craving mechanisms is impaired by practical and conceptual 
problems in craving measurement.  
1.4.1.2 Alcohol Outcome Expectancies 
Expectancies were first proposed by Tolman (1932) as memories linking cues to 
anticipated events or consequences. With respect to alcohol, it is the subjective expectation of 
the outcome of drinking behaviour. Alcohol outcome expectancies are most simply 
understood as ‘if… then…’ contingencies, informed by an individual’s directs and vicarious 
experiences with alcohol (Bandura, 1999). Expectancies of alcohol consumption may be 
positive, for example “If I drink alcohol I will feel relaxed”, or negative, e.g. “I cannot 
control my temper when I drink”. Alcohol outcome expectancies inform motivation to drink 
(Bandura, 1986; Jones et al., 2001; McMahon & Jones, 1993). They have been implicated in 
the initiation of alcohol use (Smith, Goldman, Greenbaum, & Christiansen, 1995), quantity 
and frequency of use (Lee, Greely, & Oei, 1999), and progression to problem drinking 
(Christiansen, Smith, Roehling, & Goldman, 1989). Experimental designs have shown it is 
possible to acutely manipulate AOEs via word priming procedures (Darkes & Goldman, 
1993; Roehrich & Goldman, 1995). In these settings, increasing positive expectancies has 
been demonstrated to increase consumption for a brief period (Roehrich & Goldman, 1995), 
while increasing negative expectancies reduces consumption (Darkes & Goldman, 1993).  
Individuals with AUD have consistently been demonstrated to hold stronger positive 
expectancies than non-problem drinkers (Li & Dingle, 2012; R. McD Young & Oei, 1996). 
Positively biased or unhelpful expectancies serve as a common targets within psychosocial 
interventions for alcohol use disorders (Beck et al., 1993; Kadden et al., 2003; Larimer, 
Palmer, & Marlatt, 1999). Cognitive approaches aim to challenge the accuracy of 
maladaptive expectancies, develop alternative control beliefs, and examining their advantages 
and disadvantages (Beck et al., 1993; Carroll, 2008; Barbara S McCrady, 2014). Behavioural 
paradigms challenging the accuracy of positive expectancies have also demonstrated efficacy 
among college students (Scott-Sheldon, Terry, Carey, Garey, & Carey, 2012). Though 
negative expectancies are not commonly recognised as treatment targets, motivational 
interviewing selectively attends to the patient’s negative expectations of drinking as a means 
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of developing discrepancy from the perceived benefits of abstinence (Miller & Rollnick, 
2012).  
Despite the role of alcohol outcome expectancies within AUD theory and treatment, 
evidence for expectancies as a prognostic marker in AUD treatment is mixed. In a review of 
expectancy research Jones, Corbin, and Fromme (2001) reported two studies found positive 
expectancies were associated with poorer treatment outcome, while five studies reported null 
findings. Conversely, higher negative expectancies were consistently associated with better 
treatment outcomes. There is little research examining expectancy change over AUD 
treatment, with the majority of research examining the efficacy of interventions in non-
clinical convenience samples (Jones, Corbin, & Fromme, 2001; Monk & Heim, 2013; Scott-
Sheldon, Terry, Carey, Garey, & Carey, 2012). Studies which have examined expectancy 
change have not measured its relationship with drinking behaviour (see Chapter Four for a 
review) drawing into question the evidence for targeting alcohol outcome expectancies 
(Brown, 1985; R McD Young, Connor, & Feeney, 2011). Further research is required to 
assess the utility of alcohol expectancies to inform personalised AUD treatment and 
subsequent adaptive procedures. 
1.4.1.3 Impulsivity 
Impulsivity is broadly considered a predisposition for action with insufficient 
forethought and impaired behavioural restraint (Evenden, 1999). Impulsive traits are common 
across theories of personality (Cloninger, 1993; Eysenck, 1963; Gray, 1987; Zuckerman, 
1994). Impulsiveness been linked to the onset of drinking (Urošević et al., 2015), 
development of AUDs (Sher, Bartholow, & Wood, 2000), treatment response (Charney, 
Zikos, & Gill, 2010), and relapse (Evren, Durkaya, Evren, Dalbudak, & Cetin, 2012; Loree et 
al., 2015; Müller, Weijers, Böning, & Wiesbeck, 2008).  
Interpretation of impulsivity research is complicated by non-standard conceptualisation 
of impulsive personality traits and the absence of coherent theory outlining its role within 
addiction (Gullo, Loxton, & Dawe, 2014). This issue is complicated further by the 
assessment of impulsivity related constructs across neurophysiological, behavioural, 
cognitive, and trait domains. Efforts to synthesise impulsivity research within the field of 
addiction have identified two core processes: (i) a heightened sensitivity to rewarding stimuli 
(Reward Sensitivity) increasing the susceptibility to approach drugs; and (ii) impaired 
approach inhibition causing the propensity for rash behaviour disregarding risk and ignoring 
future consequences (Rash Impulsiveness) (Boog, Goudriaan, Van De Wetering, Deuss, & 
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Franken, 2013; Dawe et al., 2004; Gullo et al., 2014; Stautz, Dinc, & Cooper, 2017). The 
neurobiological premise for Reward Sensitivity is proposed to derive from individual 
differences in activity in the mesolimbic dopamine system (Beauchaine, Zisner, & Sauder, 
2017; Dawe et al., 2004; Kalivas & Volkow, 2005). Predisposition for Rash Impulsiveness is 
proposed to arise from hypofunctioning of the orbitofrontal and cingulate cortices (Dawe et 
al., 2004; Volkow & Fowler, 2000). 
Research is suggestive of unique contribution of reward sensitivity and rash impulsivity 
in the prediction of alcohol related-behaviours. Higher reward sensitivity is causally related 
to heavier drinking (Gullo et al., 2017), predictive of earlier onset of drug use (Urošević et 
al., 2015), greater physiological sensitivity to alcohol (Brunelle et al., 2004), higher positive 
alcohol outcome expectancies (Gullo, Dawe, Kambouropoulos, Staiger, & Jackson, 2010), 
and stronger cue induced urges to drink (Kambouropoulos & Staiger, 2001). In contrast, rash 
impulsiveness appears more strongly related to disordered patterns of substance use (Sher et 
al., 2000). Sher and colleagues (2000) found higher rash impulsive traits to be predictive of 
the onset of SUDs and higher among SUD populations cross-sectionally. Stautz et al. (2017) 
found rash impulsivity, but not reward sensitivity, to be directy predictive of greater quantity 
of alcohol consumption, higher levels of binge drinking, and greater likelihood of AUD 
(Stautz et al., 2017). Rash impulsiveness has further been linked to increased risk of lapse 
during treatment (Charney et al., 2010) and higher likelihood relapse post-treatment (Evren et 
al., 2012; Müller et al., 2008).  
Impulsive traits are commonly targeted within psychosocial interventions. For example, 
activity scheduling and goal setting promotes future oriented thinking with the benefit of 
reducing the likelihood of impulsive action (Kadden et al., 2003). Problem solving skills 
training is also commonly employed to foster careful reasoning to circumvent rash behaviour 
(D’Zurilla & Nezu, 2010; Miller, Zweben, DiClemente, & Rychtarik, 1995). Treatments also 
commonly use alternative rewards to improve self-management of impulsive tendencies 
(Kadden et al., 2003). Witkiwietz et al. (2014) consider rash impulsivity within a mindfulness 
framework, suggesting that improved awareness of physical, emotional, and cognitive 
experiences can assist patients shift out of “autopilot” and improve intentional responding. 
Rash impulsiveness has been recognised as an important consideration within AUD 
interventions (Butz & Austin, 1993; Dawe et al., 2004; Loree et al., 2015; Witkiewitz et al., 
2014). However, dedicated research is required to test its value as a target within personalised 
treatment approaches. (Dawe et al., 2004; Loree et al., 2015).  
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1.5 Current Thesis 
1.5.1 Rationale 
Advances in the treatment of Alcohol Use Disorders (AUDs) have been modest despite 
substantial research attention (Connor et al., 2016). Alcohol is among the leading contributors 
to the global burden of morbidity and disease, with the majority of this burden attributable to 
AUDs (Rehm et al., 2014, 2015; World Health Organization, 2014). Evidence-based 
interventions for AUD are available, though relapse rates remain high (Assanangkornchai & 
Srisurapanont, 2007; Connor et al., 2016; Miller & Wilbourne, 2002). Comprehensive 
reviews of AUD treatment and rehabilitative services have concluded that no single treatment 
is effective for all persons and that individual differences are likely to dictate differential 
treatment response (Institute of Medicine, 1990; Miller & Wilbourne, 2002).  
Efforts at personalising AUD treatments by matching patients to treatments based on 
individual characteristics have not demonstrated improved outcomes (Project MATCH 
Research Group, 1998a; UKATT Research Team, 2007). However, little research has 
examined the effectiveness of standardised approaches to tailoring existing treatments to 
unique risk factors of individual patients. Candidate mechanisms identified as targets for 
personalised interventions include craving (Tiffany & Wray, 2012), alcohol expectancies 
(Adamson et al., 2009), and impulsivity (Loree et al., 2015). 
1.5.2 Research Aims 
The aim of this thesis is to contribute toward the progression of personalised psychosocial 
interventions for AUD. Measurement and intervention of alcohol craving, alcohol outcome 
expectancies, and rash impulsivity comprise the primary focus. The aims of each respective 
chapter are: 
• Identify limitations within craving measurement and develop a new measure suitable for 
use in treatment planning and monitoring of treatment response (Chapter Two). 
• Outline appropriate methodology for the selection and implementation of craving 
measures in clinical or research settings (Chapter Three).  
• Examine the evidence for meaningful change in alcohol outcome expectancies during 
AUD treatment (Chapter Four). 
• Conduct a pragmatic RCT examining the effectiveness of personalised CBT. Tailored 
elements will be based on psychometric risk profiles of craving, alcohol expectancies, 
and impulsivity (Chapter Five). 
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• Explore the relationships between rash impulsivity, alcohol craving, and lapse events 
during treatment for AUD (Chapter Six). 
 
Data Sources 
Data for empirical chapters were drawn from both existing and new, prospectively 
collected clinical data. These data sources are reported in Appendix B
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2.1 Chapter Foreword 
The opening chapter provides an overview of current AUD treatments and highlighted 
personalised, adaptive, interventions as an avenue for the improvement in treatment outcomes 
Alcohol craving was highlighted as a candidate target for personalised AUD interventions 
(see 1.4.1.1 Alcohol Craving). However, definitional, theoretical, and operational issues in 
craving measurement limit the generalisability of past research and utility of craving 
measures in clinical settings. This chapter is an empirical paper, published during 
candidature, which aimed to elucidate common issues in craving measurement and develop a 
new measure suitable for use in clinical and research environments.  
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2.2 Abstract 
 
Background: Standardised alcohol craving scales are rarely used outside of research 
environments despite recognised clinical utility. Scale length is a key barrier to more 
widespread application. A brief measure of alcohol craving is needed to improve research and 
treatment of Alcohol Use Disorders (AUDs). Grounded in the Elaborated Intrusion Theory of 
Desire, the Alcohol Craving Experience (ACE) questionnaire comprises two 11-item self-
report scales which assess past-week frequency and maximum strength of alcohol craving. 
This study aimed to create a brief version of the ACE while maintaining psychometric 
integrity and clinical utility.  
Methods: Patients attending a university hospital alcohol and drug out-patient service 
for treatment of AUD completed the ACE as part of a questionnaire battery. Three patient 
samples were utilised: 519 patients with pre-treatment and outcome data; 228 patients with 
pre-treatment data; and 66 patients who completed the ACE at treatment sessions one and 
two.  
Results: The Frequency scale of the ACE possessed greater clinical utility and 
predictive validity than the Strength scale. Revision of the Frequency measure produced a 5-
item ‘Mini Alcohol Craving Experience’ (MACE) questionnaire. Satisfactory validity 
(construct, predictive, concurrent, convergent, and incremental) and reliability (internal and 
test-retest) was maintained. A one standard deviation increase in pre-treatment MACE score 
was associated with a 54 percent increase in the odds of patient lapse or dropout.  
Conclusions: The MACE provides a brief, theoretically and psychometrically robust 
measure of alcohol craving suitable for use with AUD populations in time-limited clinical 
and research settings. 
Keywords: Alcohol Use Disorder, Craving, Urge, Measurement, Scale development
 
  
30 
 
Chapter Two  A Brief Measure of Alcohol Craving 
 
The Mini Alcohol Craving Experience questionnaire: Development and 
clinical application 
2.3 Introduction 
Craving is a robust marker of substance dependence severity and is implicated in 
treatment relapse (Flannery et al. 2003; Law et al. 2016; Yoshimura et al. 2016). The 
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) recently 
included ‘craving, or a strong desire or urge to use a substance’ as a diagnostic criterion for 
Substance Use Disorders (American Psychiatric Association, 2013). Craving was defined as a 
strong desire to consume a substance that makes it difficult to think of anything else 
(American Psychiatric Association, 2013; Hasin et al. 2013). Craving interventions feature 
prominently in psychological treatments, and pharmacotherapies have been developed to 
target craving neuromechanisms (Addolorato et al., 2005; Haass-Koffler et al., 2014). After 
decades of experimental, clinical, and epidemiological research, accurate measurement of 
substance craving remains a research priority (Kavanagh et al., 2013; Tiffany & Wray, 2012). 
Historically, craving has been measured by conceptually weak and often unstandardised 
methods, limiting generalisability and clinical utility (Kavanagh et al., 2013; Pavlick et al., 
2009; Sayette et al., 2000). Some standardised scales have been introduced, although uptake 
within clinical settings has been poor (Pavlick et al., 2009; Tiffany & Wray, 2012).  
A national survey of U.S. addiction services found 99% considered craving in treatment 
planning, yet only 5% employed standardised self-report craving measures (Pavlick et al., 
2009). The majority opted for single-item or non-standard open ended questions, despite well 
documented limitations to the reliability of these approaches (Cortina 1993; Hruschka et al. 
2004). This may reflect the psychometric and theoretical weaknesses in self-report craving 
scales (Kavanagh et al., 2013; Sayette et al., 2000) and time burden imposed by scale 
administration and interpretation in busy clinical environments. Alcohol Use Disorders 
(AUDs) are among the most prevalent Substance Use Disorders, placing a substantial burden 
upon global mortality and disease (Connor et al., 2016; Connor & Hall, 2015; Gowing et al., 
2015). A brief, psychometrically sound measure of alcohol craving is needed to improve 
assessment, diagnosis, and treatment of AUDs. 
Measures vary considerably in their definition of craving. In a recent review of alcohol 
craving scales, based on 47 papers published between 1990 and 2012, we argued that the 
majority contain constructs conceptually and empirically distinct from diagnostic definitions 
of craving (e.g. DSM-5 and ICD-10; Kavanagh 2013). Allied constructs such as expectancies, 
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intentions, and refusal self-efficacy were shown to be present within most craving measures 
(Kavanagh et al. 2013). In a review of the clinical utility of drug craving, Tiffany and Wray 
(2012) argue that assessments of craving which include allied constructs are useful for 
research exploring the relationship between expressions of craving and craving-related 
phenomena. The inclusion of allied constructs may also enhance predictive validity of a 
scale, by drawing on the documented explanatory power of constructs such as intention to use 
and refusal self-efficacy (Connor et al. 2007). However, scales assessing multiple constructs 
require careful interpretation to preserve construct validity. It is therefore important that 
craving measures are interpreted though a specified definition or theory. However, craving 
scales infrequently report a definition to which they adhere and are often atheoretical 
(Flannery et al. 1999; Rojewski et al. 2015; McHugh et al. 2016). We developed the Alcohol 
Craving Experience (ACE) Questionnaire to be consistent with common definitions of 
craving, while adhering to a specified theory (Statham et al. 2011). As administration of the 
22-item ACE can be too time consuming for routine clinical use, a brief version is needed. It 
is proposed that reduction of the ACE would result in a theoretically and psychometrically 
sound measure of craving which may be easily integrated in time-limited environments. 
Reflecting the Elaborated Intrusion (EI) Theory of Desire (Kavanagh et al. 2005; May 
et al. 2014b), the ACE measures three aspects of craving: the intensity of the drive to drink 
(Intensity), the presence of associated imagery (Imagery), and intrusiveness of desire 
cognitions (Intrusion; Statham et al. 2011). EI theory defines craving as an affectively laden 
cognitive event, where an object or activity and its associated pleasure or relief is in focal 
attention (Kavanagh et al., 2005). Consistent with neurobiological models of craving, 
addictive substances are believed to recruit the same physiological mechanisms that drive 
appetitive behaviours required for survival (T. E. Robinson & Berridge, 1993). EI theory 
proposes that biological, environmental, and affective cues trigger intrusive desire-related 
cognitions which occupy attention and prompt elaboration. The subsequent elaboration 
process—in particular imagery—provides momentary pleasure or relief of physical and 
emotional discomfort (Connor et al., 2014). However, pleasure or relief from elaborative 
cognitions quickly dissipates. Instead, awareness is drawn to any emotional or physical 
deprivation and to potential actions to acquire the target. Further elaboration and 
intensification of the desire ensues, unless the target is acquired or attention is captured 
elsewhere.  
EI theory aligns with treatment approaches such as motivational enhancement, 
mindfulness, acceptance-based therapies, and retraining attentional biases (Witkiewitz et al. 
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2013; May et al. 2014b; Witkiewitz et al. 2014). Recent research has directly employed EI 
theory in the development of promising new craving management strategies and novel 
treatment approaches (Kemps and Tiggemann 2007; Knäuper et al. 2011; Kemps and 
Tiggemann 2013; Hsu et al. 2014; Skorka-Brown et al. 2014; Littel et al. 2016). These 
approaches employ non-substance imagery and sensory tasks designed to compete with 
craving-based imagery within the limited capacity of working memory. The information 
provided by the ACE may facilitate more detailed formulation, treatment planning, and 
monitoring of craving.   
The ACE was originally developed in an AUD sample (Statham et al., 2011), to 
measure the frequency (ACE-F) and peak strength (ACE-S) of alcohol craving over the 
previous week. Exploratory and confirmatory factor analysis showed that the items in both 
forms of the ACE cluster into three distinct factors consistent with EI theory: Intensity, 
Imagery, and Intrusion of craving-related cognitions. The ACE has high internal reliability 
and significantly correlates with the Obsessive Compulsive Drinking Scale (OCDS), Alcohol 
Use Disorders Identification Test (AUDIT), as well as measures of psychological distress 
highly comorbid with AUDs. The ACE has further been demonstrated to discriminate non-
clinical from clinical samples (Statham et al., 2011). May and colleagues (2014) pooled 12 
studies using modified forms of the ACE to assess craving across a range of substances, 
including alcohol (May et al. 2014a). The original factor structure was replicated across all 
substances.  
The ACE provides a theoretically grounded, psychometrically robust measure, with 
strong rationale for more effectively targeting alcohol craving interventions. However, the 
full ACE is repetitive (with each item appearing in both the Strength and Frequency forms) 
and time consuming, demanding time and effort of both respondent and administrator within 
busy clinical environments. A shorter version of the ACE is likely to result in higher uptake, 
especially where repeated administration is required. The aim of this study is to develop a 
short form of the ACE for use in treatment planning and outcome assessment without 
compromising its theoretical foundation or psychometric integrity.  
2.4 Materials and Methods 
2.4.1 Participants 
Three samples of data were drawn from patients attending a metropolitan university 
hospital alcohol and drug out-patient service. The service comprises eight sessions of 
Cognitive Behaviour Therapy (CBT) conducted over 12 weeks. Treatment may be 
33 
 
Chapter Two  A Brief Measure of Alcohol Craving 
 
supplemented by pharmacotherapy (naltrexone, acamprosate, or both). The assessment 
battery is completed in a separate consultation prior to the first treatment session and again at 
the completion of treatment. All patients were over 18 years of age and met DSM-IV 
(American Psychiatric Association, 2000) criteria for alcohol dependence. Human ethics 
approval was obtained (2008/125, HREC/12/QPAH/022 HREC/14/QPAH/664) and 
participants provided informed written consent. Sample characteristics are presented in Table 
2-1.  
Scale Reduction Sample. This sample comprised 519 alcohol dependent patients (Table 
2-1). All patients were over 18 years of age and met DSM-IV(American Psychiatric 
Association, 2000) criteria for alcohol dependence. These data have been used previously in 
the original development of the ACE (Statham et al., 2011) and in examining craving as a 
mediator of change (Law et al. 2016), but have not been used to directly predict treatment 
outcome.  
Validation Sample. The validation sample comprised pre-treatment data from 228 
consecutively treated alcohol dependent patients (Table 2-1). These data were employed to 
assess the factor structure of the ACE scales and cross-sectional relationships between 
variables. 
Test-Retest (TRT) Sample. The ACE-F was administered to 66 patients at treatment 
sessions one and two, in-order to assess test-retest reliability of the ACE-F. Mean time 
between sessions was 8.40 days (SD = 2.86).  
 
Table 2-1. Patient sample characteristics 
Sample characteristics 
Scale Reduction 
Sample 
Validation Sample TRT Sample 
  n = 519 n = 228 n = 66 
Mean Age, years (SD) 39.82 (11.59) 44.39 (10.82) 
45.48 
(10.03) 
Sex, female 171 (32.9%) 84 (36.8%) 22 (33.3) 
Married/De-facto 184 (35.5%%) 82 (36.0%) 25 (37.9%) 
Education    
   Degree 70 (13.5%) 47 (20.5%) 17 (25.8%) 
   Diploma/Certificate 52 (10.0%) 16 (7.1%) 6 (9.1%) 
   Senior Secondary (Year 12) 157 (30.3%) 71 (31.1%) 22 (33.3%) 
   Junior Secondary (Year 10) 190 (36.6%) 82 (36.0%) 17 (25.8%) 
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   Primary (Year 7) 33 (6.4%) 11 (4.8%) 4 (6.1%) 
Unemployed 103 (19.8%) 44 (19.3%) 15 (22.7%) 
Mean Alcohol (grams) per 
drinking day (SD) 
147.07 (88.90) 169.80 (100.93) 
196.12 
(119.71) 
Median Baseline ACE-F 
(IQR) 
39 (48.00) 42.00 (46.75) 
43.50 
(45.50) 
Mean Baseline AUDIT (SD) 27.25 (8.6) 29.38 (7.01) 
27.47 
(10.28) 
Mean Baseline OCDS-
Obsessions (SD) 
7.82 (4.47) 8.82 (4.36) 8.46 (4.76) 
Medication Prescribed* 315 (60.7%) 25 (11.0%) 10 (15.2%) 
*The Scale Reduction Sample records medication (naltrexone/acamprosate/both) if it is 
prescribed at any point during treatment. Medication is only counted in the Validation and 
TRT samples if it was taken in the week prior to assessment. As the Validation sample 
assessment occurred prior to commencement of behavioural treatment and TRT sample was 
assessed in Session 1, the majority of patients had not yet been prescribed pharmacotherapy.  
2.4.2 Measures 
The Alcohol Craving Experience (ACE) questionnaire. The ACE comprises two 11-
item scales that assess the frequency (ACE-F) and peak strength (ACE-S) of desire-related 
cognitions over the previous week. Items load onto three classes of cognition, ‘Intensity’ 
(items 1-3), ‘Imagery’ (items 4-8), and ‘Intrusion’ (items 9-11). Participants respond via an 
11-point visual analogue scale with anchors 0 (not at all) and 10 (constantly/extremely). The 
ACE-F and ACE-S have good internal reliability and concurrent validity, and can 
discriminate between problem and non-problem drinkers (Statham et al., 2011).  
 
The Obsessive Compulsive Drinking Scale (OCDS). The OCDS is a 14-item self-report 
measure intended to reflect drinking-related obsessive and compulsive craving and behaviour 
(Anton et al. 1995). The OCDS has received extensive research attention and is currently the 
most widely used measure of alcohol craving. The OCDS has acceptable test-retest 
reliability, internal reliability, and concurrent validity (Anton et al. 1995; Kranzler et al. 
1999; Roberts et al. 1999). The OCDS cannot be considered a ‘pure’ measure of craving as 
extraneous constructs such as consumption, effort to resist drinking, functional interference 
and distress from drinking, as well as perceived control of drinking are all assessed within the 
scale. The first six items, comprising the Obsessions Subscale are most consistent with the 
clinical definitions of craving. OCDS-Obsessions is intended to assess drinking obsession 
related cognitions, for example, “How much of your time when you’re not drinking is 
occupied by ideas, thoughts, impulses, or images related to drinking?”. While less 
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confounded than the full OCDS, OCDS-Obsessions does contain extraneous phenomena, 
assessing functional interference and distress caused by obsessive cognitions. OCDS-
Obsessions has been demonstrated to improve prediction of drinking behaviour (Flannery et 
al. 2003) and likelihood of relapse post treatment (Soyka et al. 2010). As OCDS-Obsessions 
is a widely used measure of craving and considered among the better performing craving 
scales (Kavanagh et al. 2013) it was employed as a concurrent measure of alcohol craving.  
The Alcohol Use Disorders Identification Test (AUDIT). The AUDIT is a 10-item, self-
report measure assessing recent alcohol use, symptoms of alcohol dependence, and alcohol 
related problems (Saunders, Aasland, Babor, de la Fuente, & Grant, 1993). The AUDIT has 
sound internal reliability, sensitivity and specificity, and discriminant validity (Saunders et 
al., 1993). Higher scores indicate increased risk of harmful or hazardous drinking. 
The Beck Depression Inventory - Second Edition (BDI-II). The BDI-II is a 21-item self-
report measure assessing attitudes and behaviours symptomatic of depression (Beck, Steer, & 
Brown, 1996). The BDI-II is a well validated measure demonstrating strong test-retest and 
internal reliability, as well as good concurrent, content, discriminant, and construct validity 
(Beck et al., 1996; Beck, Steer, & Carbin, 1988).  
The State Anxiety Scale (S-Anxiety). The S-Anxiety Scale of the State Trait Anxiety 
Inventory (STAI) comprises 20 self-report items assessing the respondent’s current state of 
anxiety (Spielberger, 1983). The S-Anxiety has acceptable internal and test-retest reliability, 
as well as content, discriminant, and construct validity (Barnes, Harp, & Jung, 2002; Oei, 
Evans, & Crook, 1990; Spielberger, 1983).  
 
2.4.3 Procedure 
Scale Reduction. To best maintain consistency of the measured construct, an initial step 
involved selection of a form of the ACE for further refinement (ACE-F or ACE-S). Each 
form was evaluated based on perceived clinical utility and predictive validity. Decisions 
guiding subsequent item reduction were informed by the following rationale: (a) to enhance 
construct validity, items with the greatest face validity and theoretical importance within EI 
theory were prioritised; (b) to maximise the sensitivity and clinical utility of a reduced scale, 
the most highly endorsed items were also prioritised for retention; (c) to enhance predictive 
validity, the capacity of items to discriminate between patients who lapsed or withdrew from 
treatment and those who were abstinent throughout treatment was also considered. Data 
analyses within this step utilised the Scale Reduction Sample. 
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Scale Evaluation. Reduced models were further evaluated based on construct, 
predictive, concurrent, and convergent validity, as well as internal and test-retest reliability. 
Predictive validity of OCDS-Obsessions was also assessed for concurrent comparison. Data 
analysis within this step utilised the Validation and Test-Retest samples. 
Scale Selection. The shortest scale maintaining psychometric integrity would be 
selected as the final reduced version.  
2.4.4 Data Analysis 
Analyses were conducted in SPSS version 22. Confirmatory factor analyses (CFA) 
were conducted in R version 3.2.1 (R Core Team, 2015), package extension lavaan .5-18  
(Rosseel, 2012). As the distributions of all ACE item and scale scores were significantly 
negatively skewed, statistical procedures robust to non-normal distributions were utilised. 
CFA Models were compared using changes in χ2 /df ratios (smaller values indicating 
improved fit; Carmines and McIver 1981), Comparative Fit Indices (CFI, values >.93 
indicating good fit; Hu and Bentler 1999) , Standardised Root Mean Square Residual 
(SRMR; Values <.07 indicating good fit; Hu and Bentler 1999), Root Mean Square Error of 
Approximation (RMSEA; values <.07 indicating good fit; Hu and Bentler 1999), and Akaike 
Information Criterion (AIC; smaller values indicating improved fit; Bozdogan 1987).  
 
2.5 Results 
2.5.1 Scale Reduction 
Subscale-Selection. As the ACE-S asks the respondent to report on only the most 
severe episode of past week craving, it is influenced by contextual factors such as situational 
cues and novel stressors. Clinical value of this method is drawn from the isolation of a 
specific time-period where the patient may be most vulnerable to lapse. Alternatively, the 
ACE-F assesses the perceived frequency of craving symptoms over the past week, providing 
a more general overview of the patients craving experience. The ACE-F was subsequently 
identified as the preferred scale for reduction, based on its perceived benefit as a measure 
more sensitive to change in the patient’s typical craving experience.  
Using the Scale Reduction Sample, separate logistic regression analyses were employed 
to assess the capacity of pre-treatment ACE scale scores to predict the likelihood of treatment 
lapse relative to patients who were abstinent throughout treatment. Patients who discontinued 
treatment without record of lapse were conservatively included within the lapse group. All 
scale scores were standardised to facilitate the comparison of effects. AUDIT scores and 
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medication status were included as covariates, but did not significantly improve upon the 
intercepts-only model (χ2 (2) = 0.26, p = .877, Nagelkerke R2 = .001; Table 2-2, Baseline 
Model). Inclusion of either the ACE-S (Δχ2 (1) = 18.71, Δp = <.001, Nagelkerke ΔR2 = .054, 
Table 2-2, Model 1) or ACE-F (Δχ2 (1) = 21.68, Δp = <.001, Nagelkerke ΔR2 = .062, Table 
2-2, Model 2) significantly improved the predictive power of the model. As Model 2 
appeared to explain more variance than Model 1, the ACE-F was added to Model 1 in an 
additional step to examine if it would account for significantly more variance than the ACE-
S. The addition of the ACE-F to Model 1, saw the ACE-F become the dominant predictor 
within the model, though predictive power was not significantly improved (Δχ2 (1) = 3.63, Δp 
= .057, Nagelkerke ΔR2 = .011, Table 2-2, Model 3). The ACE-F was subsequently selected 
for further refinement. 
Table 2-2. Summary of hierarchical logistic regression models assessing predictive 
validity of the ACE-F and ACE-S. 
    95% CI for Odds Ratio 
  β (SE) Lower Odds Ratio Upper 
Baseline Model     
  Constant 1.18*** (.13)  3.26  
  Medication 0.11 (.22) 0.73 1.12 1.71 
  AUDIT -0.00 (.11) 0.81 1.00 1.23 
Model 1     
  Constant 1.19*** (.14)  3.28  
  Medication 0.23 (.22) 0.81 1.26 1.96 
  AUDIT -0.04 (.11) 0.77 0.96 1.20 
  ACE-S 0.46*** (.11) 1.28 1.59 1.97 
Model 2     
  Constant 1.21*** (.14)  3.34  
  Medication 0.23 (.22) 0.81 1.26 1.95 
  AUDIT -0.05 (.11) 0.76 0.95 1.18 
  ACE-F 0.53*** (.12) 1.34 1.69 2.14 
Model 3     
  Constant 1.2*** (.14)  3.32  
  Medication 0.24 (.23) 1.27 1.27 1.98 
  AUDIT 0.05 (.11) 0.95 0.95 1.18 
  ACE-S 0.15 (.19) 1.17 1.17 1.70 
  ACE-F 0.39 (.20) 1.48 1.48 2.21 
Note: * p < .05, ** p < .01, *** p < .001,  
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Item Importance. Prior to item reduction, the structure and items central to the 
theoretical foundation of the scale were considered. At least one item from each sub-scale 
was retained to represent each factor. Items 3 and 9 (Table 2-3) were prioritized for retention 
due to high semantic consistency to the Intensity and Intrusion factors respectively. Multiple 
items of the Imagery factor would be retained to capture potential individual differences in 
the most prevalent imagery modalities involved in alcohol craving.  
Feature Prevalence. Medians and interquartile ranges for all ACE-F items are 
presented in Table S1 within the online supplementary material. While all items had an 
interquartile range of at least 4 on the 11-point scale, most also received a large proportion of 
‘not at all’ responses. To identify which items were most representative of common craving 
symptoms among patients with AUD, the endorsement rates (ERs; proportion of non-zero 
responses to each item) were also calculated. McNemar’s χ2 was utilised to identify 
significant differences between items in the prevalence of endorsement rates within each 
factor. Within the Intensity factor, the endorsement rate of Item 2 (80.2%) was significantly 
lower than Item 3 (86.1%, p < .001), while Items 1 (87.6%) and 3 could not be distinguished 
(p = .169). Comparisons of endorsement rates of items within the Imagery factor revealed all 
were significantly different (p < .001), with the exception of the most highly endorsed, items 
4 (80.9%) and 8 (80.1%, p = .716). Within the Intrusion factor, item 11 was the least 
endorsed factor (75.8%, p < .001) while items 9 (84.9%) and 10 (83.8%) could not be 
differentiated (p = .291).  
Separate Mann-Whitney U tests revealed that the mean rank of patients who lapsed or 
withdrew from treatment was significantly higher for every item than those who completed 
treatment abstinent (Table 2-3). Steiger’s Z revealed no significant differences in the size of 
the effects between items.  
Item Reduction. To maximize sensitivity of the reduced craving measure items with the 
highest endorsement rates were given greater priority for retention to minimise the number of 
‘not at all’ responses within the reduced scale. Based on feature prevalence and consistency 
with the overarching factors, items 3 and 9 were retained to represent the Intensity and 
Intrusion factors respectively. The three imagery items with the highest endorsement rates (4, 
5, and 8) were retained to comprise the initial Imagery factor. 
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Table 2-3. Mean rank comparison of abstinent patients and those who lapsed or dropped out of treatment across all ACE-F items 
scores. 
 
  
Complete 
Abstinent 
Lapse or 
Dropout 
        
How often did these things happen over the last week? n 
Mean 
Rank 
n 
Mean 
Rank 
U Z p r 
1.  Did you want a drink? 118 196.24 398 276.96 16135.00 -5.19 <.001 -0.23 
2.  Did you think about needing a drink? 118 203.00 399 275.56 16933.00 -4.67 <.001 -0.20 
3.  Did you have an urge to drink? 118 203.95 399 275.28 17045.00 -4.58 <.001 -0.20 
4.  Did you picture alcohol or drinking? 118 215.42 399 271.89 18398.50 -3.64 <.001 -0.16 
5.  Did you imagine what it would taste like? 118 215.79 398 271.16 18442.50 -3.59 <.001 -0.16 
6.  Did you imagine what it would smell like? 118 217.61 399 271.24 18656.50 -3.54 <.001 -0.16 
7.  Did you imagine what it would feel like in your mouth or 
throat? 
118 214.71 399 272.10 18315.00 -3.74 <.001 -0.16 
8.  Did you imagine how your body would feel if you had a 
drink? 
118 223.04 398 269.01 19298.00 -2.96 0.003 -0.13 
9.  When you thought about alcohol over the last week, how 
often were the thoughts intrusive? 
117 223.46 388 261.91 19241.50 -2.51 0.012 -0.11 
10.  When you thought about alcohol over the last week, how 
often were you trying not to think about alcohol? 
117 211.29 398 271.73 17818 -3.88 <.001 -0.17 
11.  Did you find it hard to think about anything else? 118 203.59 399 275.56 17003 -4.55 <.001 -0.20  
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A sequential logistic regression was employed to assess the capacity for the selected 
items to predict alcohol lapse in the Scale Reduction Sample. Addition of the items intended 
to comprise the reduced ACE (items: 3, 4, 5, 8, 9) to the Baseline Model (Table S2) 
significantly improved predictive power of the model (Δχ2 (5) = 21.49, Δp < .001, 
Nagelkerke ΔR2 = .061, Model 4, Table S2). To assess whether the model could be improved 
with the inclusion of additional ACE items, the remaining items were included using forward 
entry. Sequential inclusion of items 1 (Δχ2 (1) = 7.61, Δp = .006, Nagelkerke ΔR2 = .023, 
Model 5, Table S2) and 10 (Δχ2 (1) = 9.84, Δp =.002, Nagelkerke ΔR2 = .027, Model 6, Table 
S2) would significantly improve the final model (χ2 (9) = 39.20, p < .001, Nagelkerke R2 = 
.111). 
2.5.2 Scale Evaluation 
Validity. To assess the construct validity of the initial five-item scale, the seven-item scale, 
and the complete ACE-F, confirmatory factor analyses were performed utilising the 
Validation Sample. Maximum likelihood estimation with robust standard errors and a 
Satorra-Bentler scaled test statistic were employed to reduce the effects of non-normality. 
Model fit statistics are presented in   
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Table 2-4, and parameter estimates are summarised in the supplementary material. For the 11 
and 7 item scales, the three-factor solution provided a better fit to the data than a unifactorial 
model (  
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Table 2-4). For the five item scale, both solutions showed comparable fit. The CFI, 
RMSEA, SRMR, and AIC fit statistics all improved through reduction. No covariance 
between error terms was specified in any of the models. These results support previous 
studies validating the three-factor structure of the ACE (Statham et al. 2011; May et al. 
2014a), though when reduced to a five-item scale, it could equally reflect a global construct 
of craving within a single factor (Figure 2-1).  
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Table 2-4. Robust fit indices for the 3-factor and unifactorial structures of the ACE 
scales (n = 228). 
 Scale χ2 (df) χ2 /df p CFI RMSEA SRMR AIC 
ACE-F 11       
  Unifactorial 302.13 (44) 6.87 <.001 0.898 0.160 0.069 11236.7 
  3-Factor 158.92 (41) 3.88 <.001 0.954 0.112 0.056 11013.50 
ACE-F 7 
      
  Unifactorial 78.91 (14) 5.64 <.001 0.955 0.143 0.040 7321.29 
  3-Factor 35.59 (11) 3.24 <.001 0.983 0.099 0.027 7265.35 
ACE-F 5 
      
  Unifactorial 23.23 (5) 4.65 <.001 0.983 0.126 0.026 5197.70 
  3-Factor 23.47 (4) 5.87 <.001 0.982 0.146 0.026 5199.57 
 
 
Figure 2-1. Unifactorial model of the 5-item ACE-F with standardised parameters. All 
paths are significant at p < .001. 
 
Data from the Validation Sample indicated that all scales had significant (p < 0.001) 
large positive correlations with OCDS-Obsessions, indicating an acceptable level of 
concurrent validity (r = 0.60 to 0.58). Convergent validity was demonstrated by significant (p 
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< 0.01) small to moderate positive correlations with the AUDIT (r = 0.22 to 0.20) and 
significant (p < 0.001) moderate correlations with measures of anxiety (S-Anxiety: r = 0.40 
to 0.38) and depression (BDI: r = 0.39 to 0.38). The strength of the correlations did not 
significantly differ between the three ACE versions (Steiger’s Z, p <.05), indicating that 
convergent and concurrent validity of the ACE was not significantly affected by scale 
reduction.  
Utilising the Scale Reduction Sample predictive validity of the scales administered pre-
treatment was assessed by logistic regressions with the outcomes ‘complete treatment 
abstinent’ and ‘lapsed or discontinued treatment’. When independently added to the Baseline 
Model, the five-item (Δχ2 (1) = 15.17, Δp < .001, Nagelkerke ΔR2 = .044, Model 7, Table 
2-5), seven-item (Δχ2 (1) = 20.19, Δp < .001, Nagelkerke ΔR2 = .058, Model 8, Table 2-5), 
and 11-item (Model 2, Table 2-2) scales all significantly improved predictive power of the 
model. Predictive power of OCDS-Obsessions was also assessed for concurrent comparison. 
Addition of OCDS-Obsessions significantly improved upon the Baseline Model (Δχ2 (1) = 
7.78, Δp =.005, Nagelkerke ΔR2 = .022, Model 9, Table 2-5). The incremental validity of 
each scale was assessed by systematically adding the weaker of two scales, based on 
Nagelkerke’s R2, to the Baseline Model, followed by the next strongest scale in step two. The 
5-item ACE-F was demonstrated to significantly improve upon the predictive power of 
OCDS-Obsessions (Δχ2 (1) = 7.35, Δp =.007, Nagelkerke ΔR2 = .044, Model 10, Table 2-5) 
and the 7-item scale significantly improved upon the 5-item (Δχ2 (1) = 15.43, Δp <.001, 
Nagelkerke ΔR2 = .088, Model 11, Table 2-5). The 11-item scale did not improve upon the 
seven-item scale (Δχ2 (1) = 1.19, Δp = .173, Nagelkerke ΔR2 = .064, Model 12, Table 2-5).  
Reliability. Internal consistency was assessed using the Validation Sample. Cronbach’s 
Alpha was above .90 for all scales with only minor reductions in the reduced scales (α = 0.95 
to 0.92). Test-Retest reliability utilised session one and two data from 66 patients. 
Correlations between session one and session two ACE scores indicated that test-retest 
reliability was acceptable across all scales (r = 0.731 to 0.725). Steiger’s Z revealed no 
significant changes in scale test-retest reliability following reduction. 
 
2.5.3 Scale Selection  
The procedures conducted indicate that the ACE-F may be reduced to as few as five 
items while maintaining theoretical and psychometric integrity. The five-item scale, termed 
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the Mini Alcohol Craving Experience (MACE), was chosen as the most suitable short-form 
scale for assessment of craving in AUD populations.  
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Table 2-5. Summary of hierarchical logistic regression models assessing predictive 
validity of the reduced ACE-F Scales and OBS. 
    95% CI for Odds Ratio 
  β (SE) Lower Odds Ratio Upper 
Model 7     
  Constant 1.19*** (.14)  3.28  
  Medication 0.22 (.22) 0.8 1.25 1.93 
  AUDIT -0.04 (.11) 0.78 0.96 1.19 
  ACE-F-5 item 0.43*** (.12) 1.23 1.54 1.93 
Model 8     
  Constant 1.19*** (.14)  3.3  
  Medication 0.24 (.23) 0.82 1.27 1.98 
  AUDIT -0.04 (.11) 0.77 0.96 1.19 
  ACE-F-7 item 0.50*** (.12) 1.31 1.65 2.06 
Model 9     
  Constant 1.18*** (.14)  3.24  
  Medication 0.20 (.22) 0.79 1.23 1.9 
  AUDIT -0.07 (.11) 0.75 0.93 1.16 
  OBS 0.31** (.11) 1.09 1.37 1.71 
Model 10    
  Constant 1.19*** (1.4)  3.29  
  Medication 0.225 (.23) 0.8 1.25 1.95 
  AUDIT -0.06 (.11) 0.76 0.95 1.18 
  OBS 0.10 (.14) 0.84 1.1 1.44 
  ACE-F-5 item 0.37** (.14) 1.11 1.45 1.9 
Model 11    
  Constant 1.22 (0.14)  3.38  
  Medication 0.26 (0.23) 0.83 1.29 2.02 
  AUDIT -0.03 (0.11) 0.77 0.97 1.21 
  ACE-F-5 item -2.21 (0.7) 0.03 0.11 0.43 
  ACE-F-7 item 2.67 (0.7) 3.65 14.39 56.77 
Model 12    
  Constant 1.22 (0.14)  3.37  
  Medication 0.21 (0.23) 0.8 1.24 1.93 
  AUDIT -0.06 (0.11) 0.76 0.94 1.17 
  ACE-F-7 item -0.40 (0.67) 0.18 0.67 2.48 
  ACE-F-11 item 0.93 (0.69) 0.66 2.55 9.82 
Note: * p < .05, ** p < .01, *** p < .001.  
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2.6 Discussion 
In place of the two 11–item forms of the ACE, a brief five-item measure of craving was 
validated (MACE). The MACE maintained high construct, predictive, concurrent, and 
convergent validity.  High internal and test-retest reliability consistent with the ACE-F was 
also demonstrated. The MACE measures the frequency of past week craving including 
intense urges, imagery, and intrusiveness of craving related cognitions (Kavanagh et al., 
2005). The MACE is simple to administer and may be completed in less than 60 seconds, 
reducing time burden on respondents, health professionals, and researchers. 
In addition to its brevity, the MACE maintains several strengths uncommon among 
current craving instruments, including a strong theoretical model and absence of drinking 
constructs known to confound craving measurement (Kavanagh et al., 2013; Sayette et al., 
2000). By retaining the items most representative of the ACE factors, and monitoring the 
resultant model fit, the MACE preserved the construct validity of the ACE. The MACE 
subsequently retains the capacity for unique insight into intensity and intrusiveness of patient 
craving, as well and key elements of craving based imagery. This information may inform 
case formulation and treatment planning.   
Predictive validity is infrequently examined in existing craving measures. Higher scores 
on the MACE were predictive of increased risk of lapse or dropout from treatment in this 
alcohol dependent sample. A one standard deviation increase in MACE score was associated 
with a 54% increase in the odds of lapse or discontinuation of treatment; relative to OCDS-
Obsessions, where a one standard deviation score increase was associated with a 10% 
increase in risk. The practical interpretation of this result is that for every one-point increase 
on the MACE pre-treatment (maximum score = 50), the odds of a patient completing 
treatment abstinent reduced by 3.1 percent. The MACE may therefore assist addiction 
professionals to better assess risk of relapse in their patients.  
Few craving measures assess test-retest reliability. The MACE deliberately measures 
past week frequency of craving, under the assumption that this will have greater stability and 
subsequently be a more reliable indicator of change than single time point assessments. The 
correlation of session one and two MACE scores was r = 0.73, and is interpreted as an 
acceptable degree of stability within the clinical context. Given the prominence of craving 
within clinical and research settings, a measure of craving sensitive to change over time is 
greatly needed. The MACE may enhance the validity of studies assessing the efficacy of 
craving interventions, and improve monitoring of patients’ treatment response in clinical 
settings.  
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As this study was conducted in a hospital outpatient clinic, the samples provided 
optimal, clinically relevant data. However, the practical nature of the research design 
introduced some limitations. The samples predominantly comprised middle-aged men with 
poor social or occupational functioning and moderate to severe alcohol dependence. Future 
studies should investigate the MACE in more diverse patient populations, as craving profiles 
may vary across problem severity, age, culture, social-occupational status. An additional 
limitation is that follow up data of patients who dropped out were not available, and were 
conservatively recorded as having lapsed. Assessment of test-retest reliability was also 
impaired by the treatment setting. An increased focus on drinking and attempts to change 
drinking behaviours is likely to have increased variance in patient craving from session one to 
two. While this is hypothesised to have led to the underestimation of the MACE’s stability 
future research should assess participants under stable conditions with tightly controlled time 
points. Further research is also needed to examine the performance of the MACE as a stand-
alone measure. As the MACE was only assessed as a sub-selection of the full ACE, the extent 
to which the variance of the retained items is influenced by the excluded items is unknown. 
Finally, while craving frequency presents ongoing challenges to the control of drinking, very 
intense peak levels also constitute significant risk. Utilising both frequency and strength 
forms of the ACE is recommended when time permits, as they offer a more comprehensive 
assessment of the patient’s experience of craving. The MACE and ACE scales, scoring 
instructions, and normative data are included in the online supplementary material. 
A final recommendation, which applies to the use of all craving measures, is that scores 
are carefully interpreted in light of the definition and theory under which they are proposed. It 
is argued that unclear definitions, and the absence of theoretical models have impaired 
craving measurement to date, confounding the craving construct (Tiffany and Wray 2012; 
Kavanagh et al. 2013). Interpreting ACE scores in the context of the Elaborated Intrusion 
Theory of Desire (Kavanagh et al., 2005) will improve understanding of the proposed 
construct of craving and enhance the measure’s clinical utility. 
The Mini Alcohol Craving Experience (MACE) reflects the key theoretical elements of 
the ACE, while maintaining the best performing items and preserving psychometric integrity. 
Key strengths of the MACE include excellent construct validity, predictive validity, and 
acceptable test-retest reliability. In conjunction with its brevity, these features make the 
MACE ideal for use with AUD populations in time-limited clinical and research 
environments. 
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3.1 Chapter Foreword 
Chapters One and Two highlighted that craving assessment is complicated by 
definitional, theoretical, and operational characteristics.  Chapter Two identified the ACE as a 
theoretically grounded and clinically useful measure of craving, and developed a brief, 
psychometrically equivalent version suitable for time-limited settings. The study also 
extended upon previous validation studies of the ACE questionnaire, providing previously 
unestablished predictive validity and test-retest reliability estimates. The ACE questionnaires 
are subsequently among the most rigorously evaluated measures of alcohol craving. The 
strength of the ACE questionnaires lay within their theoretical base and clinical utility. As 
detailed discussion of the applications of the ACE questionnaires was beyond the scope of 
Chapter Two, Chapter Three aims to extend upon this discussion. A detailed overview of 
suitable applications of the ACE is provided, including discussion of its strengths and 
limitations. This chapter was written as a book chapter targeted at AUD researchers and 
treatment providers to assist in selection a craving measure suited to their research questions, 
theoretical orientation, treatment approach, and context. 
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3.2 Abstract 
Craving for alcohol or a strong desire or urge to consume it, is a diagnostic marker of 
Alcohol Use Disorder (AUD). Within clinical settings, appropriate craving assessment can 
inform diagnosis, prognosis, treatment, and evaluation of treatment outcome. A number of 
craving instruments are available which complicates measure selection. Important 
considerations in measure selection include: the measure’s definition and theoretical 
foundation of craving, psychometric integrity, administration demands, temporal reference, 
and clinical utility. This chapter reviews these aspects as they relate to the Alcohol Craving 
Experience (ACE) Questionnaire. 
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3.3 Definition of Craving 
Craving, or a strong desire or urge to use a substance, is a diagnostic marker of 
Alcohol Use Disorder (AUD) in the DSM-5 (American Psychiatric Association, 2013) and 
ICD-10 (World Health Organization, 1992). Craving has long been a target of cognitive-
behavioural interventions for substance use and, more recently, pharmacotherapy 
(Addolorato et al., 2005; Connor et al., 2016; Haass-Koffler et al., 2014). While a number of 
definitions for substance craving exist, the American Psychiatric Association (APA) defines 
alcohol craving as “a strong desire to drink that makes it difficult to think of anything else” 
(American Psychiatric Association, 2013). A craving instrument consistent with this 
definition can inform AUD diagnosis,  prognosis, treatment, and outcome evaluation (Tiffany 
& Wray, 2012). 
3.4 Craving Measurement 
Despite being a prominent topic in addiction research and treatment over the past 50 
years, craving measurement remains controversial. A lack of consensus on the definition of 
craving has contributed to the development of a broad range of craving instruments. This 
chapter restricts discussion to self-report craving instruments, as non-verbal techniques are 
generally only used in research environments. Key considerations underlying measure 
selection include the measure’s: definition and theoretical foundation, temporal reference, 
psychometric integrity, administration demand, and clinical utility. Here, we outline the key 
theoretical and psychometric properties of the Alcohol Craving Experience (ACE) 
questionnaire (Statham et al., 2011).  
The ACE comprises two 11-item scales assessing the strength (ACE-S) and frequency 
(ACE-F) of past week craving-related cognitions (Statham et al., 2011). Response options for 
all items lie on an 11-point visual analogue scale (anchored 0 = Not at all; 10 = 
Extremely/Constantly). The items of each scale are semantically consistent, and load onto 
three factors consistent with EI Theory (Kavanagh, Andrade, & May, 2005). Items 1-3 of 
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each scale assess the respondent’s experience of feeling an urge or need to use a substance. 
Items 4-8 assess the presence of craving related imagery across four sensory modalities 
(visual, olfactory, gustatory, and oral tactile) and a general sense of how their body would 
feel if they had a drink (Table 3-1). The final three items 9-11 assess the intrusiveness of 
craving thoughts and the degree to which they interfere with other cognitive activity. 
 
Table 3-1. Composition of the Alcohol Craving Experience Questionnaire (ACE). 
Factor Strength Scale (ACE-S) Frequency Scale (ACE-F) 
Intensity At that time… Over the last week how often… 
  1 …how much did you want it? …/did you want it? 
  2 …how much did you need it? …did you need it? 
  3 …how strong was the urge to have it? …did you have a strong urge for it? 
Imagery At that time, how vividly to/did you… Over the last week how often did you… 
  4 …picture it? …picture it? 
  5 …imagine its taste? …imagine its taste? 
  6 …imagine its smell? …imagine its smell? 
  7 
…imagine what it would feel like in your mouth and 
throat? 
…imagine what it would feel like in your 
mouth and throat? 
  8 …imagine how your body would feel? …imagine how your body would feel? 
Intrusiveness At that time… Over the last week how often… 
  9 …how hard were you trying not to think about it? …were you trying not to think about it? 
  10 …how intrusive were the thoughts? …were the thoughts intrusive? 
  11 …how hard was it to think about anything else? …was it hard to think about anything else? 
 
 
3.4.1 Definition and theoretical foundation  
Accurate interpretation of a craving measure is reliant upon understanding the 
developers’ theoretical approach to craving. Craving measures often include constructs that 
are correlated, yet theoretically distinct from common definitions (Kavanagh, et al., 2013). 
Expectations of alcohol effects (outcome expectancies; Anton, Moak, & Latham, 1995; 
Raabe, Grüsser, Wessa, Podschus, & Flor, 2005), drinking refusal self-efficacy (Flannery, 
Volpicelli, & Pettinati, 1999), intention to use (R F Anton et al., 1995; Raabe et al., 2005), 
and perceived control of drinking are commonly included within popular craving scales. 
These are examples of correlated constructs, many of which have independently validated 
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measures. Such multidimensional ‘craving’ measures require careful interpretation to parse 
variance attributable to craving from alternative constructs. This is most important in clinical 
settings where these constructs have unique implications for diagnosis and intervention.  
The ACE was developed from Elaborated Intrusion (EI) Theory (Kavanagh et al., 
2005) with the explicit goal of measuring only the cognitive aspects of alcohol craving.  EI 
Theory is a general theory of desire experiences, defining them as  “affectively laden 
cognitive events, where an object or activity and associated pleasure or relief are in focal 
attention” (May, Kavanagh, & Andrade, 2015).  EI Theory may be used as an extension of 
neurobiological models, where addictive substances are proposed to sensitise physiological 
mechanisms responsible for appetitive behaviours (T. E. Robinson & Berridge, 1993). In the 
context of desires for substances, EI Theory proposes that physiological, environmental, and 
emotional cues can provoke drug-related representations in memory through unconscious 
associative processes. Seemingly spontaneous thoughts about the pleasure or relief associated 
with substance use are then more likely to intrude into conscious awareness. This is initially 
pleasurable, but also elicits an awareness of physiological deficit. These affective responses 
prompt controlled processing, involving elaboration in working memory, which further 
intensifies the affective reactions. Importantly, intense craving involves multisensory 
substance-related imagery, which is closely linked to emotion (Kavanagh, May, & Andrade, 
2009). Anticipated delays in obtaining the desired substance make the associated sensory 
imagery highly aversive, as physiological deficits progressively become more salient. 
Craving subsequently intensifies unless the target substance is acquired or attention is 
redirected. Figure 3-1 illustrates these theoretical processes. The ACE reflects EI Theory by 
assessing the subjective experience of desire for alcohol, the presence and nature of alcohol 
related imagery, and the perceived intrusiveness of alcohol related cognitions.  
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Figure 3-1. The Elaborated Intrusion Theory of Desire (Kavanagh et al., 2005). 
 
3.4.2 Temporal reference 
Given the temporal variability in craving, the time frame respondents are asked to 
recall is an important consideration in measurement selection. A common limitation among 
craving scales is retrospective consideration of craving experiences. Scales often require 
respondents to create averages or typical summaries of past craving. This introduces memory 
bias complicated by fluctuations in pattern, intensity, and frequency of craving. Alternatively, 
‘real-time’ assessments of craving ask respondents to report on their experience in the present 
moment. Such methods are popular in laboratory studies because of their high temporal 
control. However, real-time measures may not be suitable within clinical settings, where the 
time and context is not representative of their typical experience. Real-time measures may 
also be subject to ‘reactivity’, whereby asking the respondent to reflect on an experience 
alters the experience in question (Perlmuter, Noblin, & Hakami, 1983). For example, asking 
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respondents to rate their current level of craving for alcohol, may draw attention to, and 
increase their current levels of craving. 
As an alternative to retrospective averaging, the ACE-S focuses on recalling when 
craving was most intense during the past week. This represents a discrete, salient experience. 
This is proposed to reduce errors attributable to difficulties averaging dynamic craving 
experiences, and help identify periods of high lapse risk (Statham et al., 2011). The ACE-F 
asks patients to rate the perceived frequency of desire-related cognitions over the past week. 
Assessment of peak strength and frequency of craving provides a detailed profile of the 
respondent’s craving experiences. Further research is required to examine if this method 
reduces the impact of memory bias as intended.  
3.4.3 Psychometric integrity  
The integrity of addiction research and treatment is reliant on the validity and 
reliability of assessment measures. Psychometric properties of the ACE have been assessed 
within several studies (Coates et al., 2017; May et al., 2014; Statham et al., 2011). As noted, 
craving measures are required to be interpreted through their proposed definitions and 
theoretical models to maintain construct validity. The theoretical foundation of the ACE 
provides a framework by which construct validity may be assessed. The proposed 3-factor 
structure has been supported by exploratory and confirmatory factor analysis in alcohol 
dependent samples (Coates et al., 2017; May et al., 2014; Statham et al., 2011). A substance 
non-specific version of the ACE - the Craving Experience Questionnaire (CEQ) - has also 
been tested and structurally validated for cigarette, food, and chocolate craving (May et al., 
2014). This provides strong evidence that the ACE measures the three intended factors drawn 
from EI Theory.  
Validity may be further assessed by demonstrating relationships with an alternative 
measure of the same construct (concurrent validity), or between predicted correlates 
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(convergent and discriminant validity). The obsessions subscale of the Obsessive Compulsive 
Drinking Scale is currently one of the most theoretically valid and commonly used measures 
of alcohol craving (Kavanagh et al., 2013). The ACE Frequency (ACE-F) and Strength 
(ACE-S) forms correlate .46 to .60 with the OCDS-O (Statham et al., 2011; Coates et al., 
2017) indicating that they share sufficient variance as to reflect similar underlying constructs. 
Importantly, they diverge sufficiently to suggest the ACE examines unique variance in 
craving.  
Perhaps the most heavily weighted psychometric property considered in craving 
assessment is the capacity to predict substance-use and treatment outcome (predictive 
validity). A one standard deviation increase in the ACE-F and ACE-S increased the odds of 
lapse or discontinuation of CBT for AUD by 69% and 59% respectively, compared to 10% 
for the OCDS-O (Coates et al., 2017). These findings indicate that the ACE has prognostic 
utility, and the unique variance captured relative to the OCDS-O is important for the 
assessment of alcohol lapse risk.   
The ability of a measure to produce consistent results over repeated assessments (test-
retest reliability) is among the most important metrics to consider in scale evaluation.  As 
craving is a highly dynamic construct, variant over time and context, demonstration of test-
retest reliability is less applicable, except where all the relevant conditions can be held 
constant (Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996). Test-retest reliability of all ACE 
scales is acceptable, with correlation coefficients greater than .73 following a 7-day interval 
between assessments (Coates et al., 2017). As the respondents were seeking treatment for 
AUD and attempting abstinence during this period, the true stability of the ACE scales is 
likely underestimated. The most commonly reported index of reliability is the degree to 
which the items of a measure correlate (internal consistency), and is typically measured by 
Cronbach’s alpha (Cronbach, 1951). The ACE-F and ACE-S have consistently demonstrated 
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good internal reliability, with Cronbach’s alpha exceeding the recommended 0.90 in all 
studies (Coates et al., 2017; May et al., 2014; Statham et al., 2011).  
3.4.4 Administration demand 
Administration burden of assessment instruments is a key consideration with research 
and clinical practice. A national survey of 152 substance abuse treatment agencies in the U.S. 
found 96% of services report craving is a useful marker of dependence, 99% think it is useful 
to assess craving in treatment planning, and 97% report it as a useful predictor of lapse 
(Figure 4-2; Pavlick, Hoffmann, & Rosenberg, 2009). However, only 5% assess craving with 
standardized self-report craving measures, opting instead for single-item or non-standard 
open-ended questions (Pavlick et al., 2009). The reluctance of addiction services to apply 
standardised measures may reflect the perceived administration burden in busy clinical 
settings. The full OCDS, for example, has fourteen questions, each with five alternative 
response sentences that the respondent must read and select from, and runs to three A4 pages 
in most formats.  
Although the two 11-item ACE scales only require selection of a continuous value, 
administration of all 22 items can be considered too time-consuming for routine clinical use. 
For such purposes, a brief, 5-item Mini Alcohol Craving Experience Questionnaire (MACE, 
Coates et al., 2017) has been developed from the ACE-F with at least one item retained from 
each factor. Frequency of craving was selected as the focus, as repeated temptations were 
expected to offer a particular challenge to sustained behavioural control. Psychometric 
integrity was preserved within the MACE, with key strengths relative to other brief craving 
measures including excellent construct validity, predictive validity, and acceptable test-retest 
reliability.  
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Figure 3-2. While most practitioners recognise the value of assessing craving, there is little consistency in measurement approach and 
very few use a published scale (data from Pavlick, et al., 2009). 
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3.4.5 Clinical utility 
Effective craving measures may inform diagnosis when the theory and content of the 
measure are consistent with DSM-5 or ICD-10 definitions of craving. Prognosis and lapse 
risk may be informed by the predictive validity of a measure. When the underlying theory of 
the measure is consistent with an intervention, craving measures can also assist selection of 
treatment strategies. Additionally, craving measures may be implemented to monitor craving 
as a marker of treatment response (Tiffany et al., 2011). 
The DSM-5 definition of craving, “a strong desire to drink that makes it difficult to 
think of anything else and that often results in the onset of drinking”, (APA, 2013) is highly 
consistent with the items and underlying theory of the ACE, supporting its suitability as a 
diagnostic aid. All scales of the ACE have further demonstrated predictive validity, providing 
addiction professionals with prognostic information regarding risk of treatment lapse or 
dropout. By carefully interpreting each of its scales, the ACE can guide treatment planning. 
For example, it may be that patients with low craving frequency, but high peak strength, 
benefit more from a close analysis of triggers for that specific, particularly risky situation. 
Alternatively, patients with high frequency but low peak strength may respond well to 
mindfulness and acceptance strategies, since the primary challenge that they face is the need 
to maintain resistance to low-level temptations. Insight may be further enriched by 
consideration of the sub-factors reflecting core elements of elaborated intrusion processes. 
This information may enrich mindfulness and acceptance based therapies, which promote 
awareness of key cognitive and sensory experiences. Such approaches are consistent with EI 
Theory, as the promotion of cognitive and emotional ‘defusion’ from craving related 
cognitions is proposed to impede previously automated elaboration (May et al., 2015).  
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In addition to being consistent with current craving treatment approaches, the 
theoretical foundation of the ACE facilitates identification of novel treatment targets. For 
example, as craving-related cognitions occupy limited working memory capacity, craving 
may be reduced by cognitive tasks competing for the same working memory processes. As 
cognitive load is highest within the substance’s most prominent sensory modality, imagery-
based tasks targeting this modality reduce craving strength (Kavanagh et al., 2009). For 
example, imagery of visual or olfactory stimuli has been demonstrated to reduce craving for 
cigarettes, coffee, and food more than verbal or auditory tasks (Kemps & Tiggemann, 2007; 
May, Andrade, Panabokke, & Kavanagh, 2010; Versland & Rosenberg, 2007). Recent 
research has directly employed  EI Theory in the development of new craving management 
techniques (Kemps & Tiggemann, 2013; Knäuper, Pillay, Lacaille, McCollam, & Kelso, 
2011; Rodríguez-Martín, Gómez-Quintana, Díaz-Martínez, & Molerio-Pérez, 2013; Skorka-
Brown et al., 2014). While concurrent tasks may provide brief respite from especially intense 
craving, imagery about proximal benefits of control may have the advantage of not only 
competing with craving for working memory resources, but may also enhance motivation for 
control (Kavanagh, Andrade, May, & Connor, 2014). Application of this contention in other 
behavioural domains provides support for its utility (Andrade, Khalil, Dickson, May, & 
Kavanagh, 2016).  
The availability of information on the patient’s strongest recent experience of craving, 
as well as the perceived frequency of past week craving, affords useful clinical information to 
addiction practitioners. Clinical value of the ACE-S is derived from the identification of 
patients’ strongest bouts of craving. Exploring these salient episodes can facilitate clear 
identification of triggers, evaluation of coping strategies, and planning for future scenarios. 
Furthermore, assessing the perceived frequency of craving symptoms provides a useful 
indicator of prevalence. The availability of the brief MACE maximises the practicability of 
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undertaking this assessment on repeated occasions in clinical practice. The National Institute 
on Drug Abuse recommends craving as an outcome measure for substance-use disorders 
clinical trials (Tiffany et al., 2011). Given the ACE’s consistency with diagnostic definitions 
of craving and its multidimensional assessment across both frequency and peak strength of 
craving, it is a comprehensive measure suitable for both clinical and research environments. 
3.4.6 Limitations and practical considerations 
 There are several limitations to be considered prior to administration. First, the ACE 
does not measure the duration of craving experiences, although it is not currently clear 
whether doing so would yield useful prognostic information. Another potential limitation is 
the retrospective time period. The ACE asks patients to reflect on the past week, which would 
be problematic in settings requiring more frequent craving assessment. However, the 
generalization of the ACE-F, the CEQ-F has been applied across a wide range of time 
periods, down to a few minutes (May et al., 2014). A final consideration in the selection of 
any craving measure, is that scores are carefully interpreted within a clear definition and 
theoretical framework. Interpretation of the ACE through the lens of EI Theory is likely to 
improve understanding of research outcomes and individual experiences.   
3.5 Conclusions 
 Craving has long been a focal point of addiction research and treatment. Craving 
assessment remains a contentious and continually evolving field. Numerous self-report 
measures have been developed, though there is inconsistency in the definitions and theory 
used. Measures also differ in psychometric integrity, administration demand, temporal focus, 
and clinical utility. There is currently no measure suitable across purposes and context, so 
selection of an appropriate craving measure requires careful consideration. The ACE’s 
consistency with diagnostic definitions of craving, strong theoretical foundation, and 
assessment of peak strength and frequency of craving, deem this measure suitable for 
repeated use in clinical and research environments. 
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4.1 Chapter Foreword 
Chapters 2 and 3 have examined the construct of alcohol craving, focusing on 
properties of measurement affecting its suitability as a candidate target for intervention within 
personalised AUD interventions. Here, attention turns toward another common construct 
targeted within AUD treatment, alcohol outcome (see 1.4.1.2 Alcohol Outcome 
Expectancies). Most research examining the efficacy of targeting outcome expectancies to 
alter drinking behaviour has studies non-clinical convenience samples.) Few studies have 
examined the relationships between expectancy change and AUD treatment response. There 
is subsequently little empirical evidence to support to efficacy of targeting expectancies 
within AUD interventions. This chapter is an empirical paper, published during candidature, 
which aimed to review current evidence for the relationship between expectancy change and 
treatment response. The study extends upon this literature by examining differences in patient 
alcohol expectancies pre and post AUD treatment.  
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4.2 Abstract 
Background and Aims: Modification of elevated positive expectations of alcohol 
consumption (alcohol outcome expectancies; AOEs) is a key feature of Cognitive Behaviour 
Therapy (CBT) approaches to Alcohol Use Disorders (AUDs). Despite extensive research 
supporting the efficacy of CBT for AUD, few studies have examined AOE change. This 
study aimed to assess AOE change following completion of CBT for AUD and its association 
with drinking behaviour.   
Method: One-hundred and seventy-five patients who completed a 12-week CBT program for 
AUD were administered the Drinking Expectancy Questionnaire (DEQ) at pre-treatment 
assessment and upon completion of treatment. Abstinence was achieved by 108 (61.7%) of 
completing patients. For patients who lapsed, the mean proportion of abstinent days was 93 
percent.  
Results: DEQ scales assessing expectations of positive alcohol effects on tension reduction, 
assertiveness, and cognitive enhancement were significantly lower post-treatment (p < 
0.001).  Expectations of negative effects on mood were higher post-treatment (p < 0.001). 
The largest AOE change occurred on the tension reduction scale. Greater percentage of 
abstinent days over treatment was associated with lower pre-and post-treatment tension 
reduction expectancy scores (p < 0.05). Drinking during treatment was associated with 
smaller changes in expectations of negative effects of alcohol on mood (p < 0.05).  
Conclusions: Individuals who completed CBT treatment for AUD showed significant AOE 
change. Tension reduction and affective change expectancies may be particularly important 
for abstinence and useful markers of lapse risk.   
 
Keywords: 
Alcohol Use Disorder, Alcohol Outcome Expectancy, Cognitive-Behaviour Therapy, Alcohol 
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4.3 Introduction 
Cognitive-Behaviour Therapy (CBT) is effective in the treatment of Alcohol Use 
Disorder (AUDs; Connor, Haber, & Hall, 2016; Haber, Lintzeris, Proude, & Lopatko, 2009). 
Central to CBT for AUDs are cognitive constructs associated with the patient’s beliefs about 
the effects of alcohol (Beck et al., 1993; Marlatt & Gordon, 1985; Witkiewitz & Marlatt, 
2004). Motivation to drink among AUD populations is  informed by positively biased 
cognitions regarding the effects of alcohol (Bandura, 1999; Beck et al., 1993). Social-
cognitive theory refers to these cognitive mechanisms as Alcohol Outcome Expectancies 
(AOEs; Bandura, 1977). AOEs are strongly implicated in drinking initiation, quantity and 
frequency of use, progression to problematic use, and maintenance of AUDs (Jones et al., 
2001; Monk & Heim, 2013; R. McD Young & Oei, 1993). However, few studies have 
examined AOEs in treatment settings.  
Social-cognitive theory proposes that human behaviour is determined by two core 
cognitive constructs, beliefs regarding the outcome of a behaviour or event (outcome 
expectancies) and a person’s confidence in their ability to complete a certain behaviour (self-
efficacy; Bandura, 1977, 1986). AOEs may be positive, for example ‘drinking alcohol helps 
me relax’, or negative, ‘I become aggressive when I drink’. While positive AOEs inform 
motivation to drink, negative AOEs align with motivation to restrain from drinking 
(McMahon & Jones, 1993). Positive AOEs have been suggested to prompt onset of drinking, 
while the salience of negative expectancies mediates progression to alcohol misuse (Lee et 
al., 1999). Experimental designs have shown it is possible to manipulate AOEs to decrease 
(Darkes & Goldman, 1993) or increase drinking (Roehrich & Goldman, 1995), supporting the 
efficacy for targeting AOEs within treatment.   
Cognitive Therapy of Substance Use Disorders considers two forms of AOEs, 
‘anticipatory’ and ‘relief’ oriented (Beck et al., 1993). Anticipatory beliefs, refer to 
expectations of positive reinforcement. The most widely identified anticipatory beliefs within 
AOE assessments include: improved social assertiveness, enhancement of sexual confidence 
and enjoyment, and enhancement of cognitive function (Brown, Christiansen, & Goldman, 
1987; Nicolai, Demmel, & Moshagen, 2010; R. McD Young & Oei, 1996). Relief-oriented 
beliefs are expectations of negative-reinforcement, such as drinking alcohol to relieve tension 
or emotional distress. AOE measures commonly capture relief oriented beliefs within a factor 
reflecting tension reduction (Brown et al., 1987; Nicolai et al., 2010; R. McD Young & Oei, 
1996). Positive AOEs are targeted within CBT by assessing addiction-related beliefs, 
challenging the accuracy of maladaptive beliefs, developing alternative control beliefs, and 
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examining their advantages and disadvantages (Beck et al., 1993; Carroll, 2008; Barbara S 
McCrady, 2014). Negative AOEs are commonly addressed by motivational interviewing (MI) 
techniques. Within MI, negative outcomes of drinking are selectively attended to in order to 
resolve ambivalence by developing discrepancy between the perceived benefits and 
consequences of drinking (Miller & Rollnick, 2012). Successful alteration of unhelpful AOEs 
is proposed to reduce motivation to drink and enhance drinking refusal self-efficacy 
(Bandura, 1999; Gullo et al., 2010; R. McD Young & Oei, 1993). 
Despite the position of AOEs within cognitive conceptualisations of AUD, there is 
limited evidence supporting their role in treatment response (Jones et al., 2001; Kouimtsidis, 
Stahl, West, & Drummond, 2014). While several studies have found lower positive AOEs to 
be predictive of better treatment outcomes (Brown, 1985; Brown, Carrello, Vik, & Porter, 
1998; Connors, Tarbox, & Faillace, 1993), this finding is not consistently replicated 
(Solomon & Annis, 1990; R McD Young et al., 2011). Jones and McMahon found stronger 
delayed negative AOEs, but not immediate negative or positive AOEs, were predictive of 
improved treatment outcomes (Jones & McMahon, 1994, 1996). Crucial to the validity of 
targeting AOEs within treatment is demonstrating expectancy change, however, AOE change 
and its relationship with treatment response is rarely assessed. The majority of research 
examining AOE change has used convenience samples of non-alcohol dependent college 
students. In these studies, behavioural and cognitive paradigms have demonstrated efficacy in 
changing AOEs and reducing consumption; though these effects are typically not maintained 
beyond four weeks (Scott-Sheldon et al., 2012).  
With respect to clinical settings, Brown and colleagues (1998) examined AOE change 
of 101 patients across a four week abstinence-oriented AUD treatment program. Small, 
statistically significant changes were observed on social assertiveness and tension reduction 
AOEs, but not on sexual enhancement, social and physical pleasure, or arousal and power. 
Among 63 problem drinkers Connors, Tarbox, and Faillace (1993) found no change in 
positive AOEs following an 8-week behavioural treatment for alcohol misuse. However, a 
significant relationship between reduction in positive AOEs (social assertiveness and tension 
reduction) and reduced drinking behaviour was observed at 18-month follow up. Young et al. 
(2011) found reductions in social assertiveness, tension reduction, cognitive improvement, 
and sexual enhancement AOEs among 164 patients following a 12-week CBT program for 
AUD. Negative expectations of affective change were more strongly endorsed post-treatment. 
No significant differences in AOE change were observed between patients who completed 
treatment abstinent and those who lapsed; though trends toward significance of lower social 
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assertion and sexual enhancement scores among abstinent patients were reported. Jones and 
McMahon (1996) followed 151 patients who attended a 2-week residential detoxification 
programme, conducting monthly assessments for 12-months. Although detoxification was not 
intended to address AOEs directly, reductions were observed on the positive AOEs physical 
and social pleasure and social assertiveness, but not sexual enhancement, tension reduction, 
or negative AOEs. When pre-treatment negative AOEs were controlled within the analysis, 
greater increase in distal negative AOEs was associated with longer maintenance of 
abstinence.   
These studies provide limited support for the hypothesis that AOEs change with 
treatment, and mixed evidence for the role of expectancy change in treatment response. 
Interpretation of these findings is complicated by variations in treatment approach, sample 
characteristics, and substantial methodological and statistical limitations. Widely recognised 
covariates of AOEs such as dependence severity (Connor, Gudgeon, Young, & Saunders, 
2007), age (Monk & Heim, 2013; Mooney, Fromme, Kivlahan, & Marlatt, 1987), and gender 
(Mooney et al., 1987; Read, Wood, Lejuez, Palfai, & Slack, 2004) were not controlled within 
any of the studies, with the exception of Jones and McMahon (1996). Drinking behaviours 
were either not reported (Brown et al., 1998), or collapsed within less sensitive categorical 
variables (Connors et al., 1993; Jones & McMahon, 1996; R McD Young et al., 2011). As the 
intention of all treatments was to help patients abstain from alcohol, the relationship between 
drinking behaviour and AOE change is important to the interpretation of results. For 
example, social-cognitive theory predicts that as AOEs become less positive, or more alcohol 
averse, drinking behaviour declines (Bandura, 1999; Wiers et al., 2003). Alternatively, 
positive experiences with reduced drinking behaviour may serve as naturalistic behavioural 
experiments which challenge long-held biased AOEs (Wiers et al., 2003). More sensitive 
measures of drinking behaviours are required to examine these potential relationships. 
4.3.1 Aim and Hypotheses 
AOE change is hypothesized to be an important component of successful AUD 
treatment. This study examined AOE change after completion of CBT for AUD (R McD 
Young et al., 2011). Positive AOEs were predicted to significantly reduce over treatment. 
The largest change was expected on the Tension Reduction and Assertiveness measures 
(Brown et al., 1998; R McD Young et al., 2011). Negative AOEs were expected to be more 
strongly endorsed post-treatment (R McD Young et al., 2011). Greater AOE change was 
predicted to be associated with more abstinent days over treatment.  
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4.4 Method 
4.4.1 Participants and procedures 
Data were available from 445 patients who began a 12-week abstinence-oriented CBT 
program for AUD. Of these, 175 (39.3%) completed the treatment episode. Treatment was 
conducted in a metropolitan tertiary university hospital alcohol and drug out-patient service. 
Participation was voluntary. The program included standardised assessment, addiction 
physician review, and eight one-hour individual sessions of CBT with a registered clinical 
psychologist. The treatment goal was abstinence as controlled drinking is not a recommended 
aim among patients with severe AUD (Connor et al., 2016; Kirshenbaum, Olsen, & Bickel, 
2009; Schuckit, 2009). Common targets for intervention included: identification and 
alteration of alcohol expectancies, enhancement of drinking refusal self-efficacy, craving 
management, development of alternative coping strategies, and problem-solving skills 
training. Eligibility for the alcohol abstinence program was assessed via a structured clinical 
interview by an experienced registered nurse or social worker upon first presentation. 
Inclusion in the project required that patients meet DSM IV-TR criteria for alcohol 
dependence and be seeking abstinence as the primary treatment goal (not controlled 
drinking). Patients were excluded from the study if they had a comorbid substance 
dependence (with the exception of nicotine), were taking Disulfiram or any prescribed opioid, 
or if they could not provide written, informed consent. 
Eligible patients completed the pre-treatment questionnaire and scheduled their first 
appointment with a clinical psychologist within seven days. Blood Alcohol Level (BAL) was 
estimated by breathalyser test at the beginning of each session. Patients recording a non-zero 
reading were not seen that day and rescheduled. The questionnaire was readministered at the 
conclusion of the 12-week treatment episode. Human ethics approval was obtained. 
4.4.2 Measures 
4.4.2.1 The Alcohol Use Disorders Identification Test (AUDIT; Saunders, Aasland, Babor, 
de la Fuente, & Grant, 1993).  
The AUDIT interview version was administered during intake assessment by experienced 
alcohol and drug nursing staff. It comprises 10-items assessing recent alcohol use, symptoms 
of alcohol dependence, and alcohol related problems (Saunders et al., 1993). The AUDIT has 
good internal reliability, sensitivity, and specificity (Saunders et al., 1993). Higher scores 
indicate increased risk of harmful drinking and likelihood of AUD. 
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4.4.2.2 Drinking Expectancy Questionnaire (DEQ; Young & Oei, 1996).  
The DEQ assesses positive and negative AOEs via a 43-item self-report measure. Response 
options are a Likert scale ranging from one “Strongly Disagree” to five “Strongly Agree”. 
The DEQ contains six subscales: Assertion (10-items), Sexual Enhancement (5-items), 
Cognitive Change (4-items), Tension Reduction (4-items), Affective Change (12-items), and 
Dependence (8-items). The Assertion, Sexual Enhancement, Cognitive Change, and Tension 
Reduction sub-scales are considered positive AOEs, as they all assess expectations of positive 
effects of alcohol. The Assertion scale assesses positive beliefs regarding social confidence 
and assertiveness (e.g. “Drinking makes me feel outgoing and friendly”). The Sexual 
Enhancement scale refers to expectations of enhanced feelings of attractiveness and sexual 
interest (e.g. “I often feel sexier after I’ve been drinking”). The Cognitive Change scale 
assesses beliefs of improved thought generation and clarity (e.g. “Drinking alcohol helps me 
be more mentally alert”). The Tension Reduction scale evaluates beliefs about the relaxing 
effects of alcohol (e.g. “I drink to relieve tension”). The Affective Change scale measures 
beliefs regarding the effects of alcohol on negative mood states, such as sadness, irritability, 
and aggressiveness (e.g. “Drinking makes me bad tempered”), and is considered a negative 
AOE. Finally, the Dependence scale reflects beliefs regarding a personal sense of addiction 
(e.g. “I am addicted to alcohol”) and perceived loss of control when drinking (e.g. “I cannot 
always control my drinking”). As the Dependence scale assesses beliefs beyond the acute 
effects of alcohol, it is considered to be a broader construct than the other scales (R McD 
Young et al., 2011). The DEQ has demonstrated internal and test re-test reliability, as well as 
construct, criterion, and predictive validity (R. McD Young & Oei, 1996). Within the present 
sample, internal consistency was acceptable (α > 0.70) for the Assertion (α = 0.80), Sexual 
Enhancement (α = 0.78), Cognitive Change (α = 0.71), and Affective Change (α = 0.83) 
scales. Cronbach’s α for the Tension Reduction (α = 0.57) and Dependence (α = 0.64) scales 
were less robust, however, confirmatory factor analysis yielded acceptable model fit for the 
six scale DEQ (Robust Root Mean Square Error of Approximation = 0.064, 95%CI = 0.061, 
0.068; Standardized Root Mean Square Residual = 0.09) (Hu & Bentler, 1999). 
4.4.2.3 Drinking Behaviour.  
Guided by the Time-Line Follow-Back procedure (L. C. Sobell & Sobell, 1992), patients 
were asked to recall days when they consumed alcohol since the previous treatment session. 
Drinking behaviour was operationalised by the number of days alcohol was consumed over 
treatment. The total abstinent days was divided by the number of days the patient was in 
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treatment to generate a standardised variable indicating the proportion of abstinent days over 
treatment. 
4.4.3 Data Analysis 
4.4.3.1 Expectancy Change.  
As data were hierarchically structured, with assessment time (pre-treatment and post-
treatment) nested within patient, expectancy change over treatment was assessed using multi-
level modelling (MLM) in R package ‘lme4’  (Bates, Mächler, Bolker, & Walker, 2015a). 
Models were fitted using maximum likelihood estimation. Statistical significance of fixed-
effects was tested using Satterthwaite’s approximated degrees of freedom (Giesbrecht & 
Burns, 1985; Manor & Zucker, 2004). Separate MLM analyses were conducted for each DEQ 
scale, with DEQ scale score as the outcome variable. Baseline models included an intercept, 
and assessment time (0 = pre-treatment, 1 = post-treatment) to reflect degree of expectancy 
change over treatment. To control for potential moderation of expectancy change by non-
hypothesised variables, covariate × ‘assessment time’ interaction terms were included, but 
only retained if statistically significant. In step 2 ‘percentage of abstinent days’ x ‘assessment 
time’ interaction terms were included to assess the hypothesised moderation effect.  
4.4.3.2 Scale comparison and practical interpretation:   
As the analyses are conducted on sub-scale scores, the effects across unstandardized sub-
scales are not comparable due to differences in the number of comprising items and resultant 
score ranges. The degree to which a respondent endorses a particular AOE is also not 
intuitive based on sub-scale total scores. To facilitate comparison of effects across scales and 
interpretation of scale endorsement pre and post-treatment, fixed-effect estimates were 
divided by the number of items within the respective scale to generate item-average estimates 
(Cohen, Cohen, Aiken, & West, 1999a). Estimate ranges reflect the item-level Likert scale, 
where an estimate of 5 indicates ‘complete endorsement’, 3 is ‘neutral’, and 1 indicates 
‘complete disagreement’.   
4.4.3.3 Expectancy Change and Community Norms 
To gauge clinical significance of change, expectancy scores pre and post-treatment 
were compared to community norms using independent samples t-tests. Community 
normative data (n = 778) reported in the Drinking Expectancy Profile Test Manual (R. McD 
Young & Oei, 1996) were used for reference.  Jacobson and Truax’s (1991) Reliable Change 
Index (RCI) was used to assess the degree of change relative to community norms while 
controlling for measurement error attributable to test-retest reliability. An RCI score greater 
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than 1.96 was classified as "reliable change", indicating that the degree of change was greater 
than 1.96 standard deviations on a community sample distribution. 
4.5 Results 
4.5.1 Descriptive Statistics and Missing Data 
One-hundred seventy-five (39.3%) patients completed treatment, comprising the 
primary sample for analysis. A summary of sample characteristics for completers and non-
completers is reported in Table 4-1. Independent samples t-tests revealed no significant 
differences (p > 0.05) in age or DEQ scale scores at baseline. AUDIT scores of non-
completers were higher (ΔM = 1.84, SE = 0.85), t(443) = 2.16, p = 0.031, 95% CI (0.17, 
3.52). Pearson Chi-Square revealed no significant difference in gender proportions between 
groups (p > 0.05). Abstinence was achieved by 108 (61.7%) of patients who completed the 
treatment program. Of those who lapsed, the mean proportion of abstinent days was 93%.   
Table 4-1. Patient sample characteristics*. 
 
Completers 
n = 175 
Non-Completers 
n = 270 
 
Age, years  43.05 (10.80) 40.99 (11.30)  
Sex, female (n, %) 60 (34.3%) 94 (34.8%)  
AUDIT Total 26.21 (9.31) 28.05 (8.43)  
Sessions Complete 7.59 (1.20) 4.06 (1.88)  
Pre-treatment DEQ score 
  Assertion 35.70 (6.65) 36.49 (6.38) 
 
  Affective Change 34.45 (7.71) 34.92 (8.42)  
  Dependence 27.32 (4.57) 27.27 (4.94)  
  Sexual Enhancement 15.46 (3.62) 15.24 (4.40)  
  Cognitive Change 9.21 (2.80) 9.18 (3.03)  
  Tension Reduction 14.83 (2.66) 15.05 (3.08)  
*Scores are presented as mean (SD) unless otherwise specified.  
4.5.1.1 Expectancy Change 
Multilevel modelling was used to assess change in DEQ scale scores over treatment and 
potential covariate moderation by age, gender, and AUDIT score. Table 4-2 provides a 
summary of the final models for each DEQ scale. The main effect of ‘assessment time’ (Post-
treatment) was significant for all DEQ scales except Sexual Enhancement. All positive AOE 
scores were lower post treatment, while the negative scale, Affective Change, was higher.  
4.5.1.2 Drinking Behaviour  
Greater percentage of drinking days over treatment was associated with higher Tension 
Reduction and Dependence sub-scale scores both Pre-Treatment and Post-Treatment. 
Percentage of drinking days was not predictive of any other AOE scale. ‘Percentage of 
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drinking days’ x ‘assessment time’ interaction terms were non-significant for all positive 
AOEs, but significant for the negative Affective Change scale. This indicated that greater 
drinking over treatment was associated with less change in this scale.  
4.5.1.3 Covariates.  
Younger age was associated with higher Assertiveness and Sexual Enhancement scale 
scores, and lower negative Affective Change scores. Greater age was associated with 
significantly less change in Tension Reduction and Dependence scale scores, resulting in 
significantly higher scores post-treatment. Females reported significantly higher Tension 
Reduction, Assertiveness, and Dependence scores. Gender did not moderate degree of change 
in any scale. AUDIT scores were not predictive of DEQ scale scores. Higher AUDIT scores 
were associated with less change in the negative Affective Change scale.  
 
Table 4-2. Summary of final multilevel models for each scale of the Drinking 
Expectancy Questionnaire. 
Scale Parameter Unstandardised β t 
Tension Reduction Fixed Effects    
   Intercept 15.571 (0.914) 17.04*** 
   Time (Post-Treatment) -7.642 (1.231) -6.21*** 
   Age*Time (Pre-Treatment) -0.033 (0.021) -1.59 
   Age*Time (Post-Treatment) 0.065 (0.023) 2.83** 
   Age*Time (Interaction) 0.097 (0.027) 3.53*** 
   Gender*Time (Pre-Treatment) 1.176 (0.466) 2.52* 
   Gender*Time (Post-Treatment) 0.806 (0.526) 1.53 
   Gender*Time (Interaction) -0.370 (0.630) -0.59 
   Percent Abstinent days*Time (Pre-Treatment) -0.089 (0.039) 2.28* 
   Percent Abstinent days*Time (Post-Treatment) -0.180 (0.045) 3.99*** 
   Percent Abstinent days*Time (Interaction) -0.090 (0.053) 1.69     
 Random Effects   
   Patient ID 1.866 (1.366)  
   Residual 6.572 (2.564)  
 
   
Assertiveness Fixed Effects   
   Intercept 40.699 (2.108) 19.31*** 
   Time (Post-Treatment) -8.239 (2.431) -3.39*** 
   Age*Time (Pre-Treatment) -0.135 (0.047) -2.86** 
   Age*Time (Post-Treatment) -0.049 (0.053) -0.92 
   Age*Time (Interaction) -0.086 (0.054) 1.57 
   Gender*Time (Pre-Treatment) 1.914 (1.075) 1.78 
   Gender*Time (Post-Treatment) 2.787 (1.194) 2.33* 
   Gender*Time (Interaction) 0.708 (1.233) 0.48 
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   Percent Abstinent days*Time (Pre-Treatment) -0.058 (0.090) -0.64 
   Percent Abstinent days*Time (Post-Treatment) -0.039 (0.102) -0.39 
   Percent Abstinent days*Time (Interaction) 0.019 (0.105) 0.18     
 Random Effects   
   Patient ID 20.630 (4.540)  
   Residual 24.280 (4.930)  
    
Cognitive Change Fixed Effects   
   Intercept 9.202 (0.225) 40.86*** 
   Time (Post-treatment) -2.078 (0.275) -7.56*** 
   Percent Abstinent days*Time (Pre-Treatment) -0.003 (0.036) -0.09 
   Percent Abstinent days*Time (Post-Treatment) -0.078 (0.040) -1.92 
 Percent Abstinent days*Time (Interaction) -0.074 (0.043) -1.71     
 Random Effects   
   Patient ID 2.812 (1.677)  
   Residual 4.171 (2.042)  
    
Sexual Enhancement Fixed Effects   
   Intercept 19.029 (1.123) 16.95*** 
   Time (Post-Treatment) -2.089 (1.470) -1.42 
   Age*Time (Pre-Treatment) -0.087 (0.025) -3.45*** 
   Age*Time (Post-Treatment) -0.049 (0.029) -1.68 
   Age*Time (Interaction) 0.037 (0.033) 1.12 
   Percent Abstinent days*Time (Pre-Treatment) -0.054 (0.048) -1.12 
   Percent Abstinent days*Time (Post-Treatment) 0.041 (0.055) 0.74 
   Percent Abstinent days*Time (Interaction) 0.095 (0.062) 1.51     
 Random Effects   
   Patient ID 4.026 (2.006)  
   Residual 8.769 (2.961)  
    
Affective Change Fixed Effects   
   Intercept 32.991 (3.315) 9.95*** 
   Time (Post-Treatment) 11.069 (3.348) 3.31*** 
   Age*Time (Pre-Treatment) -0.061 (0.058) -1.04 
   Age*Time (Post-Treatment) -0.150 (0.065) -2.33* 
   Age*Time (Interaction) -0.089 (0.060) -1.471 
   AUDIT*Time (Pre-Treatment) 0.144 (0.068) 2.13* 
   AUDIT*Time (Post-Treatment) -0.043 (0.073) -0.59 
   AUDIT*Time (Interaction) -0.187 (0.069) -2.73** 
   Percent Abstinent days*Time (Pre-Treatment) -0.105 (0.111) -0.94 
   Percent Abstinent days*Time (Post-Treatment) 0.149 (0.123) 1.20 
   Percent Abstinent days*Time (Interaction) 0.254 (0.116) 2.18*     
 Random Effects   
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   Patient ID 39.100 (6.253)  
   Residual 29.240 (5.408)  
    
Dependence Fixed Effects   
   Intercept 26.951 (1.513) 17.81*** 
   Time (Post-Treatment) -12.472 (2.001) -6.23*** 
   Age*Time (Pre-Treatment) -0.009 (0.034) -0.26 
   Age*Time (Post-Treatment) 0.099 (0.040) 2.50* 
   Age*Time (Interaction) 0.108 (0.045) 2.41* 
   Gender*Time (Pre-Treatment) 0.979 (0.771) 1.27 
   Gender*Time (Post-Treatment) 2.000 (0.888) 2.25* 
   Gender*Time (Interaction) 1.021 (1.010) 1.012 
   Percent Abstinent days*Time (Pre-Treatment) -0.141 (0.065) -2.17* 
   Percent Abstinent days*Time (Post-Treatment) -0.200 (0.075) -2.68** 
   Percent Abstinent days*Time (Interaction) -0.059 (0.085) -0.70     
 Random Effects   
   Patient ID 7.095 (2.664)  
   Residual 16.039 (4.005)  
    
* p < 0.05, ** p < 0.01, *** p < 0.001 
 
4.5.1.4 Scale comparison and practical interpretation.  
To facilitate practical interpretation, model estimates were standardised as item-averages with 
a range of  1 (complete disagreement) to 5 (complete endorsement) (Cohen, Cohen, Aiken, & 
West, 1999b). Figure 4-1 provides adjusted mean scores for item-average DEQ sub-scales 
based on the final models. Assertiveness (adj M = 4.07, SE = 0.21), Tension Reduction (adj 
M = 3.89, SE = 0.23), and Sexual Enhancement (adj M = 3.81, SE = 0.23) were the most 
strongly endorsed scales pre-treatment; followed by Dependence (adj M = 3.37, SE = 0.19), 
Affective Change (adj M = 2.75, SE = 0.28), and Cognitive Change (adj M = 2.30, SE = 
0.06) respectively. The greatest reductions observed as a main effect of time occurred in the 
Tension Reduction (post-treatment adj M = 1.98, SE = 0.31) and Dependence scales (post-
treatment adj M = 1.81, SE = 0.25), moving from positively to negatively endorsed. The 
Affective Change (post-treatment adj M = 3.67, SE = 0.28) and Assertiveness scales (post-
treatment adj M = 3.25, SE = 0.24) had the next largest magnitude of change, approximating 
1-point. The Cognitive Change scale became more negatively endorsed (adj M = 1.78, SE = 
0.07) and Sexual Enhancement scale remained positively endorsed (adj M = 3.39, SE = 0.29). 
Practical interpretation of MLM effects indicate that each 10 point increase in the percentage 
of abstinent days over treatment was associated with a 0.22 (SE = 0.01) point lower Tension 
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Reduction item-average pre-treatment, and 0.45 (SE = 0.01) lower item-average post-
treatment. For the Dependence scale, a 10-point increase in the percentage of abstinent days 
equated to a 0.18 (SE = 0.08) lower item-average pre-treatment, and 0.25 (SE = 0.09) lower 
item-average post-treatment. A 10-point increase in the percentage of abstinent days was 
associated with 0.21 point increase in the change of the Affective Change scale.  
 
Figure 4-1. Expectancy Change as a Function of Time.  
Pre-treatment scores are represented by the intercept in the final multilevel model of each 
scale. Post-treatment scores are the Intercept - β(Time). Error bars represent standard errors 
of the estimates. Outcomes are standardised on a 5-point scale, reflecting the degree of 
endorsement of each scale: 5 = Complete Endorsement, 3 = Neutral, 1 = Complete 
Disagreement. *** p < 0.001. 
4.5.2 Expectancy Change and Community Norms 
Pre-treatment and Post-treatment scores were compared to community norms using 
independent samples t-tests. At time one, all scores were significantly greater than 
community norms, with the exception of Cognitive Change which was not significantly 
different (Table 4-3).  Post-treatment, the Assertion and Dependence scales were no longer 
significantly different to community norms, the Cognitive Change and Tension Reduction 
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scales were significantly lower than norms, while the Sexual Enhancement and Affective 
Change scales remained significantly higher (Table 4-3).  
3.4.1. Rates of Reliable Change. The highest rates of reliable change, as assessed by Jacobson 
and Traux’s RCI, were observed on the Dependence and Tension Reduction scales at 66 and 
56 percent respectively. Progressively lower reliable change rates were observed on the 
Assertion (46%), Cognitive Change (37%), Affective Change (30%) and Sexual 
Enhancement (18%) scales.  
 
Table 4-3. Independent samples t-test comparisons between community normative data 
and pre-and post-treatment data. 
  Pre-Treatment Post-Treatment Community Pre-Treatment - Community Post-Treatment - Community   
Scale M (SD) M (SD) M (SD) t (df) d t (df) d RCIa 
Assertion 35.70 (6.65) 31.22 (7.23) 31.95 (7.29) 5.60 (477)* 0.53 1.06 (477 ) -0.10 45.5% 
Cognitive Change 9.21 (2.80) 7.29 (2.40) 8.82 (2.67) 1.52 (477) 0.14 6.25 ( 477)* -0.59 36.5% 
Sexual Enhancement 15.46 (3.62) 14.64 (3.78) 13.13 (3.15) 7.37 (477)* 0.70 4.69 ( 477)* 0.45 17.6% 
Tension Reduction 14.83 (2.66) 11.49 (3.61) 12.43 (2.55) 9.78 (477)* 0.93 3.33 ( 477)* -0.32 56.4% 
Dependence 27.32 (4.57) 20.02 (5.67) 20.43 (4.38) 16.32 (477)* 1.55 0.89 ( 477) -0.08 66.4% 
Affective Change 34.45 (7.71) 35.99 (9.45) 29.28 (8.44) 6.66 (477)* 0.63 8.02 (477 )* 0.76 29.5% 
*p < 0.001; a RCI (%) refers to the proportion of patients who demonstrated clinically reliable change as assessed by Jacobson and Truax’s 
(1991) Reliable Change Index (RCI). 
 
4.6 Discussion 
Despite the theoretical importance of targeting AOEs in treatment of AUDs, limited 
research investigating AOE change over treatment is available. This study examined AOE 
change among patients who completed a 12-week CBT program for alcohol dependence. 
Current findings reflect change after a "full dose" of CBT and are not generalisable to 
patients who receive a "lower dose" or withdraw from treatment. As predicted, all positive 
AOEs were less strongly endorsed post-treatment. All positive AOEs were comparable to, or 
below, community norms post treatment, with the exception of sexual enhancement. This 
finding supports those of Jones and McMahon (1996), Brown et al. (1998) and Young et al. 
(2011), though is inconsistent with Connors et al. (1993) who failed to find a reduction in 
positive AOE until 18-month follow up. Consistent with the findings of Brown et al. (1998), 
the largest reductions were observed on the Tension Reduction and Social Assertion scales. 
This study also found the negative expectancy, Affective Change, was more strongly 
endorsed post-treatment. This finding contrasts that of Jones and McMahon (1996), who 
found no significant increase in proximal negative AOEs, such as Affective Change. 
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Contrary to the hypotheses, though consistent with Young et al. (2011) and Jones and 
McMahon (1996), greater proportion of abstinent days was not associated with greater 
expectancy change on the positive DEQ scales. As 61.7% of the sample was abstinent, and 
the mean proportion of abstinent days among patients who lapsed was 93%, the study may 
have had insufficient power to detect small effects within positive AOEs. Alternatively, 
modest amounts of alcohol consumption in the context of major changes to drinking habits 
may not negatively affect change in positive AOEs. Further research including a broader 
range of changes to drinking behaviour is needed.   
Greater proportion of abstinent days was associated with stronger endorsement of the 
negative Affective Change scale over treatment. Given that the Affective Change AOE was 
not significantly associated with proportion of drinking days at time one or two, this suggests 
that the scale alone is unlikely to be a useful predictor of drinking during treatment. However, 
patients who developed more negative expectations of alcohol on their mood had fewer 
drinking days than patients whose Affective Change AOE did not change. This is consistent 
with suggestions that strengthening of negative AOEs enhances motivation to resist drinking 
(McMahon & Jones, 1993). However, further research is required to determine whether 
increasing negative affective change expectations of alcohol reduces motivation to drink, if 
greater periods of abstinence facilitates change in this expectancy, or if there is a reciprocal 
relationship between these mechanisms.  
Greater proportion of abstinent days was associated with lower Tension Reduction 
expectancies at both pre and post-treatment assessment.  Among treatment completers, 
tension reduction expectancies may be useful markers of lapse risk. The large magnitude of 
change in the Tension Reduction AOE suggests that this is a common, heavily biased, and 
maladaptive belief associated with AUD that has been identified as a “high risk” expectancy 
set for many decades (Ross McD. Young, Oei, & Knight, 1990). This may be due to 
misattribution of alcohol related discomfort to other stressors, making alcohol the cause and 
solution to the symptoms (Breese, Sinha, & Heilig, 2011). An important consideration here 
may be negative affective states and mood disorders which are highly comorbid with AUD 
(Cheetham, Allen, Yücel, & Lubman, 2010; Lai, Cleary, Sitharthan, & Hunt, 2015). Given 
that expectations of negative affective change increased, while expectations of positive 
tension reduction decreased, an important interaction may exist between these AOEs with 
potential implications in the treatment of AUDs with comorbid mood disorders (Marel et al., 
2016). Addiction professionals and patients may benefit from careful monitoring of the 
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Tension Reduction AOE to inform further therapeutic work to challenge the belief itself and 
whether alternative coping strategies are required.  
Greater proportion of abstinent days was also associated with lower DEQ Dependence 
scores pre and post-treatment. As the Dependence scale assesses beliefs beyond discrete 
AOEs, prognostic utility may arise from broader beliefs about subjective perceptions of 
dependence severity and reliance upon alcohol. Such perceptions may be conceptually linked 
to drinking refusal self-efficacy, e.g. “I am powerless over alcohol, so why resist?” Targeting 
dependence related beliefs may subsequently have clinical utility by enhancing self-efficacy. 
However, it may also be that perceptions of dependence are derived from objective data such 
as number of previous attempts to abstain or true severity of alcohol dependence. Though the 
AUDIT was controlled within the analyses, controlling for history of abstinence attempts and 
including more sensitive measures of dependence severity is recommended to ascertain the 
validity of this finding. An important finding was the substantial contribution of covariates to 
the prediction of AOEs and moderation of AOE change; highlighting the importance of 
controlling for common covariates within AOE research.  As covariate effects were not 
hypothesised they require replication and should be interpreted with caution. Age related 
differences may be of particular interest, as intuitive interpretations may be derived. Elevated 
pre-treatment Assertiveness and Sexual Enhancement scores among younger patients may 
reflect differing social demands across the lifespan. Younger adults are more likely to drink 
in social contexts, while older adults may be more likely to drink at home due to familial 
demands and diminishing social activity. Chronic alcohol dependence is also associated with 
sexual impairment (Benegal & Arackal, 2007). Negative expectancies, in general, are less 
likely to be predictive of consumption in young adult drinkers (Young et al., 2006). 
Increasing age was associated with less change in Tension Reduction and Dependence scores. 
One explanation for this effect is that the attenuation is not a function of age, but history of 
AUD. Regarding tension reduction, greater AUD history is likely to be associated with the 
progressive elimination of alternative coping and relaxation strategies, and stronger 
conditioning between alcohol-use and tension reduction. For dependence, the perceived 
temporal distance between a patient’s last prolonged period of non-hazardous drinking and 
current presentation is likely to inform their sense of reliance upon alcohol.   
The findings support the CBT rationale for targeting maladaptive AOEs. However, 
practical constraints of the treatment setting introduced several limitations to the study. The 
absence of a control group prevents attribution of expectancy change to treatment. While it is 
expected that the intervention facilitated the observed AOE change, variation attributable to 
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changes in drinking behaviour versus the intervention effect could not be separated. 
Generalisability of the present findings was limited to patients who completed the entire 
treatment schedule. Important differences in AOE change may exist between patients who 
withdraw versus those who remain in treatment, although few differences were evident at 
baseline. The findings are also restricted to interventions where abstinence is the treatment 
goal. AOE change over treatment may not be consistent between abstinence-oriented and 
controlled drinking approaches, presenting an important avenue for future research. 
Limitations in assessment were also present. Reliance upon self-reported drinking behaviour 
introduces bias of memory and deception by under reporting or non-reporting. However, 
deception bias was expected to be minimised by voluntary enrolment in treatment, the 
absence of formal consequences for lapse during treatment, and breath estimated BAL prior 
to beginning each session (Bertholet, Winter, Cheng, Samet, & Saitz, 2014). The study may 
also be improved by implementing more frequent AOE assessment over treatment, analysis 
of the quantity of alcohol consumption, assessment of relevant subgroups, such as those with 
a comorbid anxiety and depressive disorders, and follow up of patients who withdraw from 
the study  to better understand the proximal relationship between AOE change, lapse, and 
relapse.  
Targeting AOEs is a key feature of CBT interventions for AUD, despite limited data 
informing its clinical utility. This study supports the theoretical rationale targeting AOE 
change as an important feature of treatment outcome, and highlights the need for further 
research within AUD samples to better understand order of effects between patient lapse and 
AOE change. 
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5.1 Chapter Foreword 
Alcohol craving, alcohol outcome expectancies, and rash impulsivity have been 
discussed as candidates for personalised AUD interventions (see 1.4.1 Candidate 
Psychosocial Targets for Personalised Treatment). Improved craving measurement and the 
clinical significance of alcohol outcome expectancies have been explored within the previous 
chapters. However, questions remain about the value of these constructs as candidates for 
personalised interventions. This chapter aims to examine the utility of tailoring CBT to 
individual patients based on pre-treatment assessment scores on measures of alcohol craving, 
alcohol outcome expectancies, and rash impulsivity. Secondary aims include examination of 
the association between change in the target constructs and treatment response.  
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5.2 Abstract 
Background: Tailored psychological interventions based on individual risk factors are 
likely to improve treatment for Alcohol Use Disorders (AUDs). Key risk factors for poor 
treatment outcome include alcohol craving, positive expectations of alcohol consumption, 
and impulsivity. Design: Pragmatic randomised Cognitive-Behavioural Treatment (CBT) 
trial. Setting: Public hospital alcohol and drug clinic. Participants: Three-hundred seventy-
nine patients (65% male; Ageyears M = 44.32, SD = 10.75)) seeking treatment for AUD. 
Procedure: Patients were randomly allocated into treatment as usual (TAU) or targeted 
treatment. Patients in targeted treatment were allocated one of three treatment modules 
focusing on craving, positive expectancy, or impulsivity based on assessment results. 
Treatment included eight, one hour, sessions of CBT over 12 weeks delivered by clinical 
psychologists. Hypotheses: Targeted treatment was expected to have fewer drinking days and 
consume less alcohol during the treatment period than TAU. Improvement in targeted 
mechanisms was predicted to be greatest for patients within matched conditions. Results: 
Patients attended an average of 4.4 sessions with 93 (25%) completing the whole 12-week 
treatment episode.  The mean proportion of drinking days between sessions was 5% with an 
average consumption of 64 grams of ethanol. No significant effect of targeted treatment was 
identified on drinking days or consumption. The craving (b = -18.97, 95%CI =  -31.44, -6.51) 
and impulsivity (b = -26.65, 95% CI = -42.09, -11.22) modules demonstrated significant 
reductions in their targeted constructs over treatment, above TAU. Only reduction in craving 
was associated with reduced drinking days (exp(b) = 0.958, p = 0.003) and alcohol 
consumption (exp(b) = 0.962, p = 0.02). Significant indirect effects for the targeted craving 
module through craving reduction were identified for reduction in drinking days (β = -0.72, 
95% CI = -1.50, -0.158) and alcohol consumption (β = -0.78, 95%CI = -1.72, -0.11). 
Conclusions: In the context of a public health service, the effectiveness of individualised 
treatment targeting risk mechanisms identified during pre-treatment assessment was not 
confirmed. Some evidence was found for improved treatment response to the implementation 
of a manualised craving module when pre-treatment craving was high. 
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5.3 Introduction 
Advances in the treatment of Alcohol Use Disorders (AUDs) have been modest in spite 
of substantial research (Connor et al., 2016). Alcohol is among the leading contributors to the 
global burden of morbidity and disease, with the majority of this burden attributable to AUDs 
(Rehm et al., 2014, 2015; World Health Organization, 2014). Evidence-based interventions 
for AUD are available, though relapse rates are high (Assanangkornchai & Srisurapanont, 
2007; Connor et al., 2016; Miller & Wilbourne, 2002). About one in five patients remain 
abstinent twelve months post-treatment (Miller et al., 2001). Comprehensive reviews of AUD 
treatment and rehabilitative services conclude that individual differences are likely to 
determine differential treatment response (Institute of Medicine, 1990; Miller & Wilbourne, 
2002).  
Efforts at personalising AUD treatments have focused on matching patients to 
treatments. Two large scale studies have been conducted examining differential treatment 
effects with a priori hypotheses of treatment response based on individual characteristics 
(Project MATCH Research Group, 1997; UKATT Research Team, 2001). The largest, 
Project MATCH, recruited 1726 patients across nine treatment sites. It tested 20 hypothesis 
regarding interactions between 10 patient characteristics in three manualised treatments – 
Cognitive-Behavioural Therapy (CBT), Motivational Enhancement Therapy (MET), and 
Twelve Step Facilitation (Project MATCH Research Group, 1997). More recently, the United 
Kingdom Alcohol Treatment Trial (UKATT) study recruited 742 patients, across two 
treatment conditions – MET and social and behaviour network therapy (UKATT Research 
Team, 2005b). Five matching hypothesis were proposed some of which were drawn from 
post-hoc findings of Project MATCH. In both studies, patients were randomly allocated to a 
condition and a priori (characteristics) hypotheses were retrospectively examined on 
treatment completion. Treatment matching was not found to improve outcomes in either 
study (Project MATCH Research Group, 1997, 1998b; UKATT Research Team, 2007). 
Authors concluded that “…the intuitively appealing notion that treatment matching can 
appreciably enhance treatment effectiveness has been severely challenged” (Project MATCH 
Research Group, 1997, p. 1690).  
As an alternative to matching patients to different treatments based on individual 
characteristics, the UKATT Research Team (2007) emphasise the scope for prospectively 
tailoring treatments to patients. Eclectic psychotherapy approaches involving personally 
tailoring therapy is widely applied in the treatment of mental health disorders (Norcross & 
Wampold, 2011). Case conceptualisation and treatment planning are central to psychological 
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interventions but little progress has been made to standardise and assess individually tailored 
approaches. This is partly due to an absence of replicable research identifying patient 
characteristics with prognostic value (Adamson et al., 2009). Furthermore, such mechanisms 
need to be modifiable to be treatment targets. Litten et al. (2015) recommend a framework by 
which target mechanisms can be derived for personalised interventions. They propose alcohol 
addiction is comprises 3-stages: binge-intoxication, withdrawal–negative affect, and 
preoccupation–anticipation (“craving”) (Litten et al., 2015). These stages reflect movement 
of drinking motivated by impulsivity and positive-reinforcement expectations to drinking for 
relief. This process maps well onto three prominent constructs within psychosocial 
conceptualisations of AUD: impulsivity (Dawe et al., 2004; Loree et al., 2015) alcohol 
outcome expectancies (Coates et al., 2018; Jones et al., 2001; Monk & Heim, 2013), and 
craving (Tiffany & Wray, 2012). Identifying individual differences in patient profiles 
comprising these constructs has potential for informing personalised interventions. 
Craving is common across Substance Use Disorders (SUDs) with implications in 
diagnosis, prognosis, and treatment (American Psychiatric Association, 2013; Coates et al., 
2017; Tiffany & Wray, 2012). Ninety-nine percent of substance abuse treatment agencies 
surveyed in the U.S. reported that it is useful to consider craving in treatment planning 
(Pavlick et al., 2009). Craving is a major risk factor for relapse, often comprising 
physiological discomfort, intrusive substance-related cognitions, and affective distress 
(Bottlender & Soyka, 2004; Kavanagh et al., 2005). Each of these experiences are recognised 
targets of cognitive and behavioural interventions (Beck et al., 1993; Marlatt & Gordon, 
1985; Witkiewitz et al., 2013). There is a high level of variance in craving severity among 
patients presenting for treatment of AUD (Coates et al., 2017), making it a prime candidate 
for individualised treatment approaches.  
Expectations of the outcome of alcohol consumption are central to cognitive and 
behavioural theories of addiction (Bandura, 1999; Jones et al., 2001; Monk & Heim, 2013). 
Positively biased alcohol outcome-expectancies (AOEs) are predictive of drinking initiation, 
progression to problematic use, and maintenance of AUDs (Jones et al., 2001; Monk & Heim, 
2013). Reduction of positive AOEs is proposed as an important aspect of successful treatment 
(Bandura, 1999; Beck et al., 1993; Coates et al., 2018; Gullo et al., 2010) and is commonly 
targeted within AUD interventions (Beck et al., 1993; Ellis, 1962; Meichenbaum, 1977). 
Reduction in positive AOEs is proposed to reduce motivation to drink and enhance drinking 
refusal self-efficacy (Bandura, 1999; Coates et al., 2018; Gullo et al., 2010). 
Page 90 of 242 
 
Chapter Five Targeted Treatment of Alcohol Use Disorder 
 
Impulsivity is broadly considered a predisposition for action with insufficient 
forethought and impaired behavioural restraint (Evenden, 1999). Impulsivity is causally 
linked to heavier alcohol use (Gullo et al., 2017) and predictive of the development of alcohol 
misuse (George, Connor, Gullo, & Young, 2010; Moffitt et al., 2011). It is related to poorer 
SUD treatment outcomes (Charney et al., 2010; Hershberger, Um, & Cyders, 2017a; Loree et 
al., 2015; Rupp et al., 2016) and associated with enhanced relapse risk 12-months post-
treatment (Evren et al., 2012; Müller et al., 2008). As impulsivity is widely considered a 
stable trait, the goal of intervention is to improve management and expression of impulsivity 
(Butz & Austin, 1993). Limited research has examined the effectiveness of targeting 
impulsivity within AUD interventions, although it is recognised as an important avenue for 
investigation (Czapla et al., 2016; Hershberger, Um, & Cyders, 2017b; Loree et al., 2015).  
 Identification of individual differences in modifiable mechanisms contributing to the 
maintenance of AUDs may facilitate individually tailored psychological interventions. Such 
interventions are expected to improve treatment efficiency and outcome. This study randomly 
allocated patients seeking treatment for AUD into treatment as usual (TAU; CBT) or targeted 
treatment in a public hospital clinic. Patients in the targeted treatment group were allocated 
one of three treatment modules – craving, positive expectancy, or impulsivity - depending on 
pre-treatment assessment results. The targeted treatment condition was expected to have 
significantly greater retention, fewer lapses during treatment, and less severe lapses than 
treatment as usual (TAU). Improvements in the mechanisms of interest (craving, AOEs, and 
impulsivity) were predicted to be greatest for patients within the individually targeted 
condition.  
 
5.4 Method 
The study was a single blind pragmatic randomised control trial with a CBT 
intervention. Consecutive alcohol dependent patients [subsequently referred to as AUD, 
consistent with DSM-5 nomenclature] attending a metropolitan hospital outpatient drug and 
alcohol service were randomly allocated to TAU or targeted treatment. Treatment was 
administered by registered clinical psychologists (masters level or above). Human research 
ethics approval was obtained and the trial was registered at the Australian New Zealand 
Clinical Trials Registry (Trial ID: ACTRN12613000865718). 
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5.4.1 Participants 
Participants were 379 patients treated consecutively from January 2014 to January 
2017. Sample characteristics are presented in Table 6-1. Inclusion in the trial required that 
patients be at least 18 years old, meet DSM IV-TR criteria for alcohol dependence and be 
seeking abstinence as the primary treatment goal (not controlled drinking). Patients were 
excluded from the study if they had a comorbid substance dependence (with the exception of 
nicotine), were taking Disulfiram or any prescribed opioid, or if they could not provide 
written, informed consent.  
5.4.1.1 Measures 
The Severity of Alcohol Dependence Questionnaire (SADQ)  
The SADQ is a 20-item self-report measure assessing physical withdrawal, affective 
withdrawal, drinking to relieve withdrawal symptoms, alcohol consumption, and rapidity of 
reinstatement of alcohol dependence (Stockwell, Murphy, & Hodgson, 1983). Higher scores 
are indicative of greater alcohol dependence severity. The SADQ has good test-retest 
reliability and concurrent validity (Stockwell et al., 1983). Internal consistency of the SADQ 
within the current study was good (Cronbach’s α = 0.93, 95% CI = 0.92-0.94). 
The Alcohol Use Disorders Identification Test (AUDIT)  
The AUDIT interview version was administered by experienced nursing staff at patient 
intake. The AUDIT comprises 10-items assessing recent alcohol use, symptoms of alcohol 
dependence, and alcohol related problems. Higher scores suggest greater risk of harmful 
drinking and likelihood of AUD. Good internal consistency, as well as sensitivity and 
specificity in the detection of AUDs has been demonstrated (Saunders et al., 1993). Internal 
consistency of the AUDIT was good within the current study (Cronbach’s α = 0.87, 95% CI = 
0.85 - 0.89). 
The Alcohol Craving Experience Questionnaire – Frequency (ACE-F) 
The ACE-F is an 11-item scale assessing desire related cognitions over the previous 
week. Participants respond via an 11-point visual analogue scale with anchors 0 (not at all) 
and 10 (constantly/extremely). The ACE-F has demonstrated good construct validity, 
predictive validity, concurrent validity, discriminant validity, internal reliability, and test-
retest reliability (Coates et al., 2017; May et al., 2014; Statham et al., 2011). Internal 
consistency of the ACE within the current study was excellent (Cronbach’s α = 0.95, 95% CI 
= 0.94-0.96). 
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Drinking Expectancy Questionnaire (DEQ)  
The DEQ is a 43-item self-report measure assessing positive and negative AOEs. 
Response options range from one “Strongly Disagree” to five “Strongly Agree” on a 5 point 
Likert scale. The DEQ comprises six subscales: Assertion (10-items) assesses positive beliefs 
regarding social confidence and assertiveness; Sexual Enhancement (5-items) refers to 
expectations of enhanced feelings of attractiveness and sexual interest; Cognitive Change (4-
items) assesses beliefs of improved thought generation and clarity; Tension Reduction (4-
items) evaluates beliefs about the relaxing effects of alcohol; Affective Change (12-items) 
measures beliefs regarding the effects of alcohol on negative mood states, such as sadness, 
irritability, and aggressiveness; and Dependence (8-items) reflects beliefs regarding a 
personal sense of addiction and perceived loss of control when drinking. The Assertion, 
Sexual Enhancement, Cognitive Change, and Tension Reduction sub-scales are positive 
AOEs, as they represent positive expectations of alcohol, while the Affective Change scale is 
a negative AOE. As the Dependence scale assesses beliefs beyond the acute effects of 
alcohol, it is considered to be a broader construct than the other scales (R McD Young et al., 
2011). The DEQ has sound internal consistency and test-re-test reliability, and good 
construct, convergent, and predictive validity (R. McD Young & Oei, 1996). The positive 
sub-scales of the DEQ were combined to form a proxy for total ‘positive expectancies’. 
Combination of all positive expectancy items demonstrated acceptable internal consistency 
(Cronbach’s α = 0.78, 95% CI = 0.75 - 0.81). 
Dickman’s Impulsivity Inventory - Dysfunctional Impulsivity Scale (DIS) 
The DIS is a sub-scale of Dickman’s Impulsivity Inventory, assessing the tendency to 
act with a lack of forethought when this tendency is a source of difficulty; (Dickman, 1990). 
The DIS comprises 12-items with dichotomous (True/False) response options. The DIS has 
demonstrated good internal reliability, construct validity, and excellent concurrent validity 
with other established impulsivity scales (Claes, Vertommen, & Braspenning, 2000; 
Dickman, 1990). The DIS demonstrated good internal consistency within the current study 
(Cronbach’s α = 0.84, 95% CI = 0.81-0.86). 
Drinking Behaviour  
Patient were asked to recall days of alcohol consumption since the previous treatment 
session and estimate the quantity consumed on each drinking occasion, guided by the time-
line follow-back procedure (L. C. Sobell & Sobell, 1992). Drinking days was standardised by 
dividing the total abstinent days by the number of days the patient was in treatment. 
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5.4.2 Procedure 
Patients were referred to the alcohol and drug service following inpatient hospital 
admission, or by their General Practitioner or self-referral. Intake was conducted by a nurse 
or social worker, who determined eligibility for the AUD treatment program. This included 
obtaining patient consent and completion of the pre-treatment assessments. No incentive was 
offered to patients enrolled in the trial. Patients were advised to remain abstinent and 
scheduled to begin treatment within 7-days. Randomisation to treatment condition (TAU or 
Targeted) was based on a random number sequence generated by program ‘Research 
Randomiser’ version 4.0 (Urbaniak & Plous, 2013). Randomisation order was concealed 
from enrolling and treating staff by a research assistant, who revealed treatment condition 
upon completion of pre-treatment assessments. Treatment comprised eight face-to-face, one-
on-one, sessions of CBT over 12-weeks. Targeted treatment involved administration of one 
of three manualised modules targeting craving, AOEs, or impulsivity over four of the eight 
sessions. Module selection was based on highest standardised pre-treatment score on the 
ACE-F, DEQ, or DIS respectively. Scores were standardised relative to AUD norms to 
enable comparison across scales. Targeted treatment modules were adapted from existing 
treatment manuals of evidence-based cognitive-behavioural therapies by registered clinical 
psychologists with extensive experience treating AUDs. Treating psychologists were trained 
in module administration. Assessment reports of the targeted treatment scales were provided 
to psychologists if their patients were allocated to the targeted condition. Psychologists 
recorded drinking behaviour and adjunct pharmacotherapy (naltrexone, acamprosate, or both) 
at each session. The assessment battery was readministered at 12-weeks. It must be 
emphasised that this was a pragmatic trial, intended to examine effectiveness of targeted 
treatment within a ‘real-world’ setting, enhancing external validity (Thorpe et al., 2009). 
Psychologists adhered as closely to the targeted treatment modules as possible, though were 
free to diverge according to their clinical judgement, such as addressing high risk situations. 
Psychologists recorded how closely they adhered to the treatment manual (0 = no fidelity to 
10 = complete fidelity) for patients enrolled in targeted treatment.   
5.4.2.1 Intervention summary 
TAU was CBT, where common treatment elements include motivational interviewing, 
psychoeducation, identification of risks for relapse, problem-solving skills training, relaxation 
strategies, and relapse prevention planning (Beck et al., 1993; Marlatt & Witkiewitz, 2005; 
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Miller & Rollnick, 2012; Monti et al., 1989). The craving module comprised: craving 
education, self-monitoring of craving and urges, short-term behavioural strategies for coping 
with craving, and cognitive strategies for craving management (Kadden et al., 2003; Marlatt 
& Witkiewitz, 2005). The expectancy module aimed to educate patients about how learned 
alcohol outcome expectancies contribute toward development and maintenance of drinking 
problems (Bandura, 1999), facilitate development of behavioural alternatives to positive 
expectancies (e.g. relaxation training, social-skills training), and challenge positively-biased 
expectancies through cognitive strategies (Beck et al., 1993). The Impulsivity module was 
process oriented, intending to help patients recognize the benefits of planning and considered 
deliberation. This was achieved through the use of clear session structure and documentation 
to encourage reflection. Specific components of the module included education about 
impulsivity, cognitive and behavioral response-inhibition strategies (Linehan, 1993), 
structured problem solving (D’Zurilla & Nezu, 2010), and identification of alternative 
rewards. Module manuals are available upon request.  
5.4.2.2 Statistical Analysis 
 Data analysis were conducted in R version 3.3.3. Assessment scores were 
standardised by percentage of maximum possible score (POMP) to facilitate interpretation 
and comparison across scales (Cohen et al., 1999a). Assumptions of normality and linearity 
were assessed via inspection of residual and diagnostic plots.  
 Power Analysis: A previous study at this treatment site, using an identical generic 
CBT treatment program (TAU Condition) demonstrated medium effect sizes to detect 
treatment group differences (Feeney, Young, Connor, Tucker, & McPherson, 2002). 
Accepting an effect size of 0.3 (w), a = 0.05 and power of 0.90, a minimum of 117 subjects 
was required for a between group contrast (Critical Chi = 3.84).   
Treatment Effects: The primary outcome of interest was drinking behaviour over 
treatment. Drinking behaviour was operationalised as two outcomes, the proportion of 
drinking days and quantity of alcohol consumed between sessions. Separate analyses were 
conducted for each drinking behaviour. Inspection of the proportion of drinking days and 
consumption variables revealed zero-inflated heavy tailed positively skewed distributions. 
Tweedie Compound Poisson models were utilised as they are appropriate for analysis of non-
negative continuous data with inflation in discrete zeros (Dunn & Smyth, 2005; Gilchrist & 
Drinkwater, 2000; Zhang, 2013). Data were hierarchically structured, with drinking 
behaviour between sessions nested within patients. Compound Poisson generalised linear 
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mixed models (CPGLMM), treating ‘patient’ as a random effect with ‘session number’ (1 to 
8) nested within, enabled assessment of within and between patient differences in drinking 
behaviours (intercepts) as well as within and between patient changes in drinking behaviour 
over treatment (slopes). All models were fit using Laplace approximated maximum 
likelihood estimation in R (version 3.3.3) package ‘cplm’ (Zhang, 2013). 
All available data were included in the models. Baseline models included a random 
intercept and ‘session number’. Covariates: age, gender, severity of alcohol dependence, and 
medication use (acamprosate, naltrexone, or both) were included sequentially as fixed effects, 
and retained if they significantly improved model fit as assessed by likelihood ratio tests 
(Royall, 1997). Pattern-mixture modelling was used to identify and model potential 
differences in outcomes between patients who dropped out and those who completed 
treatment by including patient completion (No or Yes) as a fixed effect (Hedeker & Gibbons, 
1997; Little, 1995). Moderating effects of each predictor on the trajectory of drinking 
behaviour were assessed by adding the interaction between each predictor and session 
number to the model. Upon completion of the ‘covariates model’, pre-treatment targeted 
assessment scores (DEQ-Positive, ACE-F, DIS) and corresponding assessment by session 
number interactions were included to control for bias in module allocation pertaining to 
inflation in these constructs. This formed the ‘control model’.  
Effects of treatment condition were examined by including condition (TAU or Targeted 
Treatment) as a fixed effect within the control model. Effects of condition on the trajectories 
of drinking behaviour were assessed by including interaction between treatment condition 
and session number in the model. In a separate model, differential effects among the targeted 
treatment modules were examined by including a nominal module variable (TAU, 
Impulsivity, Expectancy, or Craving) to the control model and a session number x module 
interaction term in the following step. Statistical significance of fixed effects within the final 
models was estimated by Type III Wald tests in order to partition variance of effects 
simultaneously comprising part of an interaction.  
Treatment Mechanisms: Mediation of the effect of treatment module on drinking 
behaviours by reduction in the targeted constructs (pre to post-treatment) was tested using the 
joint significance procedure (MacKinnon, Lockwood, Hoffman, West, & Sheets, 2002). 
Support for mediation would be drawn from a significant association between treatment 
module assignment and reduction in the targeted construct (path a), and a significant 
association between reduction in the targeted construct and drinking behaviour (path b). 
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Separate mediation models were tested for each treatment module and each drinking 
behaviour, resulting in six mediation analyses.   
Path a was assessed by separate linear mixed models (LMM) using R package ‘lme4’ 
(Bates, Mächler, Bolker, & Walker, 2015b). Cases without post-treatment targeted 
assessments were excluded from the analyses (complete cases, n = 93). The outcomes were 
targeted assessment (craving = ACE-F; impulsivity = DIS; positive expectancy = DEQ) 
nested within assessment occasion (0 = pre-treatment, 1 = post-treatment). ‘Patient’ was 
modelled as a random effect. Models included a random intercept, assessment occasion 
(slope), covariates (age, sex, and pre-treatment severity of dependence score), treatment 
module, and a ‘treatment module’ × ‘pre-treatment targeted assessment’ interaction term. The 
effect of interest (path a) was represented by the interaction between ‘assessment occasion: 
post-treatment’ and ‘treatment module’. An additional interaction term comprising pre-
treatment ACE-F score and medication-use was included in the craving model to control for 
potential differences in conjoint pharmacotherapy as a function of pre-treatment craving 
severity. Models were fit using Maximum Likelihood estimation. Significance was 
approximated by Wald based 95% confidence intervals around fixed effects. Random slopes 
were not assessed.  
Path b was assessed by separate CPGLMMs on the complete cases. Covariate models 
were constructed using identical procedures to the Treatment Effects analyses.  All ‘pre-
treatment targeted assessment scores’ and ‘pre-treatment targeted assessment × session 
number’ interaction terms were held constant in all models. ‘Post-treatment targeted 
assessment’ was included in the final step. As ‘pre-treatment targeted assessment’ scores 
were held constant within the models, the ‘post-treatment targeted assessment score’ 
provided a proxy for residualised change in the targeted assessment (path b). As the temporal 
sequence of the predictor in path b (change in target mechanism) is measured after the 
outcome (drinking behaviours), it is not possible to infer a causal relationship between 
reduction in target mechanisms and reduction in drinking behaviour. In fact, the relationship 
between mechanism reduction and reduction in drinking is expected to be bidirectional. 
However, differences between the targeted modules and TAU observed in these pathways 
will provide insight into the hypothesised mechanisms of action.  
Standardised indirect effects were estimated using R package ‘Rmediation’ (Tofighi & 
MacKinnon, 2011). Confidence intervals were estimated by the product of confidence limits 
for indirect effects (PRODCLIN) procedure (MacKinnon, Fritz, Williams, & Lockwood, 
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2007). Complete Treatment Effects models were constructed on the complete cases to assess 
consistency of results.  
 Disclosure of divergence to planned analyses: The present analysis method deviates 
from that proposed in the 2013 trial registration. Advanced statistical methods better suited to 
modelling this data became accessible through developments in statistical software (e.g. 63). 
In contrast to the planned analyses these developments enabled modelling of patient attrition, 
distributional properties of the outcomes, covariates, and differences in growth of drinking 
behaviour over treatment. In doing so, error variance was minimised and statistical power 
maximised (Hallgren & Witkiewitz, 2013).  
5.5 Results 
5.5.1 Descriptive statistics 
Three-hundred and ninety-seven patients consented to the trial and completed pre-
treatment assessments. Ninety-seven percent (n = 367) scored =>6 on the AUDIT, indicating 
a likely AUD (Lundin, Hallgren, Balliu, & Forsell, 2015; Reinert & Allen, 2007). Thirty-
three percent (n  = 128) scored <=15 on the SADQ, indicating mild dependence; 40% (n = 
153) scored => 16 and <= 30 indicating moderate dependence; and 26% (n = 98) scored 
=>31, indicating severe dependence. Three-hundred and thirty-eight patients (11%) attended 
at least one session, with 93 (25%) re-assessed at three months. No significant differences in 
the proportion of patients who completed treatment were observed between TAU and 
Targeted Treatment groups (χ2 (1) = 0.4, p = 0.53) or treatment modules (Impulsivity χ2 (1) = 
0.57, p = 0.45; Expectancy χ2 (1) = 0.6, p = 0.44; Craving χ2 (1) = 0.004, p = 0.95). The 
mean sessions attended was 4.4 (SD = 2.70). No significant differences in the number of 
sessions attended were observed between TAU and Targeted Treatment (U = 17970.00, p = 
0.616) or treatment modules (χ2 (3) = 1.26, p = 0.738). A CONSORT flow chart of patient 
recruitment and retention is provided in Figure 5-1, as per Boutron, Altman, Moher, Schulz, 
& Ravaud (2017). The mean proportion of drinking days between sessions was 5% (SD = 
14.71) and mean consumption was 64 (SD = 309.41) grams of ethanol. Post-treatment 
fidelity ratings were available from 50 patients. Mean fidelity rating for the targeted treatment 
condition was 6.26 (SD = 2.39) out of 10. One-way analysis of variance was not indicative of 
significant differences in fidelity among the treatment modules (F (2, 47) = 0.84, p = 0.453).  
Patients who completed treatment were significantly older (M = 46.00, SD = 10.53) than non-
completers (M = 43.17, SD = 10.78; t (377) = -2.54, p =0.012). No other significant 
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differences between treatment ‘completers’ and ‘non-completers’ were observed on any 
demographics variables or pre-treatment assessments. 
 
Figure 5-1. CONSORT flow diagram of patient trial recruitment and retention modified 
for individual randomised controlled trials of nonpharmacologic treatments (Boutron, 
Altman, Moher, Schulz, & Ravaud, 2017). 
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Table 5-1. Descriptive statistics of the sample at pre-treatment assessment (n = 379) a 
      Targeted Treatment Module   
 TAU 
Targeted 
Treatment 
Impulsivity Expectancy Craving Total 
  n = 193 n = 186 n = 45 n = 64 n = 77 n = 379 
 Mean (SD) 
Alcohol Use Measures 
  AUDIT 28.22 (8.92) 27.79 (8.28) 26.80 (8.22) 27.68 (8.29) 28.47 (8.34) 28.01 (8.60) 
  SADQ 22.06 (13.33) 23.16 (11.99) 23.53 (11.59) 21.66 (11.98) 24.19 (12.26) 22.6 (12.68) 
Targeted Assessments 
  DEQ-Positive 75.97 (10.94) 77.61 (10.10) 74.11 (9.85) 83.17 (10.54) 75.04 (7.74) 76.78 (10.55) 
  ACE-F 43.27 (29.21) 46.36 (28.69) 40.89 (24.22) 27.03 (23.55) 65.01 (23.16) 44.66 (29.01) 
  DIS 3.94 (3.28) 5.17 (3.56) 8.71 (2.74) 3.55 (3.12) 3.84 (2.93) 4.42 (3.49) 
Age, years  45.26 (10.36) 43.34 (11.09) 41.32 (10.54) 44.72 (12.01) 43.38 (10.56) 44.32 (10.75) 
Sessions Attended 4.34 (2.71) 4.47 (2.70) 4.49 (2.75) 4.73 (2.73) 4.23 (2.67) 4.4 (2.7) 
 n (%) 
Gender, Male 128 (66%) 118 (63%) 26 (58%) 39 (61%) 53 (69%) 246 (65%) 
Supplementary 
Pharmacotherapyb 
63 (33%) 65 (35%) 17 (38%) 23 (36%) 25 (32%) 128 (34%) 
aContinuous data presented as Mean (Standard Deviation), bTaken acamprosate, naltrexone, 
or both during treatment.  
 
5.5.2 Part 1: Main effects of condition 
Separate CPGLMM control models were constructed for the outcomes ‘proportion of 
drinking days’ and ‘quantity of consumption’. Superiority of targeted treatment to TAU was 
assessed by adding treatment condition (TAU, Targeted Treatment) to each control model. 
Differential effects among targeted modules were similarly examined by adding module 
(TAU, Impulsivity, Expectancy, Craving) to each control model. Results of these four models 
are summarised in Table 5-2.  
Proportion of drinking days 
After controlling for covariates and baseline targeted assessments, neither drinking 
behaviour significantly changed over the course of treatment. Each year increase in age was 
associated with a 1% reduction in the proportion of drinking days per session attended. Each 
unit increase in POMP DIS score was associated with a 0.03% increase in proportion of 
drinking days per session. Being male was associated with a 51% lower proportion of 
drinking days over treatment. Each unit increase in the ACE-F was associated with 2% 
increase in total proportion of drinking days. No significant effects of dependence severity, 
age, pharmacotherapy, or completion status on model intercepts or slopes were identified. No 
significant effect of treatment condition or treatment module was identified on the intercept 
or trajectory of the number of drinking days during treatment. 
Consumption 
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Progression of sessions attended was not independently associated with an increase in 
alcohol consumption, but was moderated by POMP ACE-F score with each unit increase 
associated with a 0.04% reduction in consumption per session attended. Independent of 
session, each unit increase in POMP ACE-F score was associated with a 2% increase in total 
alcohol consumption. A unit increase in POMP DEQ-Positive was associated with a 5% 
overall reduction in consumption over the course of treatment. Being male was associated 
with 48% less alcohol consumption over treatment (p = 0.007). Each year increase in age was 
associated with a 3% reduction in alcohol consumption during treatment. No significant 
effects of dependence severity, pharmacotherapy, or completion status on model intercepts or 
slopes were identified. Treatment condition and module were not significantly related to 
overall consumption over treatment or progression of consumption over treatment. 
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Table 5-2. Summary of final models assessing the effect of targeted treatment on treatment responsea,b. 
 Outcome: Proportion of drinking days Consumption 
Treatment Predictor: Control (none) Condition Module Control (none) Condition Module 
  b (SE) p b (SE) p b (SE) p b (SE) p b (SE) p b (SE) p 
Fixed Effects                       
  Constant 3.03 (3.33) 0.004 2.45 (3.37) 0.002 4.39 (3.58) 0.014 227.65 (5.29) 0.001 184.14 (5.38) 0.002 180.32 (5.93) 0.004 
  Session 1.64 (1.36) 0.103 1.74 (1.36) 0.07 1.44 (1.39) 0.267 0.98 (1.33) 0.954 1.03 (1.34) 0.928 1.04 (1.38) 0.906 
Covariates             
  Sex (Male) 0.49 (1.29) 0.005 0.48 (1.29) 0.005 0.46 (1.29) 0.003 0.42 (1.36) 0.005 -0.87 (0.31) 0.005 -0.91 (0.31) 0.003 
  Sex (Male)*Session ns ns ns ns ns ns ns ns ns ns ns ns 
  Age ns ns ns ns ns ns 0.97 (1.01) 0.026 0.97 (1.01) 0.028 0.97 (1.01) 0.025 
  Age*Session 0.99 (1.00) 0.042 0.96 (1.02) 0.044 0.96 (1.02) 0.04 ns ns ns ns ns ns 
  SADQ ns ns ns ns ns ns ns ns ns ns ns ns 
  SADQ*Session ns ns ns ns ns ns ns ns ns ns ns ns 
  Pharmacotherapy (Yes) ns ns ns ns ns ns ns ns ns ns ns ns 
  Pharmacotherapy (Yes)*Session ns ns ns ns ns ns ns ns ns ns ns ns 
  Complete Tx (Yes) ns ns ns ns ns ns ns ns ns ns ns ns 
  Complete Tx (No)*Session ns ns ns ns ns ns ns ns ns ns ns ns 
Pre-Tx Target Assessments             
  ACE-F 1.02 (1.01) 0.003 1.02 (1.01) 0.004 1.02 (1.01) 0.017 1.02 (1.01) 0.005 1.02 (1.01) 0.006 1.02 (1.01) 0.03 
  DIS 1.00 (1.01) 0.927 1.00 (1.01) 0.815 1.00 (1.01) 0.599 1.00 (1.01) 0.612 1.00 (1.01) 0.694 1.00 (1.01) 0.717 
  DEQ-Positive 0.98 (1.02) 0.181 0.98 (1.02) 0.194 0.97 (1.02) 0.095 0.95 (1.02) 0.022 0.95 (1.02) 0.025 0.95 (1.02) 0.054 
  ACE-F*Session 1.00 (1.00) 0.054 1.00 (1.00) 0.085 1.00 (1.00) 0.016 1.00 (1.00) 0.031 1.00 (1.00) 0.036 1.00 (1.00) 0.03 
  DIS*Session 1.00 (1.00) 0.029 1.00 (1.00) 0.018 1.00 (1.00) 0.089 1.00 (1.00) 0.101 1.00 (1.00) 0.083 1.00 (1.00) 0.072 
  DEQ-Positive*Session 1.00 (1.00) 0.748 1.00 (1.00) 0.689 1.00 (1.00) 0.622 1.00 (1.00) 0.234 1.00 (1.00) 0.264 1.00 (1.01) 0.338 
Treatment Condition             
  Condition (Targeted)   1.57 (1.38) 0.162     1.40 (1.45) 0.364   
  Condition (Targeted)*Session   0.90 (1.07) 0.096     0.94 (1.08) 0.422   
Treatment Module             
  Module (Impulsivity)     0.81 (1.81) 
0.265 
    1.28 (1.94) 
0.800   Module (Expectancy)     2.09 (1.63)     1.23 (1.78) 
  Module (Craving)     1.72 (1.53)     1.61 (1.65) 
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  Module (Impulsivity)*Session     0.93 (1.13) 
0.112 
    0.88 (1.14) 
0.728   Module (Expectancy)*Session     0.78 (1.11)     0.93 (1.12) 
  Module (Craving)*Session     1.00 (1.09)     1.00 (1.11) 
Random Effects             
  Patient 46.47 (7.09)  46.16 (7.08)  41.41 (6.89)  165.49 (9.59)  165.33 (9.58)  173.98 (9.69)  
  Session 1.03 (1.2)  1.03 (1.19)  1.03 (1.18)  1.03 (1.19)  1.03 (1.19)  1.03 (1.19)  
  Residual 1.43 (1.82)  1.43 (1.82)  1.43 (1.82)  2.93e+18(679.22) 2.87e+18 (678.25) 2.879e+18 (678.26) 
aCoefficients presented are exponentiated from the original CPGLMM model and may be interpreted as: each unit increase in the predictor is associated with change in the outcome by the 
product of 1×b.   
bAll scale scores are standardised by the percentage of maximum possible score (0-100). 
ns indicates that inclusion of the term did not significantly improve model fit (p < 0.05). 
Abbreviations: Treatment (Tx), Severity of Alcohol Dependence Questionnaire (SADQ), Drinking Expectancy Questionnaire (DEQ), Alcohol Craving Experience - Frequency Scale (ACE-F), 
Dysfunctional Impulsivity Scale (DIS).  
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5.5.3 Part 2: Mechanisms of change 
 Path a. LMMs holding covariates and baseline ACE-F score, indicated the craving 
module was predictive of a 18.97 (SE = 6.36, 95%CI = -31.44, -6.51) point reduction in 
ACE-F score (Figure 5-2). This effect occurred above a significant main effect of TAU (b = -
16.52, SE = 4.27, 95%CI = -24.89, -8.14). The impulsivity module was predictive of a 26.65 
(SE = 7.87, 95% CI = -42.09, -11.22) reduction in DIS score post-treatment, above the non-
significant effect of TAU (b = -4.51, SE = 3.75, 95% CI = -11.86, 2.83). The Expectancy 
treatment module was not significantly predictive of post-treatment Positive DEQ score (b = -
1.45, SE = 2.66, 95% CI = -8.08, 4.02), above the significant effect of TAU (b = -7.74, SE = 
1.47, 95% CI = -10.62, -4.86).  
Path b. Reconstructed CPGLMM models on the complete cases were consistent with 
the full dataset, where treatment condition was not significantly predictive of proportion of 
drinking days or quantity of alcohol consumption over treatment. Adding post-treatment 
ACE-F score to the covariates models significantly improved fit with both drinking days 
(exp(b) = 1.04, p = 0.003) and quantity of alcohol consumption as outcomes (exp(b) = 1.04 , 
p = 0.020). Each unit increase in residualised post-treatment POMP ACE-F was associated 
with a 4% increase in the proportion of drinking days and 3.8% increase in alcohol 
consumption. Residualised post-treatment ACE-F was not found to affect growth in drinking 
days (exp(b) = 1.00, p = 0.353) or alcohol consumption (exp(b) = 1.00, p = 0.243) over 
treatment. Post-treatment POMP DIS and DEQ-Positive scores were not significantly related 
to the intercepts or slopes of either drinking behaviour over treatment. As the craving module 
predicted significant reductions in craving score above TAU (path a) and reductions in 
craving significantly predicted less alcohol consumption and less drinking days over 
treatment, the joint significance procedure indicates there is evidence for mediation. This was 
further supported by significant standardised indirect effects of the craving module on alcohol 
consumption (β = -0.78, SE = 0.415, 95%CI = -1.72, -0.11) and drinking days (β = -0.72, SE 
= 0.347, 95%CI = -1.50, -0.158).  
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Figure 5-2. Path figure of the effect of the craving treatment module on drinking 
behaviours as mediated by change in craving. Craving was standardised as percentage 
of maximum possible ACE-F score (0-100). Each unit reduction in craving is associated 
with a reduction in drinking behaviour by the product of 1×exp(b). * p < 0.05, ** p < 
0.01 
5.6 Discussion 
 The study compared the effectiveness of standard CBT for AUD to a tailored CBT 
treatment program based on the psychometric profiles of three mechanisms – craving, 
positive expectancy, and impulsivity - in a public health clinic. Contrary to hypotheses, no 
significant effect of targeted treatment on patient retention, proportion of drinking days over 
treatment, or quantity of alcohol consumption over treatment was identified. Nor were 
differences observed in the trajectory of drinking behaviours over treatment. Indirect support 
may be drawn for the craving treatment module. Patients within the craving module 
demonstrated reductions in craving more than twice those within TAU, and reduction in 
craving was associated with reduced alcohol consumption and fewer drinking days over 
treatment. This resulted in a significant indirect effect of the craving module, predicting a 
0.78 SD reduction in alcohol consumption and 0.72 SD reduction in drinking days relative to 
TAU. This provides some evidence for improved treatment response to the implementation of 
a manualised craving module when pre-treatment craving is high. However, no evidence was 
found to support the prediction that targeting positive expectancies or impulsivity based on 
pre-treatment assessments would be superior to treatment as usual in reducing drinking over 
treatment.  
 The impulsivity module, and no other module, significantly reduced reported 
dysfunctional impulsivity among treatment completing patients. This finding should be 
interpreted carefully, as impulsivity is widely considered an enduring trait (Loree et al., 
2015). We do not interpret this finding as suggesting that the patients are inherently less 
impulsive, but rather that the impulsivity module improved patients’ ability to manage 
dysfunctional impulses. Surprisingly, this reduction was not significantly related to reduced 
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drinking behaviour over treatment. This may indicate that impulsivity may not be as 
important to effective treatment response as initially thought. An alternative explanation may 
be that the relative risk of lapse as predicted by the standardised assessments is not equivalent 
across measures, as is assumed by the module allocation procedure. Future module 
assignment may be improved by weighting standard scores relative to established effect sizes 
for the targeted assessments. Follow up is required to identify whether reduction in reported 
dysfunctional impulsivity is sustained over time and if it improves long-term outcomes.  
The expectancy module did not significantly reduce positive expectancies above TAU. 
This may suggest that the positive expectancy module did not offer sufficient unique 
influence over the intended construct. It may be that TAU addresses positive expectancies 
sufficiently as it stands, or that the effect of the present intervention was too small to detect. 
Furthermore, reduction in positive expectancy was not significantly associated with reduction 
in drinking behaviour over treatment.  
Caution is recommended when interpreting any non-hypothesised effects identified 
among the covariates within the analyses. As the large number of tests make the likelihood of 
a false-positive finding among the covariates high, any non-hypothesised effects of interest 
require careful theoretical consideration subsequent replication. 
  Conducting a pragmatic trial within a public drug and alcohol outpatient hospital 
facility was ideal for determining intervention effectiveness in a ‘real world’ setting. 
However, restrictions of public hospital and ethical protocols limit levels of experimental 
control. Among the primary limitations were the absence of independent fidelity testing and 
restrictions in assessment. More frequent assessment of the target construct is required to 
determine the direction of effect between targeted mechanism change and drinking 
behaviour. There were also restrictions in experimental design as treatment of patients within 
the targeted treatment module was dictated by pre-treatment assessment results not random 
allocation. This was to minimise the risk of compromising the treatment efficacy of the 
targeted treatment modules. For example, a patient who scores very high on craving and very 
low on impulsivity, but is allocated to the impulsivity module, is unlikely to respond well to 
treatment. This also increases the likelihood of low treatment fidelity by the treating 
psychologists. Conclusions drawn from this study are also limited to initial treatment 
response. Long-term follow ups are not compulsory for patients, many opt not to return, and 
the data that is available is subject to selection bias. 
 The ability to appropriately tailor psychotherapy to individual patient characteristics 
has long been recognised as crucial to the progression of treatment efficacy (Norcross & 
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Wampold, 2011). Standardised methods of treatment matching, and in this study, tailoring 
treatment, have yet to demonstrate utility in the treatment of AUD (Project MATCH 
Research Group, 1998c; UKATT Research Team, 2007). This study provides evidence for 
implementing standardised craving modules for patients with high craving pre-treatment. 
More nuanced understanding of mechanisms of risk, change, and moderators of treatment 
response are required to enhance standardised approaches to tailoring psychotherapy.  
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Chapter 6: The relationship between impulsivity and 
craving in the prediction of treatment response 
  
Coates, J. M., Gullo, M. J., Feeney, G. F. X., Young, R. McD., Dingle, G. A., & 
Connor, J. P. (Under Review). Craving Mediates the Effect of Impulsivity on 
Lapse-Risk During Alcohol Use Disorder Treatment.  
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6.1 Chapter Foreword 
The previous chapter found limited support for a standardised personalised intervention 
method based on pre-treatment assessment of craving, alcohol outcome expectancies and rash 
impulsivity.  A significant indirect effect of the craving module on drinking behaviour was 
identified through reduction in patient reported craving. It was concluded that a more 
nuanced understanding of mechanisms of risk, change, and moderators of treatment response 
is required to progress personalised approaches to AUD intervention. One such process may 
exist between alcohol craving and rash impulsivity. Chapter Six aims to review evidence for 
relationships between rash impulsivity and alcohol craving and examine how they affect 
treatment response to CBT for AUD. The study is predominantly a secondary analysis of the 
data from the study outlined in Chapter 5, which comprises 80% (n = 379) of the present 
sample (n = 470). 
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6.2 Abstract 
Background: Rash impulsivity, a propensity for approach behaviour disregarding potential 
negative consequences, is associated with stronger alcohol craving among patients with 
Alcohol Use Disorder (AUD). This relationship is poorly understood and its implications for 
treatment response are unexamined. This study explored the relationship between rash 
impulsivity and alcohol craving in a sample of AUD patients. It also tested hypothesised 
models of mediation and moderation between craving and rash impulsivity on treatment 
response. 
Design: Longitudinal study conducted over a 12-week intervention period.  
Setting: University public hospital alcohol and drug clinic.  
Participants: Patients attending an abstinence oriented cognitive-behavioural therapy 
program (CBT) for AUD (n = 470).  
Procedure: Assessments were completed pre-and-post treatment. Craving and drinking 
behaviour were assessed at each treatment session. Treatment included eight, one hour, 
sessions of CBT over 12 weeks, delivered by clinical psychologists.  
Results: Higher rash impulsivity was associated with more frequent pre-treatment alcohol 
craving (b = 1.02, 95% CI = 0.43, 1.62). More frequent pre-treatment craving was predictive 
of greater risk of lapse during treatment (b = 0.01, 95% CI = 0.004, 0.02). Alcohol craving 
mediated the relationship between impulsivity and lapse risk (µ = 0.16, SE = 0.09, 95% CI = 
0.02, 0.36). Higher pre-treatment craving frequency was associated with attenuated reduction 
in craving over treatment period (b = 0.29, 95% CI = 0.24, 0.33). This increased risk of lapse 
as treatment progressed (b = 0.01, 95% CI = 0.01, 0.02).  
Conclusions: Craving mediates the effect of impulsivity in the prediction of lapse during 
abstinence-oriented treatment for AUD. Frequent assessment of craving during treatment is 
recommended to inform lapse risk and treatment approach.  
 
Key words: impulsivity, alcohol, craving, lapse, alcohol use disorder, cognitive-behavioural 
therapy  
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6.3 Introduction 
Alcohol Use Disorder (AUD) is a chronic relapsing condition among those who are 
severely dependent (Connor et al., 2016; Cunningham & McCambridge, 2012). Several 
cognitive and behavioural treatments with strong empirical support are available. No single 
approach has demonstrated superiority (Project MATCH Research Group, 1998c; UKATT 
Research Team, 2005b). Research attention has shifted from the development of new 
interventions towards identifying the effective components of current treatments and 
specifically, what works for whom (Kranzler & McKay, 2012; Longabaugh & Magill, 2011; 
Norcross & Wampold, 2011). Substantial effort has been made to identify mechanisms 
involved in the maintenance of AUD (Adamson, Sellman, & Frampton, 2009). Little is 
known about relationships between these mechanisms (Longabaugh & Magill, 2011; Magill 
& Longabaugh, 2013). Impulsivity and craving are both robustly related to AUD. Recent 
research has found evidence of an association between impulsivity and alcohol craving 
(Evren et al., 2012). This may have important implications in the maintenance of AUD. 
Considered a subjective desire to use a substance, the experience of craving can include 
physiological discomfort, intrusive substance-related cognitions, and affective distress 
(Bottlender & Soyka, 2004; Kavanagh et al., 2005). Craving is a dynamic state, variable in 
intensity, frequency, and duration (Sayette et al., 2000), which may be induced by 
physiological, cognitive, affective, or environmental cues (Monti, Rohsenow, & Hutchison, 
2000). Temptation to drink arises from the belief that alcohol will alleviate craving-related 
distress (Kavanagh, Andrade, & May, 2005). A widely recognised symptom of substance 
dependence, craving can contribute to diagnosis and treatment prognosis (Bottlender & 
Soyka, 2004; Flannery et al., 2003; Hasin et al., 2013). Most addiction services consider 
craving within treatment planning (Pavlick et al., 2009).  
Impulsivity, as it pertains to addiction, may be best represented by two core processes: 
(i) a heightened sensitivity to rewarding stimuli increasing the motivation to approach drugs 
(Reward Sensitivity/Drive); and (ii) a propensity for approach behaviour disregarding risk 
and negative future consequences (Rash Impulsiveness) (Boog et al., 2013; Dawe et al., 
2004; Gullo et al., 2014; Stautz et al., 2017). Reward Sensitivity has similarities to Sensation 
Seeking in some models of impulsivity (Whiteside & Lynam, 2001; Woick et al., 2009) and 
(agentic) Extraversion (Gullo et al., 2014). Rash Impulsiveness is closely aligned with 
Zuckerman’s Impulsive Sensation Seeking, (Lack of) Premeditation (Whiteside & Lynam, 
2001), and Barratt’s Impulsiveness (Patton et al., 1995). Both constructs are considered 
personality traits which are relatively stable over time.  
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Reward Sensitivity is causally associated with adolescent drinking (Gullo et al., 2017), 
with earlier onset of drug use (Urošević et al., 2015), stronger physiological response to 
alcohol (Brunelle et al., 2004), greater positive expectations of alcohol consumption (Gullo et 
al., 2010), and stronger urge to drink in response to alcohol cues (Kambouropoulos & Staiger, 
2001). While reward sensitivity is related to alcohol approach behaviours, rash impulsivity is 
more heavily implicated in problematic use and Substance Use Disorders (SUDs). 
Rash impulsiveness is predictive of the onset of SUDs (Sher et al., 2000), higher levels 
of consumption (Stautz et al., 2017), greater risk of lapse during treatment (Charney et al., 
2010), and higher likelihood of relapse post-treatment (Evren et al., 2012; Müller et al., 
2008). Rash impulsivity may moderate reward sensitivity in occasions of problem use, 
causing greater issue within treatment populations. This is consistent with neurobiological 
models of addiction, maintaining that while incentive salience arises from the limbic system, 
subsequent approach behaviour is determined by ‘executive’ prefrontal inhibitory systems 
(Goldstein & Volkow, 2002; Jentsch & Taylor, 1999; Koob & Volkow, 2010; Swick, Ashley, 
& Turken, 2011; Whelan et al., 2012). AUD patients with higher rash impulsivity are likely 
to be at greater risk of lapse in response to less salient incentives. As alcohol craving is 
among the greatest challenges to drinking restraint, a patient’s capacity for impulse regulation 
is expected to moderate alcohol approach behaviour. No research has been identified that has 
examined this proposed relationship. Several recent cross-sectional and experimental studies 
have identified positive associations between craving and rash impulsivity. This has 
prompted an alternative proposition that craving mediates rash impulsivity in the prediction 
of relapse.  
Evren et al. (2012) found high rash impulsiveness was predictive of greater alcohol 
craving in alcohol dependent patients. Pre-treatment craving, but not impulsivity, was 
predictive of relapse at 12-months (Evren et al., 2012). Laboratory studies have found higher 
impulsivity to be predictive of greater cue-induced cravings among smokers (Doran, Spring, 
& McChargue, 2007), social drinkers, and alcohol dependent patients (Papachristou, 
Nederkoorn, Havermans, Van Der Horst, & Jansen, 2012; Yarmush, Manchery, Luehring-
Jones, & Erblich, 2016). Conversely, cue-induced craving has also been associated with 
impaired cognitive inhibition (Naqvi et al., 2015; Verdejo-García et al., 2012). This suggests 
that patients high in rash impulsivity may lack the cognitive resources to inhibit craving 
related cognitions. They also may be more vulnerable to further impairment in response 
inhibition induced by craving (Doran et al., 2007; Kavanagh et al., 2005; May et al., 2015; 
Naqvi et al., 2015; Zilberman, Tavares, & El-Guebaly, 2003). 
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This study aims to explore the relationships between rash impulsivity, alcohol craving, 
and lapse events during abstinence-oriented CBT for AUD. We predicted that rash 
impulsivity would be significantly positively associated craving (H1). Both craving and 
impulsivity were expected to be associated with greater likelihood of lapse during treatment 
(H2 and H3). Craving was expected to mediate the effects of rash impulsivity (H4). Finally, 
higher rash impulsivity was predicted to enhance the risk of lapse in response to craving 
(moderation, H5).  
6.4 Method 
6.4.1 Participants and Procedure 
Subjects were consecutive patients (n = 470) attending a university metropolitan 
hospital outpatient drug and alcohol service for treatment of AUD. Sample characteristics are 
presented in Table 6-1. Referral to the alcohol and drug service was typically made by 
inpatient hospital referral or a community based General Practitioner. Intake interview was 
conducted by a nurse or social worker, who determined eligibility for the AUD treatment 
program and administered pre-treatment assessments. Patients were reviewed by an 
Addiction Medicine Physician. Pre-treatment assessments included assessment of AUD, 
dependence severity, baseline craving frequency, and rash impulsivity. Inclusion in treatment 
required that patients meet DSM-IV criteria for alcohol dependence and commit to a goal of 
12-weeks of abstinence. Patients were excluded from this study if they had a co-morbid 
substance dependence (with the exception of nicotine) or if they were taking Disulfiram or a 
prescribed opioid for opiate dependence. Patients were scheduled to begin treatment within 7-
days following intake. The program included eight, one-hour sessions of CBT conducted over 
12-weeks. Treatment was administered one-on-one by clinical psychologists with Masters or 
Doctoral level qualifications. Psychologists recorded drinking behaviour, craving, and 
adjunct pharmacotherapy (naltrexone, acamprosate, or both) at each treatment session. 
Human research ethics approval was obtained.  
6.4.2 Measures 
6.4.2.1 The Severity of Alcohol Dependence Questionnaire (SADQ)  
The SADQ contains 20 self-report items on a 4-point scale from 0 (almost never) to 3 
(nearly always), assessing physical withdrawal, affective withdrawal, drinking to relieve 
withdrawal symptoms, alcohol consumption, and rapidity of reinstatement of alcohol 
dependence (Stockwell et al., 1983). For AUD patients scores ≤ 15 are indicative of mild 
dependence, scores between 16 and 30 indicate moderate dependence, and scores ≥ 31 
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suggest severe dependence. The SADQ has strong psychometric properties with good test-
retest reliability and concurrent validity (Stockwell et al., 1983). Internal consistency of the 
SADQ within this study was good (Cronbach’s α = 0.92, 95% CI = 0.91-0.93). The SADQ 
was included within the pre-treatment assessment battery at patient intake.  
6.4.2.2 The Alcohol Craving Experience Questionnaire – Frequency (ACE-F) 
The ACE-F is a self-report measure assessing the frequency of desire related cognitions 
over the previous week. The ACE-F comprises 11-items on an 11-point visual analogue 
scale, anchored 0 (not at all) to 10 (constantly/extremely). The ACE-F has good construct 
validity, predictive validity, concurrent validity, discriminant validity, internal reliability, and 
test-retest reliability (Coates et al., 2017; May et al., 2014; Statham et al., 2011). Internal 
consistency of the ACE-F within the current study was excellent (Cronbach’s α = 0.95, 95% 
CI = 0.94-0.95). The ACE-F was included within the pre-treatment assessment battery at 
patient intake and re-administered at each treatment session.  
6.4.2.3 Dickman’s Impulsivity Inventory - Dysfunctional Impulsivity Scale (DIS) 
Dickman’s Impulsivity Inventory is a self-report questionnaire comprising two scales: 
Functional Impulsivity and Dysfunctional Impulsivity. The DIS assesses the tendency to act 
with little forethought where this leads to negative consequences (Dickman, 1990), and is a 
valid measure of rash impulsivity (Boog et al., 2013; Franken & Muris, 2006). The DIS 
comprises 12-items with dichotomous (True/False) response options. The DIS has 
demonstrated good internal reliability, construct validity, and excellent concurrent validity 
when compared with other established impulsivity scales (Claes et al., 2000; Dickman, 1990). 
Good internal consistency was identified within this sample (Cronbach’s α = 0.84, 95% CI = 
0.82 - 0.86). The DIS was included within the pre-treatment assessment battery at patient 
intake. 
6.4.2.4 Drinking Behaviour  
Guided by the Time-Line Follow-Back procedure (L. C. Sobell & Sobell, 1992), 
patients were asked to recall any drinking occasions which occurred between each session, 
report the type of alcohol consumed, and estimate volume of consumption. Any alcohol 
consumption between treatment sessions was coded as a lapse.   
6.4.3 Statistical Analysis 
As craving is proposed to mediate rash impulsivity in the prediction of lapse, there are two 
primary outcomes within the study, ACE-F score (craving) and lapse status (abstinent or 
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lapsed). For each outcome, two effects were modelled: the main effects on the outcome 
(intercept) and effects on the trajectory of the outcome over time (slope). Longitudinal linear 
mixed models (LMM) enabled both effects to be modelled while controlling for intra and 
inter-personal differences. LMMs are particularly well suited to psychotherapy research as 
they allow for incomplete and unbalanced data (Gallop & Tasca, 2009; Tasca & Gallop, 
2009). The number of sessions each patient attended was included in the analyses to model 
potential effects on the outcome dependent on the missing data process (Gallop & Tasca, 
2009; Hedeker & Gibbons, 1997).  
All data analysis was conducted in R version 3.3.3. LMMs were constructed by R 
package ‘lme4’ (Bates et al., 2015a) using Maximum Likelihood estimation. Statistical 
significance at p < 0.05 was determined by Wald estimated 95% CIs excluding zero. 
Potential covariates were entered in the first step of each model, as well as ‘session number × 
covariate’ interactions to detect covariate effects on the trajectory of the outcome. Only 
statistically significant covariates were retained. When the interaction was significant, but not 
the main effect, both terms were retained. Covariates included: age, gender, dependence 
severity (SADQ), total number of sessions attended, days between sessions, tailored 
treatment, and adjunctive pharmacotherapy. As this sample includes patients enrolled in a 
personalised treatment condition as part of a randomised controlled trial (RCT; n = 171; 
Chapter 5), this was included as a covariate. This controls for potential response differences 
between groups (Witkiewitz et al., 2017).  
To identify potential bias arising from violation of statistical assumptions, sensitivity 
analyses were conducted by comparing all LMMs based on Maximum Likelihood estimation 
to Design Adaptive Scale Tau estimation, a robust LMM variant (Field & Wilcox, 2016; 
Koller, 2016). Robust LMMs were constructed by R package ‘robustlmm’ (Koller, 2016). 
When the estimates provided by both models were ostensibly the same, the original model is 
reported. When discrepancy between the models was observed the robust model is reported. 
6.4.3.1 Hypothesis Testing  
H1) Rash impulsivity will be significantly positively associated with craving. Multiple 
linear regression was used to assess the relationship between pre-treatment DIS and ACE-F 
score at baseline. LMMs were used to assess the relationship between pre-treatment DIS 
score and the trajectory of craving over treatment.  
H2 & H3) Higher craving and impulsivity will predict greater likelihood of lapse. 
Separate logistic LMMs were used to assess the prognostic value of pre-treatment ACE-F and 
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DIS in the prediction of lapse-likelihood. Prediction of the slope of lapse-likelihood was also 
assessed by including ‘predictor’ x ‘session number’ interaction terms. Session by session 
ACE-F scores were included in a separate model to examine the effect of craving trajectory 
on the slope of lapse-likelihood over treatment.  
H4) Craving will mediate the effect of impulsivity in prediction of lapse. Consistent 
with joint significance procedure (MacKinnon et al., 2002) evidence for mediation was 
determined by a significant association between predictor and mediator (Path a), and a 
significant relationship between the mediator and outcome (Path b). Indirect effects and 95% 
confidence intervals (CI) were estimated by the product-of-coefficients method using R 
package ‘Rmediation’ (MacKinnon et al., 2007; Tofighi & MacKinnon, 2011). As the lapse 
outcome variable was dichotomous, path a and b coefficients were standardized to correct for 
differences in mediator/outcome distributions and residual variance (Mackinnon & Dwyer, 
1993). 
H5) A combination of high rash impulsivity and high craving will enhance lapse risk.  
Interaction between craving and impulsivity in the prediction of lapse was assessed by adding 
‘DIS × ACE-F’ and ‘DIS × ACE-F × Session Number’ terms to a logistic LMM model. 
6.5 Results 
6.5.1 Descriptive statistics and Missing Data 
Thirty-two percent of participants (n = 149) recorded mild dependence severity (≤ 15) 
on the SADQ, 41% (n = 191) scored within the moderate dependence range (17 - 30), and 
26% (n = 123) recorded severe dependence (≥31). Three-hundred and eighty-six patients 
(82%) attended at least one session. Of those who began treatment, the mean number of 
sessions attended was 4.85 (SD = 2.34). Of these, 93 (24%) completed all 8 sessions or 12-
weeks of treatment. Among those who completed treatment, 38 (41%) completed without 
lapse. Patients who completed treatment were significantly older (M = 46.01, SD = 10.45) 
than non-completers (M = 43.24, SD = 10.64; t (468) = -2.80, p =0.005). No other significant 
differences between treatment ‘completers’ and ‘non-completers’ were observed on any 
demographics variables or pre-treatment assessments. 
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Table 6-1. Descriptive Statistics of the Sample (N = 470) 
 Mean SD Range 
Age (years) 44.26 10.65 20 - 76 
Alcohol Use Disorder Identification Test 28.16 8.46 0 - 40 
Severity of Alcohol Dependence 23.10 12.75 0 - 58 
Dysfunctional Impulsivity 4.86 3.49 0 - 12 
Pre-treatment Alcohol Craving Experience 47.33 29.15 0 - 110 
    
 n %  
    
Gender    
  Female 174 38.08  
  Male 296 61.91  
    
Pharmacotherapy    
  Yes 146 31.06  
  No 324 68.61  
    
Active Treatment Trial    
  Yes 171 36.38  
  No 299 63.61   
 
H1) Rash impulsivity will be significantly positively associated with craving. DIS score 
was significantly associated with pre-treatment ACE-F score (b = 1.06, SE = 0.36, p = 0.003), 
while holding age (b = -0.25, SE = 0.12, p = 0.031*), gender (bMale = -6.01, SE = 2.49, p = 
0.016), and SADQ (b = 0.88, SE = 0.09, p < 0.001*) constant within multiple linear 
regression. LMMs were used to examine the relationship between the pre-treatment DIS 
score and the slope of ACE-F score over treatment. Covariates RCT enrolment and treatment 
completion had no significant effect on the ACE-F intercept or slope and were not retained. 
Age, gender, RCT enrolment, number of sessions attended, and treatment completion had no 
significant effects on the slope of ACE-F score over treatment, so their respective session 
number interaction terms were excluded. Session number predicted a significant reduction in 
craving over treatment, with each session associated with a 2.77 (95% CI = -3.76, -1.87) 
point reduction in craving score (Table 6-2. Summary of linear mixed-effects regression 
models predicting alcohol craving (N = 470).Table 6-2, Model 2). Higher dependence 
severity and combined pharmacotherapy were each associated with an increased rate of 
reduction (Table 6-2). Each unit increase in baseline DIS score was associated with a 0.95 
(95% CI = 0.40, 1.50) higher ACE-F score, however no significant association between DIS 
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Score and ACE-F slope was identified (Table 6-2, Model 1) and this interaction term was not 
retained (Table 6-2, Model 2). All robust analyses yielded consistent results, indicating that 
any violations to statistical assumptions did not meaningfully affect the present findings. 
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Table 6-2. Summary of linear mixed-effects regression models predicting alcohol craving (N = 470). 
Parameter Model 1 Model 2 Model 3 
Fixed Effects b (SE) 95% CI b (SE) 95% CI b (SE) 95% CI 
  Intercept 41.14 (5.30) 30.76, 51.53 41.44 (5.28) 31.09, 51.78 46.87 (4.52) 38.01, 55.74 
  Session Number -2.65 (0.53) -3.70, -1.60 -2.77 (0.50) -3.76, -1.78 -5.95 (0.53) -7, -4.91 
  Age -0.22 (0.09) -0.40, -0.04 -0.22 (0.09) -0.40, -0.04 -0.26 (0.08) -0.42, -0.1 
  Severity of Dependence 0.80 (0.08) 0.64, 0.96 0.81 (0.08) 0.65, 0.97 0.87 (0.07) 0.73, 1.01 
  Gender (Male) -7.87 (1.93) -11.65, -4.09 -7.91 (1.93) -11.69, -4.14 -8.22 (1.73) -11.62, -4.83 
  Combined Pharmacotherapy 3.81 (2.28) -0.65, 8.27 3.82 (2.28) -0.64, 8.28 3.90 (2.07) -0.16, 7.95 
  Sessions Attended -1.15 (0.37) -1.89, -0.42 -1.16 (0.37) -1.89, -0.43 -1.21 (0.34) -1.88, -0.55 
  Time Between Sessions -0.57 (0.11) -0.79, -0.36 -0.57 (0.11) -0.79, -0.36 -0.6 (0.11) -0.81, -0.4 
  Session Number × Severity of Dependence -0.07 (0.02) -0.10, -0.04 -0.08 (0.02) -0.11, -0.05 -0.08 (0.01) -0.11, -0.05 
  Session Number × Combined Pharmacotherapy -0.84 (0.39) -1.60, -0.08 -0.84 (0.39) -1.60, -0.09 -0.88 (0.37) -1.61, -0.16 
  Session Number × Time Between Sessions 0.14 (0.02) 0.09, 0.18 0.14 (0.02) 0.09, 0.18 0.15 (0.02) 0.11, 0.19 
  Dysfunctional Impulsivity 1.02 (0.30) 0.43, 1.62 0.95 (0.28) 0.40, 1.50   
  Session Number × Dysfunctional Impulsivity -0.04 (0.06) -0.15, 0.08     
  Session Number × Intercept     0.29 (0.02) 0.25, 0.33 
Random Effects σ2 (SD)  σ2 (SD)  σ2 (SD)  
  Patient (Intercept) 280.80 (16.76)  280.70 (16.75)  215.80 (14.69) 14.69 
  Residual 251.40 (15.86)   251.50 (15.86)   233.80 (15.29) 15.29 
 
Note: Boldface indicates p < 0.05 as 95% confidence intervals do not include zero. All parameters are unstandardized. 
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H2 & H3) Higher craving and impulsivity will predict greater likelihood of lapse.  
Logistic LMMs were used in the prediction of lapse-likelihood. Covariates age, gender, 
severity of dependence, combined pharmacotherapy, and RCT enrolment had no significant 
effect on the intercept or slope of log-likelihood of lapse, and were excluded. Number of 
sessions attended was not associated with the intercept of lapse-likelihood, but was predictive 
of slope, so both terms were retained (Table 6-3.). Each progressive session was associated 
with an increase in lapse-likelihood. Pre-treatment ACE-F (b = 0.01, SE = 0.001, 95% CI = 
0.001, 0.02) and DIS (b = 0.11, SE = 0.04, 95% CI = 0.04, 0.19) scores were both 
significantly predictive of lapse likelihood when assessed in separate models. Both effects 
were non-significant when time-dependent effects were considered (Table 6-3., Model 4-5). 
Higher scores on both scales related to higher lapse-likelihood as treatment progressed (Table 
6-3., Model 4-5). When both ACE-F and DIS scales were included in the model, ACE-F 
score remained significant in the prediction of the slope of lapse likelihood, though DIS score 
was non-significant (Table 6-3., Model 6).  
H4) Craving will mediate the effect of impulsivity in prediction of lapse. As pre-
treatment DIS was significantly predictive of pre-treatment ACE-F score (path a) and Pre-
treatment ACE-F was predictive of lapse-likelihood during treatment (path b), there is 
evidence for mediation under the joint-significance approach (Figure 6-1). Product-of-
coefficients estimates of the indirect effect of DIS score on lapse-likelihood was significant 
(µ = 0.16, SE = 0.09, 95% CI = 0.02, 0.36). When slope of craving and lapse-likelihood were 
considered, no paths supported joint-significance as the main effect of ACE-F intercept was 
not predictive of lapse (Table 6-3., Model 5) and DIS score was not predictive of the ACE-F 
slope (Table 6-2, Model 1).  Including an ‘intercept’ × ‘session number’ interaction term 
within the covariates ACE-F LMM (Model 1) indicated that pre-treatment ACE-F score was 
positively associated with ACE-F slope (Table 6-2, Model 3).  A two stage assessment of 
indirect effects revealed significant mediation of DIS score by ACE-F intercept in the 
prediction of ACE-F slope (µ = 0.30, SE = 0.09, 95% CI = 0.12, 0.48), and significant 
mediation of ACE-F intercept on lapse-likelihood slope via ACE-F slope (µ = 0.40, SE = 
0.09, 95% CI = 0.24, 0.57; Figure 6-2). Rash impulsivity is implied to indirectly increase 
lapse risk through three paths: 1. Higher rash impulsivity predicts more frequent pre-
treatment craving; 2. Higher baseline craving (intercept) is predictive of attenuated reduction 
in craving over treatment (slope); and 3. Attenuated reduction in craving frequency is 
associated with enhanced lapse-risk (Figure 6-2).  
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H5) Higher rash impulsivity will increase vulnerability to craving in the prediction of 
lapse. Interaction terms ‘ACE-F × DIS’ and ‘ACE-F × DIS × session number’ were added to 
Model 6. Neither interaction term was significant (Table 6-3., Model 7), yielding no support 
for moderation of craving by impulsivity in the prediction of the intercept or slope of lapse 
likelihood over treatment. 
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Table 6-3. Summary of mixed-effects logistic regression models predicting lapse (N = 470). 
Parameter Model 4 Model 5 Model 6 Model 7 
Fixed Effects b (SE) 95%CI b (SE) 95%CI b (SE) 95%CI b (SE) 95%CI 
  Intercept -5.08 (0.57) -6.20, -3.97 -5.99 (0.84) -7.63, -4.35 -5.96 (0.89) -7.7, -4.21 -5.95 (0.99) -7.89, -4.01 
  Session Number 1.01 (0.18) 0.66, 1.36 0.96 (0.26) 0.45, 1.46 0.90 (0.26) 0.38, 1.42 0.91 (0.28) 0.37, 1.45 
  Time Between Sessions 0.12 (0.02) 0.09, 0.16 0.12 (0.03) 0.06, 0.18 0.13 (0.03) 0.07, 0.18 0.13 (0.03) 0.07, 0.18 
  Sessions Attended 0.07 (0.08) -0.08, 0.22 0.07 (0.11) -0.14, 0.28 0.07 (0.11) -0.14, 0.28 0.07 (0.11) -0.14, 0.28 
  Session Number × Sessions Attended -0.10 (0.02) -0.15, -0.05 -0.09 (0.03) -0.16, -0.02 -0.09 (0.03) -0.16, -0.02 -0.09 (0.03) -0.16, -0.02 
  Session Number × Time Between Sessions -0.02 (0.001) -0.02, -0.01 -0.02 (0.01) -0.03, -0.03 -0.02 (0.01) -0.03, 0.001 -0.02 (0.01) -0.03, 0.001 
  Dysfunctional Impulsivity 0.02 (0.05) -0.08, 0.12    -0.02 (0.08) -0.17, 0.13 -0.02 (0.13) -0.27, 0.23 
  Session Number × Dysfunctional Impulsivity 0.03 (0.01) 0.01, 0.05    0.01 (0.02) -0.02, 0.04 0.01 (0.03) -0.04, 0.06 
  Alcohol Craving    0.001 (0.01) -0.01, 0.02 0.001 (0.01) -0.01, 0.02 0.001 (0.02) -0.03, 0.03 
  Session Number × Alcohol Craving    0.01 (0.001) 0.01, 0.02 0.01 (0.001) 0.01, 0.02 0.01 (0.001) 0.001, 0.02 
  Alcohol Craving × Dysfunctional Impulsivity          0.001 (0.001) -0.01, 0.01 
  Session Number × Alcohol Craving × Dysfunctional Impulsivity          0.001 (0.001) 0.001, 0.004 
Random Effects σ2 (SD)  σ
2 (SD)  σ
2 (SD)  σ
2 (SD)  
  Patient (Intercept) 3.75 (1.94)   4.39 (2.1)   4.47 (2.11)   4.48 (2.12)   
Note: Boldface indicates p < 0.05 as 95% confidence intervals do not include zero. All parameters are unstandardised on a log-likelihood scale. 
Page 123 of 242 
 
Chapter Six Impulsivity, craving, and treatment response 
 
 
 
Figure 6-2. Path model of rash impulsivity and craving in the prediction of the 
likelihood of lapse over treatment. 
* 95% confidence intervals non-inclusive of zero.  
ns Non-significant.  
 
  
Figure 6-1. Mediation model of pre-treatment rash impulsivity and craving in the 
prediction of lapse risk during treatment. 
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6.6 Discussion 
This is the first study to investigate the relationship between impulsivity and craving in 
the prediction of alcohol treatment response. Higher rash impulsivity was associated with 
more frequent alcohol craving pre-treatment. More frequent pre-treatment craving was 
predictive of greater risk of lapse. The indirect effect of rash impulsivity via craving in the 
prediction of lapse was significant, supporting the hypothesised mediation. The moderation 
hypothesis, that higher rash impulsivity would increase risk of lapse in response to craving 
frequency, was not supported.  
This study replicated previous research finding a positive association between craving 
and rash impulsivity among AUD patients (Evren et al., 2012; Joos et al., 2013). Consistent 
with previous studies, higher craving (Bottlender & Soyka, 2004; Flannery et al., 2003; Law 
et al., 2016) and impulsivity (Charney et al., 2010; Evren et al., 2012) were independently 
predictive of poorer treatment outcomes. Craving was found to diminish the unique effect 
attributed to impulsivity when included within the same model. This supports the present 
findings that craving mediates rash impulsivity as the final path to lapse. One explanation for 
this mediational process, is that patients high in rash impulsivity have an impaired cognitive 
ability to inhibit craving cognitions (Naqvi et al., 2015; Verdejo-García et al., 2012). A 
cognitive model of desire, Elaborated Intrusion (EI) Theory, provides a theoretical 
framework by which this process may occur (Kavanagh et al., 2005; May, Kavanagh, & 
Andrade, 2015). EI theory suggests that intrusive desire-related cognitions demand 
elaboration upon entering conscious awareness. Elaboration includes planning and appraisal 
of substance related behaviours, and is self-reinforcing as cognitions oriented toward craving 
relief provide fleeting moments of pleasure. An individual’s capacity to intervene early 
within this cycle, via distraction or reorientation is crucial to restricting the intensity of the 
craving experience. As patients with high rash impulsivity are more likely to have difficulties 
on tasks requiring cognitive inhibition (Bari & Robbins, 2013), they may be more vulnerable 
to elaboration of craving cognitions, resulting in more frequent and intense bouts of craving.  
Craving frequency was found to diminish over the treatment period. Patients with high 
craving frequency at pre-treatment experienced smaller reductions. Smaller reductions in the 
frequency of craving were associated with greater lapse risk as treatment progressed. This 
pattern may be due to persistent demands on craving inhibition, involving executive 
processes such as appraisal and reappraisal of proximal and distal expectations of alcohol 
consumption (Bandura, 1999; Kavanagh et al., 2005). Reappraisal may lead to fluctuations in 
motivation for abstinence and drinking refusal self-efficacy (Gullo, Dawe, Kambouropoulos, 
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Staiger, & Jackson, 2010). For example, patients whose experience of craving causes more 
distress than anticipated may develop stronger positive expectations of the effects of alcohol 
on tension reduction, motivating use via negative reinforcement contingencies which 
undermine self-efficacy. As drinking refusal self-efficacy has been found to mediate rash 
impulsivity in the prediction of hazardous drinking among AUD patients (Gullo, Dawe, 
Kambouropoulos, Staiger, & Jackson, 2010), future research should consider whether craving 
mediates rash impulsivity in the prediction of drinking refusal self-efficacy. 
Frequent assessment of craving, alcohol expectancies, motivation, and drinking-refusal 
self-efficacy is required to better understand the temporal relationships between these 
constructs in relation to treatment response (Gullo et al., 2010; N. Robinson, Kavanagh, 
Connor, May, & Andrade, 2016).  These findings support regular assessment of craving as a 
prognostic tool to inform risk of lapse (Tiffany et al., 2011). Future research may also 
consider including craving as a marker of treatment response within adaptive algorithms for 
personalised interventions (Kranzler & McKay, 2012; Nahum-Shani et al., 2017; Tiffany et 
al., 2011). Patients with persistent craving are likely to benefit from greater emphasis on 
coping strategies, craving psychoeducation, or adjunctive pharmacotherapy (Leggio, 2009; 
Marlatt & Witkiewitz, 2005; Witkiewitz et al., 2014).  
An important feature of this study was its control of common covariates. However, as 
covariate hypotheses were not developed a-priori, effects identified should be interpreted 
modestly and within the context of past research. Patients prescribed naltrexone, 
acamprosate, or both, were found to have significantly greater reductions in craving over the 
course of treatment. This is consistent with past research supporting efficacy of their 
combination with CBT (Feeney, Connor, Young, Tucker, & McPherson, 2006; Jonas et al., 
2014; Subbaraman, Lendle, van der Laan, Kaskutas, & Ahern, 2013). Better understanding of 
pharmacological and cognitive mechanisms may inform differential treatment response and 
guide progression of personalised interventions (Litten et al., 2015). Younger patients were 
subject to more frequent cravings, supporting findings from an actively drinking alcohol 
dependent sample (Chakravorty et al., 2010). Finally, women reported significantly more 
frequent craving than men. Few studies have considered gender with respect to alcohol 
craving, though females have been demonstrated to experience stronger cravings for cocaine 
(Elman, Karlsgodt, & Gastfriend, 2001) and food (Cepeda-Benito, Fernandez, & Moreno, 
2003). Affective, endocrine and neurobiological differences between males and females have 
been recognised as potential mechanisms contributing to differences in craving (Kiefer, Jahn, 
& Wiedemann, 2005; Kraus et al., 2004; Zilberman et al., 2003). Future research may explore 
Page 126 of 242 
 
Chapter Six Impulsivity, craving, and treatment response 
 
in detail gender differences in alcohol craving, and whether craving mediates the relationship 
between impulsivity and lapse similarly for women and men.  
This study has several limitations. As rash impulsivity was only measured at time one, 
the direction of effect between impulsivity and craving could not be tested statistically. The 
direction of mediation was inferred from theory proposing impulsivity is a relatively stable 
trait (Dawe, Gullo, & Loxton, 2004) and experimental research demonstrating that 
impulsivity predicts strength of craving (Doran et al., 2007; Papachristou et al., 2012; 
Yarmush et al., 2016). However, without frequent assessment of both impulsivity and craving 
this study cannot confirm directionality. Another limitation, is the craving measure used 
reflects past-week craving frequency, which does not capture phasic cycles in craving 
strength. Rash impulsivity may be differentially related to strength and frequency of craving. 
For example, impulsive patients may have more difficulty resisting episodes of strong 
craving than persistent low levels of craving. Reliance upon self-report is another limitation, 
restricting insight into the unconscious features of impulsivity and craving discussed within 
the proposed theoretical processes. Assessment of drinking behaviours was also reliant upon 
self-report, except for breathalyser testing at the beginning of each session and routine liver 
function tests. Additional biological markers of alcohol use would be beneficial to 
corroborate self-reports. 
AUD patients with high rash impulsivity experienced more frequent craving. Higher 
rash impulsivity was predictive of greater risk of lapse, though this effect was mediated by 
craving. More frequent craving pre-treatment was associated with more persistent cravings 
over the treatment period, increasing risk of lapse as treatment progressed. These findings 
support frequent assessment of craving in patients with AUD to inform lapse risk and 
treatment approach.  
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7.1 Research Problem 
Despite a variety of effective interventions for AUD treatment, response is modest and 
relapse rates remain high (Assanangkornchai & Srisurapanont, 2007; Miller & Wilbourne, 
2002). Improvement of AUD treatment outcomes was expected to result from matching 
patients to the most appropriate treatment based on characteristics of the individual patient 
(Project MATCH Research Group, 1997). However, substantial research attention with 
comprehensive experimental designs, large samples, and significant financing, has yielded 
sparse evidence to support the efficacy of this approach (Project MATCH Research Group, 
1997; UKATT Research Team, 2007). An alternative, though more complex approach, is to 
tailor treatment to individual patients. This could include factors across biological, 
psychological, and social domains, as well as interactions between them. Personalised 
interventions are currently in their infancy due to insufficient understanding of the complex 
mechanisms which maintain AUD and dictate treatment response (Litten et al., 2015).  
This thesis sought to identify individual characteristics which have prognostic value in 
the prediction of AUD treatment response, are implicated in the maintenance of AUD, and 
are suitable targets of psychosocial treatment strategies. (ie. are potentially modifiable) 
Alcohol craving, alcohol outcome expectancies, and rash impulsivity met these criteria, 
comprising the focus of this thesis. The strengths and limitations of these mechanisms were 
examined within a series of studies with the intention to progress understanding of their 
suitability as candidates for personalised AUD interventions. This program of research has 
direct implications for treatment providers, researchers, and the progression of future 
research.  
The purpose of this final chapter is to: 
i. summarise the core findings of the thesis; 
ii. highlight implications for theory, research, and practice; 
iii. identify future directions of research; 
iv. contextualise the findings taking into account limitations of this research; 
v. present the final conclusions. 
7.2 Summary of findings and implications 
7.2.1 Chapter Two – A brief measure of alcohol craving 
Effective utilisation of craving information within research and practice is complicated 
by issues of measurement. Chapter Two recognised administration time, construct validity, 
psychometric integrity, and clinical utility as common issues across craving measures. The 
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ACE questionnaire was proposed to have strong construct validity and psychometric 
integrity, owing to its theoretical foundation and excellent performance across indices of 
internal consistency, factor structure, concurrent validity, and discriminant validity. 
Administration and scoring demand of the 22-item ACE may not encourage use in busy 
clinical environments or research settings which already employ extensive assessment 
batteries. The study within Chapter Two aimed to develop a shortened version of the ACE 
which can be more easily integrated within practice and research.  
The frequency scale of the ACE (ACE-F) was proposed to possess greater stability than 
the strength scale (ACE-S), making it the more suitable of the two for monitoring patient 
outcomes. Contrasting the ACE-F and ACE-S in the prediction of treatment outcome 
revealed the ACE-F was a stronger predictor of lapse within this sample. The ACE-F was 
subsequently chosen for item reduction. Reduction of the ACE-F involved consideration of 
each item’s importance to craving theory, sensitivity to craving change, and predictive 
validity. Six items were removed, with the remaining comprising the 5-item ‘Mini Alcohol 
Craving Experience’ (MACE) questionnaire. The MACE maintained satisfactory construct, 
predictive, concurrent, convergent, and incremental validity, as well as good internal 
consistency and test-retest reliability. The MACE was further demonstrated to have superior 
predictive validity to one of the most widely used craving measures (the OCDS Obsessions 
scale). In addition, Chapter Two extended upon previous validation studies of the ACE 
questionnaire, generating previously unestablished predictive validity and test-retest 
reliability estimates.  
The MACE is suitable for measurement of alcohol craving in clinical and research 
settings. The MACE is semantically and theoretically consistent with DSM-V and ICD-10 
definitions of craving, making it a useful supplement to AUD diagnosis. The predictive 
validity of the MACE suggests that it is suitable for informing lapse and dropout risk among 
patients seeking treatment for AUD. The brevity of the MACE makes it ideal for settings 
which are time-limited, already have a heavy assessment burden, or require regular repeated 
administration. Therefore, the MACE is useful for weekly assessment of craving, a common 
format of AUD treatment programs. Focus on past week craving frequency is expected to be 
more sensitive to enduring changes in craving than peak strength. The MACE is therefore 
expected to be useful for monitoring lapse risk and gauging craving response to 
psychological or pharmacological interventions. These properties make the MACE as a 
suitable candidate for inclusion within adaptive algorithms in personalised AUD 
interventions.  
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7.2.2 Chapter Three – Craving measurement and application of the Alcohol Craving 
Experience questionnaire 
Chapter Two extended upon the psychometric evaluation of the ACE questionnaires, 
making them among the most rigorously validated measures of alcohol craving available. The 
true strengths of the ACE questionnaires, however, lay within their theoretical foundation and 
clinical applications. As discussion of these elements was beyond the scope of the empirically 
driven chapter Two, Chapter Three sought to outline these properties in detail. The chapter 
was structured to highlight important considerations in the selection of a craving measure, 
including definition and theoretical orientation, temporal reference period, psychometric 
integrity, administration demand, and clinical applications. 
The ACE assesses cognitive features of alcohol craving as outlined by EI theory of 
desire. This approach is consistent with the DSM-Vs definition of craving, “a strong desire to 
drink that makes it difficult to think of anything else”, supporting its validity in informing the 
craving criteria for diagnosis of Alcohol Use Disorder. The temporal reference of past-week 
experiences is well suited to treatment contexts where sessions are typically spread over 
weekly intervals. For settings where administration burden is of concern the MACE provides 
a brief option. Pre-treatment assessment of craving can inform the degree of lapse risk 
(prognosis) for each patient, while regular assessment may further serve as a tool for 
treatment response and marker of lapse risk. Interpretation of the ACE through EI Theory 
may inform treatment approach, depending on the strength and frequency of craving as well 
as the profile of craving related imagery, intensity, and intrusiveness scores. Constructs 
measured by the ACE and broader concepts of EI theory are consistent with a variety of 
craving intervention strategies. This chapter can assist researchers and treatment providers in 
the selection, effective application, and accurate interpretation of the ACE scales.  
 
7.2.3 Chapter Four - Clinical Implications of Alcohol Outcome Expectancies 
The opening chapter recognised alcohol outcome expectancies as common constructs 
within AUD theory and interventions. Modification of maladaptive alcohol outcome 
expectancies is a common goal of CBT for AUD. However, little research had examined 
outcome expectancies as mechanisms of change within successful interventions. Chapter 
Four reviewed previous research examining this process, finding few clinical studies which 
assessed expectancies both pre- and post-treatment. Among those that did, corresponding 
drinking behaviours were either not reported or collapsed within categorical variables with 
Page 132 of 242 
 
Chapter Seven Discussion and conclusions 
 
low statistical sensitivity. The importance of targeting expectancies within AOE treatment, or 
monitoring them as an index of successful treatment outcome could not be empirically 
supported. 
Chapter Four comprised a study seeking to extend upon this literature by examining the 
relationship between expectancy change and the proportion of drinking days over a 12-week 
CBT program for alcohol dependence. Consistent with past research, positive alcohol 
outcome expectancies were less strongly endorsed post-treatment, approximating community 
norms. Expectations of sexual enhancement was the only exception, remaining consistent 
before and after treatment. Importantly, the negative expectations of alcohol’s effect on mood 
was significantly higher following treatment. Contrary to predictions, change in positive 
outcome expectancies was not associated with the proportion of drinking days over treatment. 
In contrast, enhancement of negative expectancies was associated with less drinking days 
over treatment, supporting suggestions that strengthening of negative expectancies enhances 
motivation to resist drinking. Higher positive expectation of alcohol to facilitate tension 
reduction was predictive of more drinking days during treatment.  
The finding that significant reductions in positive alcohol outcome expectancies during 
abstinence orientedated AUD treatment supports cognitive-behavioural theory that change in 
attitudes and beliefs toward alcohol use is an important part of recovery (Beck et al., 1993). 
However, as the magnitude of change was not linked to drinking behaviour during treatment, 
the utility of alcohol expectancies as direct treatment targets or as a measure of treatment 
response remains unclear. In contrast, the finding that patients’ whose negative expectations 
of alcohol on their mood increased over treatment had fewer drinking days, suggests that 
monitoring of negative expectancies may be useful in gauging ongoing lapse risk. This also 
supports monitoring of mood and affect to facilitate identification and reinforcement of 
change in expectations of alcohol effects on mood.  
Some positive expectancies, in particular, stronger beliefs pertaining to alcohol as a 
means to relax and reduce stress, may inform lapse risk in treatment contexts. Addiction 
professionals and patients may benefit by monitoring the tension reduction expectancy, using 
it to inform treatment approach. For example, psychoeducation regarding the relationship 
between stress, tension, and alcohol withdrawal may facilitate change in patients’ attribution 
that alcohol brings acute relief from discomfort, to recognising that alcohol is the reason for 
its chronicity. In addition, treatment focus may be oriented toward acceptance or alternative 
coping strategies to enhance patient’s self-efficacy in managing without alcohol. 
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This chapter highlights several important avenues of future research. Further research is 
required to examine positive expectancy change and treatment response. High powered 
studies including regular expectancy assessment and follow up of patients who withdraw 
from treatment would be particularly beneficial in understanding the relationships between 
alcohol expectations and treatment response. Patient age emerged as significant covariate 
within several of the present analyses, highlighting importance of its consideration within 
expectancy research. Finally, as alcohol outcome expectations of negative affective change 
increased, while tension reduction expectations decreased, an important interaction may exist 
between these AOEs reflecting a shift in the attribution of positive and negative effects of 
alcohol. This provides an important direction for future research, with implications for 
treatment response and treatment of comorbid mood disorders.  
7.2.4 Chapter Five - Targeted Treatment of Alcohol Use Disorder 
Personalising treatments based on individual risk factors which can be targeted by 
cognitive-behavioural strategies may improve treatment outcomes. Alcohol craving, alcohol 
outcome expectancies, and rash impulsivity have been introduced as candidate targets for 
personalised interventions. Chapter Five aimed to test the effectiveness of tailored CBT for 
AUD based on assessment and individualised intervention of the aforementioned risk factors. 
The study was a pragmatic RCT. Patients attending an 8-session, 12-week, CBT program for 
AUD were randomly assigned to treatment as usual (general CBT) or a personalised variant 
of the program (targeted CBT treatment). Four of the eight sessions for patients in the 
targeted treatment conditions were dedicated to addressing the most salient risk factor as 
determined by standardised assessment of craving, alcohol outcome expectancies, and rash 
impulsivity.  
Contrary to predictions, treatment response of patients in the targeted treatment 
condition was not superior to treatment as usual. Patient attrition, alcohol consumption and 
number of drinking days during treatment were consistent across conditions. Patients within 
the craving module demonstrated reductions in craving more than twice those within TAU. 
Reduction in craving was associated with reduced alcohol consumption and fewer drinking 
days over treatment, resulting in a significant indirect effect of the craving module on both 
outcomes. Unexpectedly, rash impulsivity was also significantly lower post-treatment among 
patients in the impulsivity condition. However, this reduction was not associated with 
drinking behaviours. Patients in the expectancy condition did not have a significantly greater 
change in global positive expectancies post-treatment than those in TAU, nor was reduction 
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in positive expectancy significantly associated with reduction in drinking behaviour over 
treatment. 
This research found little evidence for the superiority of this standardised approach to 
individualised treatment of AUD to treatment as usual. within the context of a public health 
service. However, this study has several important implications. First, implementing 
standardised craving modules for patients with high craving pre-treatment may have superior 
outcomes to treatment as usual. This finding highlights the clinical utility of standardised pre-
treatment assessment of craving and value of using craving measures to inform treatment 
approach. Second, although rash impulsivity is considered a stable personality trait, patient 
perceptions regarding their propensity for rash impulsive behaviour is amenable to cognitive-
behavioural strategies. Although clinically meaningful implications of this finding were not 
identified within this study, this may have important implications for personalised 
interventions, or other mental health disorders where impulsivity is considered a maladaptive 
trait (e.g. Borderline Personality Disorder, Attention-Deficit/Hyperactivity Disorder). Third, 
targeting global positive alcohol outcome expectancies may have little clinical value above 
treatment as usual. Future research should restrict focus to individual expectancies implicated 
most heavily within problem alcohol use (e.g. tension reduction expectancies). Limiting focus 
will afford greater insight into potential mechanisms at play and identification of individual 
expectancies which may be suitable targets within personalised interventions. More nuanced 
understanding of mechanisms of risk, change, and moderators of treatment response is 
required to enhance standardised approaches to tailoring psychotherapy. 
7.2.5 Chapter Six - The relationship between impulsivity and craving in the prediction of 
treatment response 
Among the explanations for the null primary findings of the personalised treatment trial 
in Chapter Five, is that the relationship between the risk factor and lapse events are more 
complex than the direct effects implied by the intervention strategies employed. More 
nuanced understanding of the processes at play, such as mediating and moderating effects, is 
required to refine personalised interventions for AUD. Chapter Six aimed to explore such 
processes, examining potential relationships between alcohol craving and rash impulsivity. 
Past research and theory based on cognitive, behavioural, and neurological models of craving 
and impulsivity was reviewed. A positive association between rash impulsivity and craving 
has been demonstrated among AUD patients. Experimental research has found rash 
impulsivity to be predictive of a stronger craving response to alcohol cues, suggesting craving 
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may mediate the effects of rash impulsivity. No previous research had tested this mediation 
model within a clinical setting. Higher rash impulsivity was also predicted to increase the risk 
of lapse at lower levels of craving. This was the first study to investigate the relationship 
between impulsivity and craving in the prediction of alcohol treatment response. 
Consistent with past research, higher rash impulsivity was associated with more 
frequent alcohol craving. Both craving and rash impulsivity were independently predictive of 
greater risk of lapse during abstinence-oriented treatment for AUD. As predicted, craving was 
found to mediate impulsivity in the prediction of lapse. However, contrary to hypothesis, 
higher rash impulsivity was not associated with greater vulnerability to lapse at lower levels 
of craving. Greater reduction in craving as treatment progressed reduced lapse risk. Higher 
craving at pre-treatment was associated with attenuated reduction in craving over treatment, 
which significantly increased lapse risk.    
One interpretation of the finding that craving mediates impulsivity in the prediction of 
lapse is that patients high in rash impulsivity lack the cognitive resources to inhibit craving 
related cognitions. Once craving is elicited, patients are then vulnerable to further impairment 
in response inhibition induced by craving. This interpretation would imply that patients with 
high rash impulsivity may have difficulty with cognitive craving management strategies due 
to difficulties with cognitive inhibition. Impulsive patients may benefit more from 
behavioural craving management strategies which avoid or circumvent elicited craving 
cognitions. The finding that sustained craving was associated with greater lapse risk also has 
several implications. Regular assessment of craving may be beneficial in informing treatment 
response. This further highlights the suitability of craving as a marker of treatment response 
within adaptive treatment algorithms. Patients with persistent craving may benefit from 
craving psychoeducation, emphasis on coping strategies, or combined pharmacotherapy. 
7.3 General Discussion 
This thesis sought to examine key psychological mechanisms which may be targeted 
within personalised treatments for AUD. The research scope encompassed construct 
measurement, prediction of lapse risk and treatment outcome, and the relationship between 
change in these constructs and treatment response. Alcohol craving, alcohol outcome 
expectancies, and rash impulsivity were all demonstrated to have prognostic value in AUD 
treatment contexts. Patients with high alcohol craving were found to respond better to a 
treatment program targeting craving, than standard CBT. Alcohol craving stands out as an 
important construct for consideration within personalised adaptive treatment designs. The 
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utility of targeting alcohol outcome expectancies in AUD interventions remains unclear. 
Positive outcome expectancies were found to significantly reduce toward community norms, 
however this change was not related to better treatment response. In contrast, negative 
expectancies were not significantly predictive of treatment response, but patients whose 
negative expectancies increased over treatment had fewer drinking days. Expectancies remain 
an important construct within AUD treatment. Further research is required to better 
understand their role in treatment response before they can be effectively utilised within 
personalised treatments.  Finally, self-reported rash impulsivity, unexpectedly, was found to 
be responsive to targeted intervention.  However, no clinical significance of this finding was 
evident, as change was not related to improved treatment response. An important relationship 
between rash impulsivity and craving was identified, where craving was found to mediate the 
effect of rash impulsivity on treatment response. This finding may have implications 
regarding treatment approach when these two constructs are considered in combination.  
Consideration of future directions of research have been discussed throughout this thesis. 
When considered together, these finding offer insight into broader implications for the 
progression of personalised AUD interventions.   
7.3.1 Limitations and Future directions 
7.3.1.1 Research design 
Research designs can be conceptualised on a continuum from explanatory (e.g. ‘‘Can 
this intervention work under ideal conditions?’’) to pragmatic (e.g. ‘‘Does this intervention 
work under usual conditions?”) (Thorpe et al., 2009). Many of the limitations of this program 
of research are attributable to the pragmatic context within which the studies were conducted. 
As all of the data analysed within this thesis was drawn from an outpatient drug and alcohol 
service within a public-hospital, practical and ethical restrictions limited levels of 
experimental control. For example, administrative demands on staff and patients were 
required to be kept to a minimum, attendance and consent to research was voluntary, and 
patients were not reimbursed for participation. This restricted follow-up of patients who 
withdrew, impairing generalisability to patients who do not complete a full treatment 
program. Furthermore, session-by-session evaluation of all key constructs was not practical 
due to the assessment burden, preventing inference of causal relationships among 
mechanisms of interest and drinking behaviour. For example, as assessment of alcohol 
expectancies could only occur at pre-treatment and three-month follow-up, we could not infer 
whether change in expectancy precipitates reduction in drinking, or if reduction in drinking 
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promotes expectancy change. The treatment setting also greatly restricted control over 
comorbid mental disorders, which are highly prevalent among patients with AUD (Hasin et 
al., 2007; Lai et al., 2015) and associated with poorer treatment outcomes (Martin & Rehm, 
2012). Explanatory paradigms are able to eliminate or reduce these confounds by integrating 
more stringent experimental protocols such as strict patient follow up, comprehensive 
assessment batteries, assessment only controls. and strict inclusion criteria.      
The advantage of pragmatic trials, however, is that data generated yields high 
generalisability to other treatment contexts and is a more accurate reflection of the 
effectiveness of treatment strategies. Whereas experimental studies may identify robust 
effects within highly controlled settings, they may not translate to clinical practice. As a study 
cannot simultaneously possess both high experimental control and high external validity, a 
solution to this dilemma is to conduct multiple experiments, from pre-clinical experimental 
designs through to application in treatment services. Initial research may seek to understand 
the structure, stability, and correlates of a construct. Human pre-clinical studies may then test 
causal directions between constructs, establishing potential treatment targets. Treatment 
strategies may then be assessed within highly controlled clinical settings to establish efficacy, 
before being assessed within pragmatic designs. Such approaches are well placed to uncover 
key ‘ingredients’ of successful interventions and identify individual risk factors suitable for 
progression of personalised interventions.  
7.3.1.2 Assessment of risk 
Among the limitations of the RCT within Chapter Five, was the process of allocating 
patients in targeted treatment to the most suitable treatment module. The decision was based 
on the standardised scores on measures of craving, outcome-expectancies, and rash 
impulsivity constructs. The highest standardised score, relative to AUD norms, dictated 
condition allocation. It is likely that the magnitude of risk attributable to each construct is not 
a 1-1 relationship with the AUD standardised construct. More nuanced decision models may 
better inform treatment allocation. For example, weighting assessment scores by their 
respective effect sizes in the prediction of treatment outcome. Alternatively, machine learning 
algorithms has shown promise in prediction of treatment response (Connor, Symons, Feeney, 
Young, & Wiles, 2007). Machine learning algorithms are an a-theoretical method of 
producing the ‘best’ statistical model of relationships between an outcome and set of 
predictor variables identified within an existing dataset. After the model has been ‘learned’ 
predictions can be made for new cases. The algorithm may be continually updated as more 
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cases are included within the dataset. Individual treatment services may utilise their own 
historical data to generate predictive models most representative of their population. It is 
important to note that as these algorithms are a-theoretical, careful consideration of the 
theoretical mechanisms underlying the resulting models is required. This approach to 
statistical model is considered to be ‘prediction’ rather than ‘explanation’ oriented, and is 
rarely adopted within psychological research (Yarkoni & Westfall, 2017). Careful integration 
and application of both approaches may accelerate understanding of complex mechanisms of 
risk and inform personalised AUD interventions based on comprehensive pre-treatment 
assessments.  
7.3.1.3 Fixed versus adaptive personalised interventions 
This thesis sought to personalise treatment, by targeting mechanisms recognised as high 
risk at pre-treatment assessment. A potential limitation of this approach is that there was no 
opportunity for re-assessment during treatment, or modification of treatment approach if the 
patient was non-responsive to the targeted intervention. Future research may consider 
adaptive treatment designs. Adaptive treatments involve an algorithm including key outcome 
variables. In their simplest form, adaptive algorithms for AUD interventions include a 
measure of treatment response, such as drinking days or alcohol consumption. Patients 
showing insufficient change on this outcome would prompt a change in treatment response. 
Alternatively, highly positive responses may prompt scaling back of treatment services, 
maximising efficiency of the service provider. An alternative use for adaptive designs may be 
to personalise interventions via inclusion of a targetable outcomes within adaptive 
algorithms. This thesis supports the inclusion of craving within adaptive designs, as pre-
treatment scores and change in craving have both been demonstrated to be predictive of 
lapse. Patients scoring high on craving at pre-treatment were shown to respond better to 
standardised craving intervention (Chapter Five), while patients whose craving remained high 
were at greater risk of lapse (Chapter Six). Adaptive algorithms would allow service 
providers to recognise and plan for craving related risk pre-treatment and adapt treatment 
strategies in the event of poor treatment response. Alcohol outcome expectancies, in 
particular tension reduction and negative expectancies, should also be considered as 
candidates within adaptive designs, though this thesis could not confirm their suitability as 
treatment targets.    
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7.3.1.4 Holistic research: Biopsychosocial assessment and intervention 
The focus of this thesis has been limited to candidate mechanisms which may be 
targeted by psychosocial intervention and self-report assessment. However, the influences of 
genetic, biological, and neuroadaptive processes, as well as broader social and occupational 
factors also warrant consideration. Mann and Hermann (2010) recommend including 
biological markers in addition to psychosocial assessment to validate the proposed biological 
mechanisms of action. For example, functional magnetic resonance imaging (fMRI) has been 
utilised to examine change processes within neurological structures in response to 
behavioural interventions (Vollstädt-Klein et al., 2011). Vollstädt-Klein et al. (2011) found 
cue exposure training affected mesocorticolimbic reward pathways involved in alcohol 
incentive salience, craving, and attentional bias (Vollstädt-Klein et al., 2011, 2012). These 
findings have implications for personalised interventions, as it is suggested that AUD patients 
with high cue reactivity will have greater therapeutic response to cue-exposure based 
extinction training (Mann & Hermann, 2010). Research seeking to examine this hypothesis, 
subsequently has the advantage of assessing the neurological (e.g. via fMRI), physiological 
(e.g. via heart rate variability), and psychological (e.g. via self-reported craving) processes by 
which treatments work. Such information has the potential to further refine treatment 
approaches and individualise interventions for AUD. 
Targeted pharmacotherapy is another avenue by which personalised interventions may 
be refined. As discussed in Chapter One, Mann and colleagues (2017) sought to identify 
AUD phenotypes comprising neurological and psychological characteristics. The authors 
predicted that patients who primarily consumed alcohol in the context of reward seeking (in 
contrast to relief drinking), would have differential functioning of within the opiodergic 
system, and respond better to the opioid antagonist naltrexone. Consistent with the 
hypothesis, patients who predominantly drink for reward responded better to naltrexone, 
suggesting that psychological assessments may provide useful indicators of 
neurophysiological process and inform personalised pharmacological interventions. 
Alternatively, genetic variants have been proposed as potential bio-markers to identify who is 
more likely to respond to certain medications. For example, AUD patients with a greater 
number of AUD family members respond better to naltrexone (Krishnan-Sarin, Krystal, Shi, 
Pittman, & O’Malley, 2007; Rubio et al., 2005), suggesting that there are genetic variants 
within the opiodergic system which moderate its effects (Kranzler & McKay, 2012). 
Specifically, possession of the G allele of A118G polymorphism of µ‐opioid receptor gene 
(OPRM1) is related to greater response to naltrexone among alcohol dependent patients 
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(Chamorro et al., 2012). Furthermore, the effect of topiramate on the reduction of heavy 
drinking among problem drinkers has been found to be moderated by the glutamate receptor 
GRIK1 (Kranzler et al., 2014). The application of genetic information may advance the 
efficiency and effectiveness of personalised pharmacotherapy for AUD.  
Finally, patients social networks have been demonstrated to strongly influence the 
likelihood of treatment initiation (Barber & Crisp, 1995) and affect treatment response (Allen 
et al., 1997; B S McCrady et al., 1986). Social factors are commonly included in models of 
relapse (Marlatt & Gordon, 1985), which is reflected by a high number of treatments 
including social components and even dedicated social interventions (Copello et al., 2002). 
Though treatment matching based on social characteristics has not demonstrated superior 
effectiveness (UKATT Research Team, 2007), social functioning is another avenue worthy of 
exploration for personalised interventions (Best et al., 2016).  
7.3.2 Final Comment 
The progression of AUD treatment requires careful consideration of biological, 
psychological, and social mechanisms underlying AUD maintenance and treatment response. 
Greater understanding of these processes can inform personalised AUD interventions. This 
program of research extended knowledge of the clinical applications of self-reported alcohol 
craving, alcohol outcome expectancies, and rash impulsivity. Each construct was implicated 
within treatment response, supporting their position within AUD theory. However, limited 
evidence was found for the effectiveness of personalising treatment with respect to individual 
differences among these constructs. Further research is needed to understand the complex 
processes dictating treatment response, and equally sophisticated procedures are required to 
effectively adapt treatment to individuals. The findings of this thesis progress understanding of 
the mechanisms of risk and response within AUD treatment; and can inform the progression of 
theoretical and methodological approaches to personalising treatments for AUD.  
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Study 
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Data* 
Active 
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Active 
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Chapter 2: Study 1 
✓ ✓ 
 
Chapter 4: Study 
2Chapter 3: 
✓ ✓ 
 
Chapter 5: Study 3   
✓ 
Chapter 6: Study 4   
✓ 
*Historical treatment program was identical to the RCT control condition (treatment as 
usual).  
  
181 
 
Appendices  
 
Appendix F 
Supplementary Material for Chapter 2 
 
Supplementary Tables 
The Mini Alcohol Craving Experience Questionnaire: Development 
and clinical application 
 
Jason M. Coates1,2,  Matthew J. Gullo1,3, Gerald F.X. Feeney1,3, David J. Kavanagh4, Ross 
McD. Young3,5, Genevieve A. Dingle1,2, Jon May6, Jackie Andrade6, Dixie J. Statham7, & 
Jason P. Connor1,3,8 
 
1 Centre for Youth Substance Abuse Research, The University of Queensland, Brisbane, 
Australia 
2 School of Psychology, The University of Queensland, Brisbane, Australia  
3 Alcohol and Drug Assessment Unit, Department of Medicine, Princess Alexandra Hospital, 
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4 Centre for Children’s Health Research, Institute of Health & Biomedical Innovation and 
School of Psychology & Counselling, Queensland University of Technology, Brisbane, 
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5 Faculty of Health, Queensland University of Technology, Brisbane, Australia 
6 School of Psychology, Cognition Institute, Plymouth University, Plymouth, UK 
7 School of Social Sciences, University of the Sunshine Coast, Sunshine Coast, Australia 
8 School of Medicine, The University of Queensland, Brisbane, Australia 
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Table S1.  
Percentiles, interquartile ranges, and endorsement rates (ER) of ACE-F items.  
    Percentile    
How often did these things happen over the last week? n 25 50 75 IQR ER (%) 
1.  Did you want a drink? 518 2 5 7 5 87.6 
2.  Did you think about needing a drink? 519 1 3 7 6 80.2 
3.  Did you have an urge to drink? 519 2 5 8 6 86.1 
4.  Did you picture alcohol or drinking? 519 1 3 6 5 80.9 
5.  Did you imagine what it would taste like? 518 0 2 6 6 73.0 
6.  Did you imagine what it would smell like? 519 0 1 4 4 61.3 
7.  Did you imagine what it would feel like in your mouth or throat? 519 0 2 5 5 67.1 
8.  Did you imagine how your body would feel if you had a drink? 518 1 4 7 6 80.1 
9.  When you thought about alcohol over the last week, how often 
were the thoughts intrusive? 
507 1 4 7 6 84.9 
10.  When you thought about alcohol over the last week, how often 
were you trying not to think about alcohol? 
517 1 5 8 7 83.8 
11.  Did you find it hard to think about anything else? 516 1 2 5 4 75.8 
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Table S2.  
Summary of logistic regression models assessing additional predictive value of ACE-F items. 
 
    95% CI for Odds Ratio 
  B (SE) Lower Odds Ratio Upper 
Model 4         
  Constant 1.23*** (0.14)  3.41  
  Medication 0.17 (0.23) 0.76 1.19 1.86 
  AUDIT -0.03 (0.11) 0.79 0.98 1.21 
  Item 3 0.51** (0.18) 1.16 1.66 2.37 
  Item 4 -0.04 (0.24) 0.60 0.96 1.55 
  Item 5 0.11 (0.21) 0.74 1.11 1.66 
  Item 8 0.03 (0.17) 0.74 1.03 1.43 
  Item 9 -0.10 (0.16) 0.67 0.91 1.24 
Model 5     
  Constant 1.24 (0.14)  3.45  
  Medication 0.20 (0.23) 0.78 1.23 1.93 
  AUDIT -0.02 (0.11) 0.79 0.98 1.21 
  Item 3 -0.01 (0.26) 0.59 0.99 1.67 
  Item 4 -0.07 (0.25) 0.58 0.93 1.51 
  Item 5 -0.01 (0.21) 0.65 0.99 1.51 
  Item 8 0.04 (0.17) 0.75 1.04 1.45 
  Item 9 -0.12 (0.16) 0.65 0.89 1.21 
  Item 1 0.70 (0.26) 1.22 2.01 3.32 
Model 6     
  Constant 1.28*** (0.14)  3.61  
  Medication 0.19 (0.23) 0.77 1.21 1.92 
  AUDIT -0.02 (0.11) 0.79 0.98 1.23 
  Item 3 -0.02 (0.27) 0.57 0.98 1.68 
  Item 4 -0.08 (0.25) 0.56 0.92 1.50 
  Item 5 -0.03 (0.21) 0.64 0.97 1.47 
  Item 8 0.00 (0.17) 0.71 1.00 1.41 
  Item 9 -0.50 (0.21) 0.41 0.61 0.91 
  Item 1 0.78 (0.26) 1.30 2.18 3.66 
  Item 10 0.51 (0.17) 1.20 1.67 2.32 
Note: * p < .05, ** p < .01, *** p < .001,  
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Table S3.  
Standardised parameter estimates of unifactorial confirmatory factor analysis for proposed 
ACE-F scales. 
  ACE-F-11 ACE-F-7 ACE-F-5 
Item Loading p R2 Loading p R2 Loading p R2 
1 0.812 <.001 0.766 0.825 <.001 0.681       
2 0.866 <.001 0.866       
3 0.862 <.001 0.889 0.867 <.001 0.752 0.830 <.001 0.689 
4 0.872 <.001 0.702 0.878 <.001 0.770 0.888 
 
0.789 
5 0.815 <.001 0.774 0.787 <.001 0.620 0.806 <.001 0.649 
6 0.712 <.001 0.673       
7 0.750 <.001 0.728       
8 0.780 <.001 0.596 0.778 <.001 0.606 0.791 <.001 0.625 
9 0.886 <.001 0.838 0.879 <.001 0.772 0.881 <.001 0.777 
10 0.515 <.001 0.298 0.499 <.001 0.249    
11 0.729 <.001 0.58             
 
Table S4.  
Standardised parameter estimates of three factor confirmatory factor analysis for proposed 
ACE-F scales. 
  ACE-F-11 ACE-F-7 ACE-F-5 
Item Loading p R2 Loading p R2 Loading p R2 
Intensity                 
1 0.875 <.001 0.766 0.884 <.001 0.782    
2 0.931 <.001 0.866       
3 0.943 <.001 0.889 0.941 <.001 0.886 1  1 
Imagery         
4 0.838 <.001 0.702 0.884 <.001 0.781 0.890 0.793 
5 0.880 <.001 0.774 0.809 <.001 0.655 0.808 <.001 0.652 
6 0.820 <.001 0.673       
7 0.853 <.001 0.728       
8 0.772 <.001 0.596 0.796 <.001 0.634 0.790 <.001 0.625 
Intrusion         
9 0.916 <.001 0.838 0.913 <.001 0.833 1  1 
10 0.546 <.001 0.298 0.517 <.001 0.267 1  1 
11 0.762 <.001 0.580             
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Table S5.  
Standardised factor correlations of three factor confirmatory factor analysis for proposed 
ACE-F scales. 
  ACE-F-11 ACE-F-7 ACE-F-5 
Factor Correlation p Correlation p Correlation p 
Imagery*Intensity 0.779 <.001 0.873 <.001 0.827 <.001 
Imagery*Intrusion 0.916 <.001 0.968 <.001 0.878 <.001 
Intensity*Intrusion 0.858 <.001 0.860 <.001 0.736 <.001 
 
Table S6.  
Correlations between the ACE-F scales and the OCDS-Obsessions, AUDIT, S-Anxiety, and 
BDI 
  OBS AUDIT S-Anxiety BDI 
ACE-F 11 .598*** .215*** .381*** .380*** 
ACE-F 7 .585*** .196** .401*** .388*** 
ACE-F 5 .583*** .211*** .385*** .382*** 
**p<.01, ***p<.001 
 
Table S7.  
Cronbach’s alphas and correlations between session one and two ACE scale scores. 
  α  r 
ACE-F 11 0.946 .731*** 
  Intensity 0.940 .718*** 
  Imagery 0.917 .741*** 
  Intrusion 0.807 .636*** 
ACE-F 7 0.919 .725*** 
  Intensity 0.908 .672*** 
  Imagery 0.866 .732*** 
  Intrusion 0.641 .632*** 
ACE-F 5 0.922 .728*** 
 
Table S8.  
 
ACE normative data for an alcohol dependent sample upon presentation for treatment. 
 
  Female Male Total 
  Percentile  Percentile  Percentile 
Measure n 25 50 75 n 25 50 75 n 25 50 75 
MACE Total 255 10 23 34 490 8 18 32 747 8 19 33 
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ACE-F Total 255 23 46 70 490 16 37 66 747 18 41 67 
  Intensity 255 6 13 18 490 4 10 16 747 4 11 17 
  Imagery 255 5 14 30 490 5 14 27 747 5 14 28 
  Intrusion 255 6 14 20 490 3 12 18 747 4 12 19 
ACE-S Total 171 36 62 80 345 25 55 75 518 30 56 76 
  Intensity 171 14 21 26 345 8 18 24 518 10 18 24 
  Imagery 171 8 19 37 345 7 20 34 518 8 20 35 
  Intrusion 171 11 18 24 345 6 15 20 518 7 15 21 
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Appendix G 
Confirmation of acceptance for publication – Chapter 3.  
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Appendix H 
Patient information sheet for Chapter 5 
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Appendix I 
Patient information sheet for Chapter 5 
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Appendix J 
Targeted Treatment Modules for Chapter 5 
Impulsivity Module Overview 
Module Summary: 
This module is process oriented and helps patients recognize the value of planning and careful 
deliberation in achieving their goals. Impulsivity is managed by fostering a reflective, future-oriented 
perspective that produces clearly identifiable benefits. Because it is process-focused, it is designed to 
fit in with the techniques you would normally use with a patient. Modeling structure in-session through 
agenda-setting is also important. Your treatment should incorporate as much documentation as 
possible to facilitate the patient’s reflection. Ask patients to document their use of strategies and 
record their effectiveness (pre/post) in changing behavior / craving / emotion. This emphasis on 
documentation will be challenging for impulsive patients at first. Persisting with homework tasks and 
facilitating compliance (via motivational interviewing) is essential. 
Session 1 
 
Handout 1 
The role of impulsivity in treatment 
1. Provide assessment feedback and discuss the positive and negative effects 
of impulsivity on the patient’s life. Provide psychoeducation that highlights 
that being impulsive is not “bad”, but that it increases risk for substance 
abuse and relapse. 
2. Introduce or remind the patient of relevant strategies that address their 
specific difficulties related to their impulsivity (e.g. stop – think – go or wise 
mind from DBT) 
3. Promote future thinking: Introduce using a calendar or diary to encourage 
organisation and planning. Problem-solve barriers to acquisition & use 
(Handout 1). 
Homework: 
• Acquire calendar/diary and commence future planning 
Session 2 
 
Handouts 
2 and 3 
Early Success 
1. Review homework (use of calendar/diary and future planning) 
2. Identify a treatment target that can be addressed quickly (e.g., exercise) 
3. Address it as you normally would, with an emphasis on written evaluation of 
outcomes 
4. Assist patient to schedule times to employ skills outside of session. 
Homework: 
• Record effectiveness of each use of skill and its effect on behavior/emotions 
before and after each use (Handout 3) 
Session 3 
 
Handout 4 
Problem Solving - Getting Through The Tough Times 
1. Review homework (effectiveness of new skills) 
2. Explore a current problem using the 6 steps of problem solving.  
3. Identify set of tasks to be completed to solve the problem (Handout 4). 
Homework: 
• Carry out the tasks identified in the session to solve the problem.  
Session 4 
 
Handout 5 
Alternative Rewards 
1. Review homework (problem solving) 
2. Discuss the importance of non-drug rewards and the need to replace role 
played by past drug use as reward 
3. Investigate cognitions concerning non-alcohol rewards  
4. Choose new or previously rewarding activities to try (Handout 5). 
Homework: 
• Try out non-drug rewarding activities. 
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Impulsivity Module 
 
Detailed Sessions 
 
 
• Session 1: The Role of Impulsivity in Treatment 
 
• Session 2: Early Success 
 
• Session 3: Problem Solving 
 
• Session4: Alternative Rewards 
 
 
  
198 
 
Appendices  
 
 
Session 1 – The Role of Impulsivity in Treatment 
 
 
Overview: 
• Patients learn about the how impulsivity increases substance abuse 
risk and reduces treatment effectiveness.  
• The focus of this session is on strengthening the rationale behind the 
module’s content, which will initially seem ‘unnatural’ to an impulsive 
patient.  
 
Set Agenda and Psychoeducation 
• Provide feedback on patient’s impulsivity scores in relation to 
normative data. As much as possible, have the patient elicit the 
advantages and disadvantages of their high impulsivity and link it back 
their drinking. You can use some of the points below: 
 
•  “Impulsivity is a personality trait that is strongly influenced by our 
genes and early learning experiences. Research shows people high in 
impulsivity are ‘present-oriented’ and good at thinking quickly. Such 
individuals are more likely to end up in leadership roles and make good 
entrepreneurs. There are many positive aspects of being high in 
impulsivity.” 
• “However, they are also more likely to have problems with alcohol and 
drugs. Individuals high in impulsivity also tend to discontinue treatment 
early. The flip-side of their quick thinking and ‘present’ orientation is 
that impulsive people are not as good with time management or 
sticking to long-term goals. They usually run late or run out of time to 
do important things because their fast cognitive tempo causes them to 
underestimate how long things take. This includes important aspects of 
their treatment like completing homework assignments. As a result, 
they won’t see improvements as quickly as other patients and drop-out 
of treatment.” 
Getting ‘Future-Oriented’ 
• Provide rationale for promoting future orientation, e.g.: 
•  “Abstinence takes work, more than can be done within 
our one-hour sessions. To really make the most of the 
12-week program and the changes you want to make, 
we first need to organize the time outside these 
sessions you can devote to your treatment. This way, 
we can make best use of that time.” 
 
• Create a weekly schedule together  
 
• E.g. “To make the most of your time over the course of 
the program, we first need to get an idea of what a 
typical week for you looks like.” 
• “Using this calendar (Handout 1) let’s record how you 
spent your last week. For each activity, I’d like you to 
Handout 1 
199 
 
Appendices  
 
also record your sense of mastery of the activity, as well 
as how pleasurable it was for you (0-10).” 
• “Looking over the past week, what strikes you most 
about how you spend your time? What things do you 
like about it and what things would you like to change?” 
• “We gain a different perspective when everything is laid 
out paper like this. That’s why it is an important part of 
treatment for alcohol problems. Do you have a 
diary/calendar at home? Does your phone have a 
calendar app?” 
Homework 
• Problem-solve acquiring a calendar and potential obstacles to using it.  
• Ask the patient to fill out at least one week in advance (schedule a time 
for this) in their new calendar and bring it to the next session. 
• Advise patient to update calendar whenever a new arrangement is 
made or something comes up that they need to do. It needs to become 
‘a reflex’. 
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Session 2 – Early Success 
 
Rationale:  
• Many elements of structured therapy will feel unnatural at first, especially 
to patients high in impulsivity.  
• An ‘early success’ in treatment will emphasize the tangible gains 
available through persisting with therapy activities, enhancing the 
rationale for their use. 
Set Agenda and Review Homework 
Patient should have brought in their calendar. Look over it with 
them and discuss how they are finding using it. How is it helping? 
Is it causing any problems? 
Many patients allocated to this module will likely not bring it in. 
They may forget, or may not have gotten around to acquiring 
one. If this happens: 
1. Administer Homework Questionnaire (Handout 2) 
2. Look over patient responses and discuss these with them 
3. Problem-solve obstacles and foster motivation for calendar 
use. Revisit rationale and weigh up pros/cons of calendar 
use. 
Be understanding of the difficulty they may experience with it. 
Use this as an example of how therapy will involve doing a lot of 
different things that may be difficult at first. 
It can be tempting to collude with the patient and let the issue 
slide, particularly if you are not a calendar/diary user yourself. 
However, non-compliance on this should be treated like any other 
‘therapy-interfering’ behaviour. Spend as much time in-session 
discussing this as needed. 
 
 
 
 
 
 
 
 
 
 
Handout 2 
 if needed 
Early Success with Psychology 
This is the therapist’s chance to demonstrate to the patient with 
the value of psychological skills. 
1. Identify a target relevant to the patient’s presenting 
problem that can be addressed quickly (e.g., exercise, 
insomnia, boredom) 
2. Address the problem as you normally would, having the 
patient evaluate its effectiveness in writing with skill use 
(see ‘Monitoring Your Relaxation Level’ – Handout 3 for an 
example) 
3. Schedule time for skill practice in their calendar 
4. Discuss patient’s expectations of the success of the 
negotiated plan and have them quantify how effective their 
‘gut’ tells them the approach will be (0-100% effective). 
Have them write this down. 
5. If you sense reservation or indifference, discuss this with 
the patient and the pros/cons with ‘giving it a go’ – the 
patient will see they have nothing to lose and trying it is in 
the spirit of 12 weeks of change. 
 
 
 
 
 
 
 
Handout 3 
Homework 
1. Record skill practice and its effectiveness in calendar or on activity 
schedule 
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Session 3 – Problem Solving 
 
Rationale:  
• Patients review the 6 steps in effective problem solving when working 
through examples.  
 
Set Agenda and Review Homework 
 
• Review the patient’s record of skill practice and its effectiveness. 
Compare the actual effectiveness with their initial ‘gut feeling’ to 
emphasize the tangible gains being made. 
• Review patient’s use of their calendar as if they are finding it helpful. 
• Problem-solve unexpected obstacles. If there are difficulties with 
compliance, refer to Session 2. If indicated, revisit patient’s 
motivation/readiness for the program and if they need a ‘vacation’. 
 
Getting through the tough times 
Introduce the patient to formal problem solving, e.g.: 
“Difficult situations can lead you to respond based on emotions, 
feelings or instinct. This can lead to problems as you often 
haven’t thought through the consequences of those actions 
beforehand. Reviewing the steps in effective problem solving can 
help you to work through things in a logical way before making 
decisions and acting. This way your actions may be more likely 
to have positive outcomes and work toward your goals. There 
are six steps that can be used when solving most problems. 
Let’s look at the steps and how they could help you to solve a 
recent problem you’ve faced.” 
 
Problem Solving 
 
Encourage the patient to think about a recent time when they 
faced a dilemma or problem. It could be a problem they are 
facing right now and aren’t sure what to do.  
 
1) Define the problem 
You firstly need to be specific about the problem you are facing. 
Often you might have a worry that is made up of several 
problems. Separate them out. Think about the different parts of 
the problem and tackle each one at a time.  
 
2) Brainstorm solutions 
Think of all the possible things you could do to solve the 
problem. Bring them all up, even if they seem unlikely. The 
more possible solutions you have the better the chances of 
success. Thinking of what has worked when you faced similar 
problems in the past can help you brainstorm.  
 
 
 
Handout 4 
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3) Pros and cons of each solution 
Choose three of your possible solutions. Work through the pros 
and cons of each option to see which might be the best one. 
 
4) Choosing a solution and planning to put it into action  
Based on looking at the options more closely and doing the 
pros/cons, which option looks like it is most suited to the 
problem? Which option looks most likely to succeed? 
 
Make a plan. Think of how and when you can try out the 
solution. Write it in your diary as an action or set of actions so 
you’re clear on what you need to do to tackle the problem. 
 
5) Doing it 
Think about other things you do day to day. What makes you 
more likely to complete tasks? Putting it in your diary, on a to-
do list, getting someone to check you’ve done it, telling a loved 
one? Use this knowledge to help you get the task completed.  
 
6) Reviewing the outcome 
Checking how it went is important. You can check what went 
well and what to change for next time. 
 
Homework 
 
Negotiate a problem the patient can apply their new problem-solving skills to 
over the next week. Schedule a time and review it in next session. 
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Session 4 – Alternative Rewards 
 
 
Rationale:  
• Alcohol can be a potent source of pleasure and reward and impulsive 
persons are particularly reward sensitive 
• Long-term abstinence requires a suitable alternative that the patient 
finds rewarding. Some patients may additionally be in need of a 
hobby/activity that provides meaning and that they can be passionate 
about. 
 
Set Agenda and Review Homework 
 
• Review the patient’s record of problem-solving. Work through any 
difficulties they may have experienced. 
• Review patient’s skill practice (if necessary) and use of their calendar. 
Reinforce benefits they have observed and recorded. 
• If there are difficulties with compliance, refer to Session 2. If indicated, 
revisit patient’s motivation/readiness for the program and if they need a 
‘vacation’. 
 
Activity Scheduling 
 
“Alcohol has played an important role in your life. While it is the 
negative effects of drinking that brought you here, there is no 
denying that it has had some positive effects as well. Most 
patients do not realize at first that they can still enjoy all of those 
positive effects without alcohol. Today, we will be exploring some 
alternative sources of reward.” 
1. Explore their beliefs about the rewards of alcohol use 
2. Have them recall the last time they had a drink and rate 
the experience in terms of ‘Mastery’ and ‘Pleasure’ 
3. Compare these ratings to the Patient’s calendar or Activity 
Schedule from Module Session 1 – how do they 
compare? 
4. If alcohol scores higher, explore what activities would 
match/exceed this. If they cannot think of anything, give 
them the Pleasant Activities Schedule. 
5. Look over their responses and ask “Which ones would 
come closest to being as enjoyable as drinking?” 
6. Focus on these. If none match/exceed drinking, discuss 
the pros/cons of engaging in these activities given that 
they do not have the negative effects that drinking does. 
7. Schedule in at least one of these activities for the next 
week to determine how rewarding it really is. 
8. This will form the basis for continued discussion of pros 
and cons of these alternative rewards compared to 
alcohol. On balance, which provide the best balance of 
positives and negatives? 
 
 
Handout 5 
 if needed 
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Alcohol Expectancies Module Overview 
Module Summary: 
This module helps patients explore how learnt alcohol outcome expectancies contribute towards the 
development and maintenance of drinking problems. Given that alcohol has been used as a key coping 
strategy for patients in the past, it is desirable that patients develop alternative approaches.  
 
A number of coping strategies are provided and selection should be based on the patient’s Drinking 
Expectancy Questionnaire Assertion, Tension Reduction, and Affective Change (i.e. Anger 
Management) subscales scores, as well as your own clinical judgement relating to key areas of patient 
concern.  
 
Although drinking expectancies are cognitive in nature, the module aims to assist the patient with 
behavioural strategies first, before challenging expectancies with behavioural experiments then 
introducing more advanced cognitive strategies towards the end. 
Session 1 
 
Handouts  
1 – 5 
Alternative Coping Skills 
1. Explore patient’s existing coping skills and reasons for using them 
2. Introduce new skills in their specific areas of individual need, as highlighted by 
the Drinking Expectancy Questionnaire. These strategies may address the 
following areas: 
o Tension Reduction/ Stress (Handouts 1, 2, 3, 4). 
o Assertiveness (Handout 8). 
o Anger Management (Handout 5). 
Homework: 
• Practise using skills learned in session 
Session 2 
 
Handouts  
6 – 7 
  
Expectancies & My Drinking 
1. Review homework (practise of skills learned in session 1). 
2. Explore with the patient some of the key expectancy beliefs driving their use of 
alcohol as a coping mechanism (Handout 6). 
3. Set up a behavioural experiment to test patient’s expectancy beliefs. Use 
SMART goal framework – specific, measurable, achievable, realistic, timely. 
Homework: 
• Carry out behavioural experiment.  
Session 3 
 
Handouts  
8 – 10 
Challenging Expectancy Beliefs 
1. Review homework (behavioural experiment). 
2. Identify other expectancy beliefs and develop behavioural experiments to 
challenge them (No Handout) 
3. Provide psychoeducation about communication styles, and explore when they 
do and don’t use the various styles (Handout 7).  
4. Introduce cognitive challenging in relation to circles of control (Handout 8). 
5. Develop a coping plan for risky situations (Handouts 9 and 10). 
Homework: 
• Carry out more behavioural experiments (if applicable). 
• Practise assertive communication skills. 
• Apply “circles of control” cognitive challenging.  
• Use coping plan in risky situations. 
Session 4 
No Handouts 
Wrap-up 
1. Review any tasks completed for homework (e.g. behavioural experiments) 
2. Briefly return to the Session 2 – “Psychoeducation about Expectancies” and 
highlight need to continue to utilise alternative coping strategies. 
3. Review use of assertive communication, circles of control, or coping plan  
4. Reinforce that alternative coping strategies need to be practised in order to 
weaken the (expected) link between alcohol and coping.  
5. Focus on the future, what skills need to be learnt next? 
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Expectancies Modules 
 
Detailed Sessions: 
 
 
 
 
• Session 1: Alternative Coping Skills 
 
• Session 2: Expectancies & My Drinking 
 
• Session 3: Challenging Key Drinking Expectancies 
 
• Session 4: Wrap-up 
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Session 1 – Alternative Coping Skills 
 
Overview: 
This session aims to assist patients develop alternate coping strategies to replace drinking. 
The selection of coping strategies is dependent on DEQ sub-scale scores and clinical 
judgement.  
 
Extra Information for Psychologists: 
Strategies are outlined to enhance coping skills in the specific areas of individual need, as 
highlighted by the Drinking Expectancy Questionnaire. They are linked to the Tension 
Reduction, Assertion, and Affective Change sub-scales, targeting stress, anger 
management, and assertiveness. Clinical judgment will be necessary to determine if the 
patient drinks as a coping strategy for their anger or if they become angry as a result of 
drinking and to assess risks related to this (as measured by Affective Change sub-scale).  
 
Tension Reduction/Managing stress (high on Tension Reduction sub-scale)  
Teach the patient progressive muscle relaxation or abdominal breathing. 
Describe both of these to the patients and encourage them to state a 
preference. 
 
Handouts 1 
and 2 
Managing Anger (high on Tension Reduction, Assertion & Affective Change 
sub-scales, psychologist assesses that anger management is relevant) 
 
Explore a recent episode of anger. Discuss what healthy behavioural coping 
strategies they’ve used in the past that have been effective and promote using 
these again (e.g. getting back into a regular gym routine, going for a walk to 
calm down, counting to 10). If necessary, teach them additional coping 
strategies, discussing the role of in-the-moment techniques, as well as ‘slow-
release’ techniques for more general anger management/ emotional release.  
 
In the moment strategies: 
• Count to 10;  
• Imagery (e.g. taking 10 slow deep breaths and when you slowly breath 
out, imagine the anger being released like steam or the gas coming 
out of a soft drink bottle); 
• Removing yourself from the situation and/or any temptations to behave 
in ways you don’t want to (e.g. going to a local park, for a walk, or to 
the movies to cool down rather than to a bottle shop). 
 
General anger management strategies: 
• Emotional expression. Exploring options for an emotional outlet – 
someone to talk to, keeping a diary/journal, painting/artistic expression, 
exercise routine, woodworking projects etc. 
• Basic needs – correcting any problems in eating or sleeping patterns. 
• Regular Relaxation/breathing exercises (e.g. daily, regardless of 
whether angry or not (see Handout 2 for abdominal breathing sample 
script). 
• Self-talk- identify negative thoughts – discuss and practise with patient 
a small range of simple, positive self-statements statements that can 
be used during at risk periods (e.g. driving a car, existing interpersonal 
tensions) and actual escalation of anger episodes. 
Handout 5 
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Assertion (scored high on Assertion sub-scale and the psychologist has 
ascertained that they have difficulties with assertion in their relationships) 
 
Discuss with the patient their difficulties with interpersonal relationships (you 
may wish to use their sub-scale score to introduce this topic). If they agree 
that social anxiety and lack of assertion is a problem, assist with problem-
solving to:  
• Explore the link between their social anxiety and their drinking (if it 
exists) 
• Discuss situations that trigger their anxiety 
• Encouraging practising abdominal breathing in challenging situations  
Handouts 2 
and 4 
Homework 
Tension Reduction/Managing stress: 
Provide Handout 3 or Handout 4 and ask patient to practice once a day until 
their next appointment. You may also direct them to search for YouTube 
videos on PMR (e.g. http://www.youtube.com/watch?v=HFwCKKa--18) 
 
Managing Anger: 
Practice alternate coping strategies ‘in-the-moment’ and general strategies 
discussed in session to improve anger management. Give them Handout 5. 
 
Assertion: 
Practice abdominal breathing twice a day, for 2 minutes at a time. Give them 
Handout 4 as a reminder and discuss potential suitable times, e.g. 
immediately before bed etc. 
  
Handouts 3 
and 4 
 
 
 
 
Handout 5 
 
 
 
Handout 4 
 
  
208 
 
Appendices  
 
 
Session 2 –  Expectancies & My Drinking 
 
Overview: 
• Patients explore some of the key expectancy beliefs driving their use of alcohol as a coping 
mechanism.  
• Patients develop a better understanding of the relationship between their alcohol 
expectancies, perceived coping and use of alcohol.  
 
Psychoeducation about Expectancies 
Expectancies can take different forms: 
- Believing that alcohol can be helpful in bringing about positive thoughts, 
emotions or behaviour e.g. happiness and mixing with people. 
- Believing that alcohol can be helpful in removing negative thoughts, emotions 
or behaviours e.g. reducing anger and stopping an outburst. 
 
These can maintain negative patterns of drinking behaviour because the patient 
might come to rely on alcohol to bring about these effects, in order to cope or 
manage. As this becomes a habit people might expect negative consequences if 
they abstain from alcohol in those situations. People typically do not test out their 
predictions by entering the situation without having a drink to see what would happen 
and behavioural Experiments help them to establish a more accurate picture.  
 
Discuss a recent time when the patient had a drink, exploring the expectations they 
had about what would happen when they drank.  
 
Explain to the patient that part of their treatment will involve identifying drinking 
expectancies, and developing alternate ways of coping. The more they practise 
these alternate coping strategies, the more they will weaken the link between alcohol 
and coping.    
 
Assist the patient to complete Handout 6. Assess if this is a belief that could be 
challenged through a behavioural experiment – anxiety is probable, but work with 
patient to assess likelihood of a severe response to the task. If possible, set this 
behavioural experiment as homework. Start with small, tangible tasks to give the 
patient the best chance of success. If there are additional coping strategies they may 
need to perform the behavioural experiment, teach these to the patient, e.g. 
rehearse saying no to a drink in a social situation to a close friend/partner.  
 
Handouts 6 
and 7 
 
Homework 
Undertake behavioural experiment. 
 
Handout 7 
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Session 3 – Challenging key drinking expectancies 
 
 
Overview:  
• Review homework task 
• Identify other expectancy beliefs and other ways these could be challenged.  
• Help the patient to make develop a richer understanding about the consequences of their 
drinking.  
 
Review Homework Task 
Reinforce what they learned from the task or troubleshoot with them if they were not 
able to complete it successfully. 
Handout 7 
Identify Other Expectancy Beliefs 
Determine if these can be challenged through behavioural experiments and set 
these as homework tasks. In the process, identify if this requires alternate coping 
strategies to be developed. Alternately, these may be able to be challenged 
cognitively through the activities outlined below. 
Handout 7 
Communication Styles  
 
Provide psychoeducation about passive/ assertive/ aggressive/ passive-aggressive 
communication styles. Discuss with the patient the times they use various styles and 
explore impediments to assertion in certain situations or with certain people. 
Reinforce that it is not always appropriate to be assertive at all times. Discuss 
possible experiments they could undertake to become more assertive without 
alcohol.  
 
Psychologists will need to be aware of the patient’s circumstances and monitor any 
risks with changing their communication style (e.g. may not be safe to become more 
assertive towards their domestically violent partner). 
 
 
 
Handout 8 
Circles of Control 
 
When assertion is difficult, patients’ may also struggle with taking on too much 
responsibility or worrying about things that are beyond their control. It can be useful 
to challenge this thinking by exploring what things in their life they have no control 
over, some control, and total control. Refocus the patient on aspects of their life they 
have some control over. 
 
Handout 9 
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Coping Plan Development 
 
Rationale: 
• Assist patient to identify risky situations 
• Give the patient an opportunity to consider and rehearse potential excuses 
they may give and/or refusal skills 
• Combine these aspects into a Coping Plan  
 
Step 1: Identifying Triggers/ Risky Situations 
Most people describe triggers that fall into certain categories: 
• Negative emotions – anger, sadness, anxiety 
• Positive emotions – excitement, happiness 
• Withdrawal effects – symptoms, cravings and urges from alcohol withdrawal 
• Physical pain or discomfort – aches, pain, tiredness 
Questions that may help you elicit these risky situations: 
• What makes you more tempted to have a drink? 
• Think about lapses and slippages. What were the triggers?  
• What times are more risky for you? 
 
Step 2: Plan how to handle those triggers/ risky situations 
 
• Refusal skills rehearsal  
Normalise the pressure that social situations can place on people to drink, but also 
recognise that we can magnify the pressures to justify our own behaviour. This may 
involve encouraging the patient to experiment with refusing a drink and seeing how 
people respond (they may actually accept this without any further comment!). 
Discuss with the patient the importance of giving a clear refusal in both your 
language and body language, and that they may not need to give a reason. Discuss 
with the patient what has worked for them in the past – what did they say? How did 
people react? Go through the roleplay exercise in Handout 10. 
 
• Avoiding Risky Situations 
Discuss the importance of avoiding risky situations at this early stage in their 
treatment. You may need to discuss strategies to avoid risky situations, e.g. taking a 
different route home to avoid a favourite bar, talking to their partner about removing 
alcohol from the house, or not going to parties for a few weeks. 
 
• Putting controls in place  
If the patient has a risky situation that they cannot easily avoid, a discussion about 
how they can put controls in place will be more appropriate. Discuss a range of 
different strategies they can use, e.g. being the designated driver; being on a special 
diet to lose weight and get fit or training for a fun run; rehearsing giving the excuse of 
a work/other commitment the following day which means they cannot drink. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Handout 10 
 
Homework 
Document Coping Plan for patient to take this away with them  
Handout 11 
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Session 4 – Wrap-up 
 
Overview: 
• This session refocuses on the idea that our expectancies form over our lifetime, and take 
sustained effort to alter 
 
• Revisit the psychoeducation about expectancy beliefs and drinking from session 2 
o Treatment so far has involved identifying drinking expectancies, and developing 
alternate ways of coping.  
o The more they practise these alternate coping strategies, the more they will weaken 
the link between alcohol and coping.    
• Review any tasks completed in session and for homework and discuss what was helpful 
and what was not helpful 
o Use of relaxation exercises 
o Practice of communication skills 
o Carrying out behavioural experiments 
o Development and use of coping plan 
o Focus on the future, what skills need to be learnt next? 
o Create a plan for the final sessions 
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Craving Module Overview 
 
Module Summary: 
This module helps patients assess the difference between cravings and urges. Patients will 
then develop short-term behavioural coping strategies to ‘surf’ cravings. After this, patients will 
learn how unhelpful thinking feeds craving and develop more helpful thoughts to assist them to 
overcome cravings.  
Session 1 
 
Handouts 
1 – 5 
 
Cravings & Urges 
1. Provide psychoeducation about cravings versus urges (No Handout). 
2. Identify risk situations and triggers (Handouts 1 and 2). 
3. Introduce short-term behavioural strategies – 3Ds (Delay, Distract, Deep 
breaths) (Handout 4). 
4. Explore motivation to change and create a visual reminder of this to help 
during cravings (No Handout – Patient to develop). 
Homework: 
• Monitor cravings throughout the week by filling out the Craving Diary 
(Handout 3). 
• Practice deep breathing when relaxed (Handout 5). 
• Use the 3Ds to ‘surf’ the cravings (No Handout). 
• Implement visual reminder of reason for abstinence (Patient to develop). 
Session 2 
 
Handouts 
6 – 8 
Beating the Urge 
1. Review homework (Craving Diary, Use of 3Ds, Use of Visual Reminder). 
2. Explore patient’s existing coping skills (No Handout). 
3. Introduce effective problem solving steps to effectively manage cravings 
and urges (Handouts 6 and 7). 
4. Assist patients to create their Craving Management Plan to help them 
through the discomfort (Handout 8). 
Homework: 
• Monitor cravings throughout the week with Craving Diary (Handout 3). 
• Use Craving Management Plan (Handout 8). 
Session 3 
 
Handout 9 
 
Unhelpful Thoughts 
1. Review homework (Craving Diary, Use of Craving Management Plan) 
2. Discuss relationship between unhelpful thinking and cravings and urges.  
3. Identify unhelpful thoughts and introduce thought countering by working 
through recent cravings on thought record (Handout 9). 
Homework: 
• Practice helpful thinking and continue to add to their thought record, 
noting down if it changes the strength of their craving (Handout 9). 
Session 4 
 
Handout 10 
Moving Beyond Cravings 
1. Review coping skills for managing cravings (particularly thought record) 
2. Practice any coping skills that the patient is less confident in using. 
3. Create map of drinking (Handout 10). 
4. Identify other longer-term goals that will help the patient to create an 
abstinent lifestyle. Use the problem-solving steps to break these into 
small, achievable steps.   
Homework: 
• Work on identified goals from map, e.g. join club, talk to partner 
• Record their efforts and results to share next session.  
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Craving Module 
 
Detailed Sessions: 
 
 
 
 
• Session 1: Exploring Cravings & Urges 
 
• Session 2: Beating the Urge 
 
• Session 3: Unhelpful Thoughts 
 
• Session 4: Moving Beyond Cravings 
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Session 1 – Cravings & Urges 
 
 
Overview 
• Psychoeducation – differentiating between cravings and urges. 
• Identifying risk situations and triggers. 
• Short-term behavioural intervention – 3Ds. 
• Explore motivation to change and creating a visual reminder of this to 
help during cravings. 
 
Psychoeducation 
Cravings & Urges – What’s the difference? 
Craving: Desire to experience the positive effects of alcohol.  
Urge: Impulse to satisfy a craving. 
Psychoeducation about the time-limited, wave-like nature of 
cravings and our ability to ‘surf’ them.  
 
High-Risk Situations 
Discuss situations when strong cravings occur (high risk 
situations) – locations, people, emotional states, triggers etc 
(e.g. bars, smelling cigarette smoke, feeling down, etc). If 
appropriate, the therapist may wish to assist the patient to 
complete the handouts.  
 
Therapists should also encourage the patient to further identify 
high risk situations by recording when they experience a 
craving in the next week by completing Handout 3 for 
homework. 
 
Handouts 1 
and 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
Handout 3 
Behavioural Intervention 
• Discuss 3Ds – delay, distract, deep breaths – as 
methods for responding to cravings.  
• Teach patient deep breathing  
 
 
 
 
Handouts 4 
and 5 
Motivation to Change 
In exploring high risk situations and behavioural intervention, 
also discuss the patient’s reasons for changing (e.g. to improve 
relationship with family, to save themselves from a life-
threatening illness etc).  
 
For homework, encourage the patient to locate/create a visual 
reminder of this motivation/s (e.g. find photo of family, print off 
a picture or a phrase important to them) that they can carry 
with them as a reminder when cravings are strong. Discuss 
where the best location/s would be. 
 
 
Homework 
1. Monitor cravings throughout the week by filling out the 
Craving Diary (Handout 3). 
2. Practice deep breathing when relaxed. 
3. Remember 3Ds to ‘surf’ the cravings. 
4. Implement visual reminder of reason for abstinence. 
 
Handout 3 
 
Handout 5 
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Session 2 – Beating the Urge  
 
 
Overview 
• Review homework. 
• Clients explore existing coping skills.  
• Clients review effective problem solving steps to effectively manage 
cravings and urges. 
• Clients put together their Craving Management Plan to help them 
through the discomfort. 
 
Review 
Review the homework tasks (cravings diary) to reinforce the idea that the 
work outside of sessions is equally important as the sessions. Discuss what 
the patient learnt about their cravings from this experience – are there new 
triggers to add to the high risk situations sheet from last session? Did they use 
the 3Ds to respond to cravings? How did it go implementing the visual 
reminder? Did they practice deep breathing? How did it go for them? 
Troubleshoot any difficulties they had using the strategies. 
 
Resisting Cravings – Lessons Learnt from the Past 
A strengths-based discussion about how they’ve handled cravings in the past.  
 
Use Thoughts-Feelings-Behaviour to generate a T-F-B-T-F-B loop detailing 
the chain of events.  
 
“Firstly, think of a recent time when you had a craving or an urge to have a 
drink but didn’t have one. Tell me a bit about the situation”.  
“What was the first thing you noticed when you wanted a drink? Was it a 
thought, image or feeling in your body?”  
“How did that affect X? What did you notice about your X?” 
“What got you through?” 
“How did you change your thoughts?” 
“How did you change your actions?” 
“What skills did you use?” 
“What other things helped?” 
“Think of other recent times when you have managed a craving or an urge 
without drinking. Are there any other things that get you through?” 
 
NB. If the patient has never experienced a craving where they did not drink, 
explore other behavioural coping skills that the patient could use to resist 
cravings. For example, pleasant activity scheduling, identifying a list of things 
they can do to distract themselves, using imagery in combination with deep 
breathing (e.g. picturing themselves somewhere serene) etc.  
 
Exploring what works for the patient when they experience a craving involves 
problem-solving. You may wish to explain this to the patient as an introduction 
to information about problem-solving – it’s about finding what works (and is 
healthy) to assist them to manage the craving period until the wave subsides.  
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Problem Solving 
Explain the six steps involved in successful problem-solving.  
Firstly, think about a recent time when you faced a dilemma 
or problem. It could be a problem you are facing right now 
and you aren’t sure what to do.  
 
Six Problem-Solving Steps 
1) Define the problem 
You firstly need to be specific about the problem you are 
facing. Often you might have a worry that is made up of 
several problems. Separate them out. Think about the 
different parts of the problem and tackle each one at a time.  
 
2) Brainstorm solutions 
Think of all the possible things you could do to solve the 
problem. Bring them all up, even if they seem unlikely. The 
more possible solutions you have the better the chances of 
success. Thinking of what has worked when you faced similar 
problems in the past can help you brainstorm.  
 
3) Pros and cons of each solution 
Choose three of your possible solutions. Work through the 
pros and cons of each option to see which might be the best 
one. 
 
4) Choosing a solution and planning to put it into action  
Based on looking at the options more closely and doing the 
pros/cons, which option looks like it is most suited to the 
problem? Which option looks most likely to succeed? 
 
5) Doing it 
Think about other things you do day to day. What makes you 
more likely to complete tasks? Putting it in your diary, on a to-
do list, getting someone to check you’ve done it, telling a 
loved one? Use this knowledge to help you get the task 
completed.  
 
6) Reviewing the outcome 
Checking how it went is important. You can check what went 
well and what to change for next time. 
 
 
Handouts 6 
and 7 
Craving Management Plan  
Based on the previous work done on motivations for change, 
3Ds, problem-solving, and what’s worked for them in the past, 
the Craving Management Plan can be completed as a 
summary that the patient can take with them. 
Handout 8 
Homework 
1. Continue monitoring cravings, and practice using craving management 
plan  
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Session 3 – Unhelpful Thoughts 
 
 
Overview 
• Review homework. 
• Discuss the relationship between unhelpful thinking and cravings and 
urges.  
• Patient identifies their unhelpful thinking and has opportunity to 
challenge it. 
• Patient leaves with list of helpful thoughts to challenge their unhelpful 
thinking. 
Review  
Review how the patient went with abstinence this week, focusing especially 
on cravings and what worked (or did not) from their management plan. If 
necessary, discuss additional behavioural coping strategies.  
How our Thoughts can contribute to Drinking Behaviour 
Give a brief explanation of the CBT model – link between 
thought, feelings and behaviours, building on the concepts 
introduced in Session 2. Ask the patient to identify some of the 
thoughts they’ve had in the past that led to them giving in to 
craving, e.g. “I’ll stop at one”; “It’s a celebration!”; “It would be 
rude not to drink”; “It will help me sleep” etc. Try to create as 
comprehensive a list as possible (the therapist may need to 
prompt them with reminders about their high risk situations) 
and write the thoughts on the whiteboard. Explain that these 
are known as unhelpful thoughts because they lead to 
engaging in undesirable behaviour (i.e. drinking).  
 
Take the patient through the process of challenging their 
thinking – e.g. what evidence was there to support this 
thought? Did you stop at 1? Etc.  
Create a list of questions/ helpful thoughts that the patient can 
use to rebut their unhelpful thoughts. Use Handout 9 to create 
a list of unhelpful thoughts and their corresponding helpful 
thoughts (you probably won’t use the strength of craving 
columns). Alternately, the patient may prefer alternate 
reminders they can take with them and use in craving 
situations (e.g. a list for their wallet; a voice memo on their 
phone). Emphasise that this cognitive strategy is used in 
conjunction (not instead) with the behavioural strategies 
already discussed. For example, they could read the list, if that 
doesn’t work, go for a run. Or go for a run and listen to the 
voice memo of the list for the first 5 minutes while the craving 
occurs. Encourage creativity.  
 
Handout 9 
Homework 
1. Practice helpful thinking. Record thoughts and changes in strength of 
craving. 
2. Continue to use craving management plan. 
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Session 4 – Moving beyond Cravings 
 
Overview 
• Review homework.  
• Review the work achieved in the past 3 sessions, including reviewing the coping 
skills learnt for managing cravings. 
• Practice any coping skills that the patient is less confident in using. 
• Identify other longer-term goals that will help the patient to create an abstinent 
lifestyle. Use the problem-solving steps to break these into small, achievable 
steps.   
 
Homework Review 
Review unhelpful thinking handout from homework task. What has the patient learnt 
about how their thinking affects craving? Did writing down helpful thoughts reduce the 
strength of the craving? Did they use other behavioural coping strategies as well?  
Review of Craving 
Review what the patient has learnt about craving from the previous sessions. What 
behavioural coping strategies did they learn? Are they confident using these? Practice 
any coping strategies they are less confident using so they have several to choose from 
as they move into the next phase of treatment. 
Map of Drinking 
Assist the patient to create a map of factors that contribute to the patient 
drinking (see Handout 10 for template). This will be as simple or 
complex as the patient needs it to be, but keep in mind the 
biopsychosocial factors that contribute to the patient’s drinking. For 
example, the focus may remain on craving - immediate triggers, risky 
situations, emotional triggers, unhelpful thinking patterns. However, the 
patient may also be able to identify historical factors (e.g. victim of 
physical abuse as a child), genetic factors (e.g. father, grandfather both 
drank). 
 
Encourage the patient to identify the next area to work on in order to 
develop a lifestyle that is not conducive to drinking, for example, trying 
new activities to expand their social network. 
 
Use the problem-solving steps to break things down into small, 
achievable steps. Identify which ones the patient can do over the next 2 
weeks. This might involve working on several goals at once because 
some steps involve waiting, e.g. goal might be to join a karate club to 
make new friends; however, the patient has identified an obstacle which 
is that this costs money. In order to overcome this obstacle, the patient 
needs to work on their other goal of finding a job, so their homework 
task for this week might be to update their résumé and apply for two 
jobs, or go to a job centre etc. Create a short list of goals that the 
patient thinks they can achieve in the next fortnight. 
 
Handout 9 
Homework 
1. Work on identified tasks from the session.  
2. Write down efforts and results to share next session. May only be small progress, 
but still important to note it. 
